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High visceral adipose tissue (VAT), more so than subcutaneous adipose tissue, is associated 
with an increased risk of chronic disease and mortality. Following a higher quality diet is 
associated with lower VAT, and a reduced risk of death from all-causes, CVD, and cancer. 
This dissertation further explored the relationships between patterns of eating, VAT, and 
mortality through three distinct studies. Exploration of the Healthy Eating Index-2015 (HEI-
2015) scores among the Multiethnic Cohort (MEC) examined the association between HEI-
2015 scores and risk of all-cause and cause-specific mortality. A pilot study was conducted 
to determine the effects of intermittent energy restriction combined with a Mediterranean 
diet (IER+MED) compared to an active comparator, a euenergetic Dietary Approaches to 
Stop Hypertension (DASH) diet, on VAT reduction among East Asian American adults. 
Assessing the association between Healthy Eating Index-2010 (HEI-2010) scores, VAT and 
overall adiposity among a multiethnic adult population constituted the third study. These 
studies were completed using observational and interventional designs. For the HEI-2015 
study, the primary analysis was a survival analysis among MEC participants followed over 
a 17-22 y period. The IER+MED study was a randomized study where participants followed 
the prescribed diets over 12 weeks. The HEI-2010 study was cross-sectional and used DXA-
based VAT. Among the MEC sample, comparing those with the highest quality diets to 
those with the lowest quality, the reduction in risk of mortality from all-cause, CVD, and 
cancer was 21%, 24%, and 20%, respectively, for men and 21%, 25%, and 16%, respectively, 
for women. Those following the IER+MED had significantly larger reductions in DXA-
derived VAT and total fat mass (−22.6 ± 3.6 cm2 and −3.3 ± 0.4 kg, respectively) vs. DASH 
(−10.7 ± 3.5 cm2 and −1.6 ± 0.4 kg) (p = 0.02 and p = 0.005). For the HEI-2010 study, BMI, 
percent body fat, total body fat, trunk fat, insulin, and HOMA-IR were inversely related to 
HEI-2010 scores (all p values < 0.004). Findings from this dissertation support following a 
healthy dietary pattern is associated with lower VAT, and a reduced risk of mortality from 
all-causes, CVD, and cancer. In particular, IER+MED, may help to lower VAT and improve 
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CHAPTER 1. DISSERTATION OVERVIEW 
1.1 Introduction 
Approximately 133 million people in the US suffer from a chronic disease [1-4], and this 
number continues to increase [1]. Along with the high cost of managing these conditions, heart 
disease, cancer, chronic obstructive pulmonary disease, diabetes, and stroke are responsible 
for more than two-thirds of deaths in the US [1,4]. Diet, physical activity, and tobacco use are 
modifiable risk factors with the most considerable influence on chronic disease [5]. This 
dissertation will focus on the effect of diet on risk for chronic disease and mortality. 
Traditionally researchers studied the relationships between single foods or nutrients and 
health outcomes; however, diet is a complex mixture of foods and nutrients [6,7]. More 
recently there has been a shift to studying the relationship between dietary patterns, chronic 
disease, and mortality [6,7]. Dietary patterns take into account the synergistic effect of foods 
and nutrients on health [6,7]. Also, if the effect of foods consumed as part of a dietary pattern 
is cumulative, the impact on health outcomes may be more extensive and therefore, easier to 
detect [6,7]. There is substantial evidence demonstrating the beneficial effects of the 
Mediterranean-style (MED) diet, the Dietary Approaches to Stop Hypertension (DASH) diet, 
and patterns of eating recommended by the Dietary Guidelines for Americans (DGA)[8-11]. 
Each of these dietary patterns have unique features and close adherence to each has been 
associated with a reduced risk of mortality from all-causes, cardiovascular disease (CVD), and 
cancer [12]. 
The relationships between diet quality and risk of chronic disease morbidity or mortality 
have been examined across interventional and observational studies [11]. In order to score 
compliance to the MED diet, DASH diet, and the DGA, a priori, or theoretically based scoring 
systems have been developed [8-10]. For this dissertation, the a priori index of focus is the 
Healthy Eating Index (HEI), in particular, the Healthy Eating Index-2010 (HEI-2010), and 
Healthy Eating Index-2015 (HEI-2015), which score adherence to the DGA 2010, and the DGA 
2015-2020, respectively [9,13]. Given the relatively recent release of the HEI-2015, there are 
limited studies that have used this index. This dissertation examined the relationships 
between HEI-2015 scores, and risk of all-cause, CVD, and cancer mortality, which will 
contribute to the evidence base of this most recent translation of the DGA. 
Studying visceral adiposity has become a research priority, as higher levels of visceral 
adipose tissue (VAT) are associated with greater risk of CVD [14], type 2 diabetes [15,16], 
certain cancers [17-19] and mortality [20-22]. Determinants of VAT include age [23-25], sex 
[23,25,26], physical activity [23,27], ethnicity [23,25], alcohol intake [28], and diet [23,29-31]. 
With advancing age, there are increases in VAT for both men and women across ethnic groups 
[24]. In regards to ethnicity, ethnic/racial heterogeneity, has been found to influence the 
propensity for VAT storage over subcutaneous adipose tissue (SAT) [32,33]. Higher diet 
quality has been shown to be inversely related to VAT and researchers have also reported 
higher intakes of medium-chain triglycerides, dietary fiber, calcium, and phytochemicals 
being associated with reduced VAT levels [29,30]. 
There is limited research on the effect of following the MED diet, DASH diet, and dietary 
patterns derived from the DGA on VAT levels. However, studies in this area demonstrate that 
following any of these patterns more closely is inversely related to VAT levels [30,34,35]. 




to reduce body fat and insulin resistance [36,37]. IER includes periods of marked energy 
restriction on at least one day (typically 60–75% below estimated energy requirements) but no 
more than six days per week, interspersed with periods of regular or ad libitum energy intake 
[38-42]. This dissertation will explore the association between HEI-2010 scores and VAT, and 
the effect of IER combined with a MED (IER+MED) diet vs. an active comparator (a 
euenergetic DASH diet) on reducing VAT. This dissertation does not cover validation of 
compliance to the MED or DASH diets. 
 
1.2 Problem Statement  
Closer adherence to the MED diet, DASH diet, and dietary patterns derived from the 
DGA is associated with a reduced risk of morbidity and mortality from chronic disease in the 
US [12]. A prori indices are among methods used in research to demonstrate this reduced risk 
[6]. As new a priori indices are introduced, to correspond with updates to dietary guidelines, 
these indices need to be tested to ensure prediction of health outcomes [9,13]. 
High VAT is a risk factor for chronic disease morbidity and mortality [14,34]; however, 
there are no known clinical guidelines for preventing or managing VAT. There is also limited 
research assessing the relationship between diet quality and VAT. Therefore, further research 




Objective 1: Examine the association between the HEI-2015 and mortality from all-causes, 
CVD, and cancer in the Multiethnic Cohort (MEC), which represents a large cohort of adult 
men and women representing five distinct ethnic groups residing in Hawaii and Los Angeles 
(LA). 
 
Objective 2: Demonstrate the feasibility to conduct an intermittent energy restriction 
combined with a MED (IER+MED) diet vs. an active comparator (a euenergetic DASH diet) 
randomized interventional pilot study to reduce VAT among East Asian Americans in 
Hawaii; evaluate study retention and protocol adherence, and explore the differences between 
IER+MED and DASH diet groups with regard to total adiposity and metabolic risk 
biomarkers. 
 
Objective 3: Examine the cross-sectional association between diet quality (HEI-2010 
scores) and DXA-based VAT, overall adiposity, and blood-based biomarkers of metabolic risk, 
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CHAPTER 2. LITERATURE REVIEW 
This literature review will explore methods for assessing dietary intake data to establish 
quantitative estimates of nutrients and foods, examine the influence of dietary patterns in 
interventional and observational studies, and summarize key study designs and outcome 
measures used to quantify the effect of dietary patterns on health outcomes. The aim of this 
review is to provide essential background information and rationale for conducting the 
three research studies making up this dissertation. 
2.1 Methods of Assessment to Quantify Dietary Intake  
This section will concentrate on methods of collecting self-reported dietary intake at the 
individual level for use in group-level analyses in a research study. Collecting information on 
foods and beverages consumed allows researchers to assess the relationship between dietary 
intake and health. Assessment methods covered include; dietary records (with focus on the 
mobile food record (mFR™)), 24-hour dietary recall, and food frequency questionnaire (FFQ). 
Greater detail will be provided on the mFR™ and FFQ as these methods were used to collect 
dietary data in research studies comprising this dissertation.  
Traditional dietary records provide detailed descriptions of food and beverages 
consumed and allow for assessment of usual diet in research studies [1]. Participants are 
trained to record (and sometimes weigh) intakes of food and beverages in real-time [2], and 
add detailed information on brands, ingredients, portion size, and cooking preparation 
methods [3]. Consequently, participants must be highly motivated and literate [3]. This 
potential for selection bias may limit the generalizability of research results to the general 
population [3]. Theoretically, completing dietary records in real-time reduces the reliance on 
memory to recall foods eaten [3]. However, if participants forget to record a food or beverage 
consumed, intake is recorded retrospectively [3]. On completion, a trained interviewer should 
review dietary records to check for completeness and probe for missing food items [4].  
The level of detail and diversity of dietary data collected is a strength of the dietary 
record. A limitation of this assessment method is reactivity bias [5]. For example, recording 
foods consumed in real-time may increase participants’ self-awareness of their intakes and 
influence their eating behaviors [5]. Therefore, dietary records may not be representative of a 
participant’s regular diet [5]. However, this reactivity bias may be beneficial in studies where 
the goal is behavior change (e.g., weight loss studies) [6]. Underestimation of energy from 
dietary records has been reported to be approximately 18% to 37% among adult men and 
women [7-10]. Under-estimation of energy intake from dietary records is known to be higher 
for women [11] and people with a higher BMI [11,12], which may be due to dieting behaviors 
among these groups [13]. Another limitation of dietary records is the time and cost required 
to train study staff to code and enter dietary data into a nutrient database [3].  
Advances in technology have led to the development of image-based methods for 
collecting dietary records, including the mFR™ [9,14-16]. These advanced technologies may 
help reduce the user and technician burden, cost, and improve the accuracy of dietary records 
[1,2]. The mFR™ is designed to capture images of foods/beverages before and after (to record 
waste) each eating occasion and allows for automatic uploading of images to a secure cloud-
based server when in 3G/4G/Wi-Fi range [9,14-16]. The mFR™ app can be loaded onto a 
participant’s mobile device or a study mobile device [17,18]. Participants are trained on how 




dimensions and colors) to include in images [9,16]. Images from the mFR™ can be reviewed 
in person or remotely via the cloud-based server [17,18]. 
Unlike traditional methods, when participants use the mFR™, there is no need to weigh 
and write down details of food and beverages consumed. Removing these tasks may help 
improve the usability of dietary records [9,16], and allows groups with lower literacy to 
participate in the research (e.g., children [19], people with Down syndrome [20]). Under-
reporting of energy intake using the mFR™ has been reported as 12% and 10% for adult men 
and women, respectively, which is comparable to traditional dietary records [9]. Portion size 
and identification of food and beverages in images is conducted manually by a trained staff 
or automated methods [21]. Limitations of the mFR™ include; participants need to remember 
to take before and after eating images, include the fiducial marker in each image, and take 
high-quality images (e.g., not blurry) [16,22]. 
Other dietary records include; wearable cameras, handheld digital cameras, and mobile 
apps with additional details on food and beverages consumed added by text or audio by 
participants [22]. These dietary record methods were not used in this dissertation. 
The FFQ estimates daily intakes over a more extended time, e.g., past week, month, or 
year [23,24]. FFQs vary in length (e.g., ~100 to 200 questions). Participants select foods 
consumed from the listed food items, and in the case of a quantitative FFQ, the participants 
also select the frequency the food was consumed [3]. The foods listed can be single food items 
(e.g., beans), or mixed dishes (e.g., chili) [3]. In general, FFQs collect less detailed information 
than other assessment methods (e.g., 24-hour recalls and dietary records). Given this, FFQs 
are generally more appropriate for ranking participants according to food or nutrient intakes 
rather than estimating actual intakes [3]. However, if a FFQ is designed to assess total diet, it 
will generally list a higher number of food and beverages, with additional questions on 
portion size [3]. Due to the finality of items listed in a FFQ, the food and beverages listed need 
to be appropriate for the target population being assessed [25,26]. For example, the FFQ used 
for the Multiethnic Cohort study (MEC) was developed and validated for five ethnic groups; 
i.e., white, African American, Japanese American, Latino and Native Hawaiian [27]. The FFQ 
must also align with food and beverages listed in a nutrient database to allow for accurate 
analysis of the questionnaire [3,27]. For the MEC, an ethnic-specific food composition 
database was developed to allow for analysis of FFQ data [27]. 
Compared to other dietary assessment methods, FFQs are relatively simple, cost-efficient, 
and time-efficient to administer and analyze [3,24]. For example, most FFQ are self-
administered either electronically or by paper-and-pencil, and completed FFQs can be 
scanned electronically for analysis [3,28,29]. Consequently, a FFQ is ideal for large 
epidemiology studies [24,29]. Limitations of the FFQ include this method relies heavily on 
cognitive ability to recall foods consumed, and is associated with significant measurement 
error [3]. FFQs have been found to under-report energy intake by up to 36% in adults [3,30-
33]. This measurement error can be reduced by handling missing data appropriately, 
adjusting for energy intake, and regression-calibration [2,27,34-36]. 
The 24-hour dietary recall is used to assess total diet, and asks participants to recall 
everything eaten in the previous 24 hours [3]. This assessment method can be interviewer-
administered, and interviewers need to be highly trained to probe for additional details (e.g., 
brands, ingredients, preparation methods, time consumed), and missing food items [37,38]. 
The most advanced interview-administered 24-hour dietary recall method in the US is the US 




Alternatively, 24-hour recalls can be administered electronically, e.g., using the Automated 
Self-Administered 24-hour dietary recall (ASA24) [41]. Research has found that results from 
the AMPM and the ASA24 are comparable, but which assessment tool is used is dependent 
on the research study design [42]. If participants have higher literacy, including computer 
literacy, the ASA24 would be an appropriate tool. For those with lower literacy, the AMPM 
may be more suitable as an interviewer can record details provided by the participant [3]. For 
larger studies, the ASA24 may be more appropriate as responses are automatically coded on 
entry; whereas, responses from the AMPM require manual coding and entry [3]. 
Similar to dietary records, for the 24-hour recall, women, and people of higher BMI tend 
to have higher under-reporting [13,43,44]. Under-reporting of energy intake with 24-hour 
recalls ranges from 3-34% among adults [3,30,40,44]; however, adjusting for energy intake 
helps to correct for this error [43]. 
In this dissertation, collection of dietary data using the mFR™ and FFQs allowed for diet 
as an exposure to be analyzed.  
 
2.2 Examining Diet Using Dietary Patterns 
Traditionally researchers studied the relationship between single foods or nutrients and 
estimated health outcomes; however, diet is a complex mixture of foods and nutrients [45,46]. 
More recently there has been a shift to studying dietary patterns as an exposure [45,46]. 
Dietary patterns take into account the synergistic effect of foods and nutrients on health 
[45,46]. Also, if the effect of foods consumed as part of a dietary pattern is cumulative, the 
impact on health outcomes may be larger and therefore, easier to detect [45,46]. An example 
of a dietary pattern is the Mediterranean (MED) diet. The MED diet represents the traditional 
food habits of individuals living around the Mediterranean Sea [47,48]. It is primarily a plant-
based diet rich in olive oil, olives, fruits, vegetables, whole grains, legumes and nuts with 
moderate amounts of dairy products (principally cheese and yogurt), fish, poultry, red wine, 
and limited amounts of red meat [47-49]. Other dietary patterns explored as exposures in this 
dissertation are the Dietary Approaches to Stop Hypertension (DASH) diet [50,51], patterns 
derived from the Dietary Guidelines for Americans (DGA) 2010 [52] and the DGA 2015-2020 
[47], and intermittent energy restriction (IER) [53].  
Diet indices are one method used to measure compliance to following dietary patterns 
[46,54-56]. This dissertation incorporated a priori diet indices, which are theoretically driven 
dietary patterns [45,46]. These include the Healthy Eating Index-2010 (HEI-2010)[56], and the 
Healthy Eating Index-2015 (HEI-2015)[57], which score compliance to the DGA 2010 and the 
DGA 2015-2020, respectively. Also, a priori indices for the DASH diet and the MED diet will 
be discussed as the MED and DASH diets were used as dietary guidance in research that 
makes up this dissertation. Alternative methods for assessing dietary pattern exposures, not 
adopted in this dissertation, include data-driven indices (predominantly through cluster 
analysis, principal component, factor analysis, or reduced rank regression) [46,58-61]. 
As the MED diet represents the food habits of individuals in the Mediterranean region, it 
is not a single eating pattern, but a style of eating [48,52,62]. The Lyon Diet Heart Study and 
the Prevención con Dieta Mediterránea (PREDIMED) cohort are the only two long-term 
intervention studies providing evidence on the health benefits of the MED diet [49,63-65]. In 
the Lyon Diet Heart Study, participants were randomized to a Western-style diet or a 
Mediterranean-style diet for 104 weeks [49,65,66]. The study was stopped early because 




the control group (the Western-style diet) [49,64]. In the PREDIMED study, participants were 
randomized to a MED diet supplemented with extra virgin olive oil, a MED diet 
supplemented with nuts, or to the control group following a low-fat diet [63,64]. The 2018 
reanalysis of the PREDIMED study demonstrated that the MED groups had a significantly 
lower risk of stroke, myocardial infarction, and cardiovascular disease (CVD) mortality, 
compared to the control group [63].  
Many a priori dietary patterns have been used in observational studies to assess 
compliance to the MED diet, the most common being the MDS developed by Trichopoulou et 
al. [67,68], and the Alternative Mediterranean diet (aMED) score [69,70]. The MDS has nine 
components including; vegetables, fruits and nuts, legumes, fish and seafood, meat and meat 
products, cereals, dairy products, moderate alcohol intake, and the ratio of MUFA to SFA [67]. 
Scores range from 0-9 points, with higher scores representing diets more in line with the 
traditional MED diet [67]. The aMED score is similar to the MDS; however, was adapted for 
use among the US population [69,71]. Consistently, observational studies employing these 
diet indices have reported greater adherence to a MED diet being associated with a significant 
reduction in risk of CVD, morbidity, or mortality [72,73]. This evidence has led to the MED 
diet being one of the recommended healthy dietary patterns for the US population to follow 
in the 2015-2020 DGA [47]. The MED diet is promoted for the management of non-alcoholic 
fatty liver disease (NAFLD) in joint clinical practice guidelines issued by the European 
Associations for the Study of Liver (EASL), Diabetes (EASD) and Obesity (EASO) [74]. Also, 
the MED diet may help to reduce other ectopic fat stores, including visceral adipose tissue 
(VAT) [75,76]. This research area will be explored in Chapter 4. 
The DASH diet is rich in fruit, vegetables, low-fat dairy products, whole grains, poultry, 
fish, and nuts, and limits total fat, saturated fat and sodium, and is recommended by the 
American College of Cardiology and the American Heart Association for the reduction of low-
density lipoprotein (LDL) and blood pressure [50,51,64,77]. Intervention studies have shown 
following the DASH diet is associated with decreased systolic and diastolic blood pressure, 
total cholesterol, LDL, HbA1c, fasting blood insulin, and body weight [78]. The effect of DASH 
on blood pressure may be greater when sodium is restricted [50], or when the macronutrient 
composition is altered (e.g., higher protein, or higher ratio of unsaturated fat) [79]. DASH has 
proven to be helpful for normotensive people; however, it may have a more significant effect 
on lowering blood pressure in people with hypertension [50]. Like the MED diet, the DASH 
diet is recommended as a healthy dietary pattern in the 2015-2020 DGA [47]. Across 
prospective cohort studies DASH is associated with decreased risk of CVD, coronary heart 
disease, stroke, and diabetes [78]. An a priori DASH index is one method used to obtain these 
findings [80]. There are multiple versions of the DASH index; however, the DASH index by 
Fung and colleagues is the version used in the Dietary Patterns Methods Project (DPMP); 
therefore, relevant to this dissertation [80,81]. The DASH index by Fung and colleagues is 
based on eight food and nutrients components that make up the DASH diet [80]. A higher 
DASH score is achieved by greater intakes of fruits, vegetables, nuts and legumes, whole 
grains, low-fat dairy, and by consuming less sodium, red and processed meats, and sweetened 
beverages [80]. To add to the evidence for using dietary patterns to guide dietary advice, the 
National Cancer Institute (NCI) initiated the DPMP [83,84]. The DPMP is a collaborative 
project between three large cohort studies, including the NIH-AARP Diet and Health Study 
(AARP) [85,86], the Multiethnic Cohort Study (MEC) [29,87], and the Women’s Health 




complementary research questions and have conducted a standardized diet analysis using 
four dietary indices, including DASH [84]. Results from the DPMP highlighted greater 
adherence to DASH was consistently associated with a reduced risk of death due to all-causes, 
CVD, and cancer compared to those with the lowest adherence to the diet [84].  
The DGA are evidence-based guidelines that guide all federally funded nutrition 
programs in the US [47,90], including; food policies, food assistance programs, and education 
programs [90]. The DGA were first released in 1980, and a federal mandate specifies updates 
every five years [90]. In 1995, an a priori index, the HEI, was introduced to assess compliance 
to the DGA recommendations [91]. To match updates to the successive dietary guidelines, the 
NCI developed the HEI-2005 [92], HEI-2010 [56], and HEI-2015 [57]. These indices have 
provided a tool to evaluate the strength of the DGA recommendations [57]. The HEI-2015 
consists of 13 components, and the maximum HEI score is 100 points [57]. There are nine 
adequacy components (foods to eat enough of) including Total Fruits, Whole Fruits, Total 
Vegetables, Greens and Beans, Whole Grains, Dairy, Total Protein Foods, Seafood and Plant 
Proteins, and Fatty Acids [57]. There are four moderation components (foods to limit), 
including Refined Grains, Sodium, Added Sugars, and Saturated Fats [57]. The Alternate 
Healthy Eating Index (aHEI) is an adaption of the original HEI developed by McCullough and 
colleagues in 2002 [93], and later updated by Chiuve and colleagues in 2012 [94].  
A systematic review and meta-analysis, with all HEI versions up until the HEI-2010, 
found that people with the highest diet quality (highest HEI scores) were at significantly lower 
risk of all-cause mortality, CVD, cancer, type 2 diabetes, and neurodegenerative disease [81]. 
This systematic review included subgroup analyses with the different versions of the HEI, 
and found that the inverse association between HEI scores and cancer incidence was only seen 
for the HEI-2005 and HEI-2010 versions [81]. This may be due to the scoring differences 
between these HEI indices (e.g., the original version of the HEI did not score refined and 
unrefined grains separately) [81]. Given the relatively recent release of the HEI-2015, there are 
limited studies that have used this index to assess the relationship between diet quality and 
health outcomes. Research evaluating the predictive validity of the HEI-2015 will be covered 
in Chapter 3 of this dissertation.  
IER is an emerging pattern of eating that is becoming more widely studied [53,95,96]. IER 
includes periods of marked energy restriction on at least one day (typically 60–75% below 
estimated energy requirements) but no more than six days per week, interspersed with 
periods of regular or ad libitum energy intake [53,97-100]. Harvie et al. suggested combining 
two consecutive days of IER with five days of a MED type diet (IER+MED) to promote satiety 
and high-quality nutrition [95]. Long term adherence to daily energy restriction, also known 
as continuous energy restriction (CER), is known to be challenging [101]. Therefore, IER was 
developed as an alternative method of energy restriction for weight loss and to help optimize 
health outcomes [53,101]. Currently, there is no a priori index to measure compliance to IER. 
However, total energy restriction and percentage energy from macronutrients can be used to 
measure compliance with dietary prescriptions during IER interventions [95]. IER, as a 
method for reducing visceral adiposity, will be discussed in this dissertation in Chapter 4.  
 
2.3 Quantifying the Effect of Dietary Patterns on Health Outcomes 
In order to explore the merits of dietary patterns, multiple study designs, and multiple 




dissertation to assess the relationship between diet quality, VAT, and risk of mortality will be 
the focus of this section.  
The MEC is a prospective cohort study. MEC was used in this dissertation to assess 
whether diet quality (HEI-2015 scores) influenced the risk of mortality over a 17-22 y follow-
up. Cohort studies are one of the strongest study designs to help minimize bias and infer 
causality between dietary patterns and mortality [102]. Cohort studies generally enroll people 
who are disease-free at baseline, assess baseline measures, and follow the participants over 
time until an event of interest; e.g., death [3]. A limitation of using cohort studies is that they 
are time and resource-intensive to administer due to the large sample size required and study 
duration [3].  
The Healthy Diet and Lifestyle Study (HDLS) intervention, detailed in Chapter 4 of this 
dissertation, adopted a randomized active comparator design. Intervention studies generally 
take measures across at least two periods (e.g., baseline and the end of the intervention) and 
are useful for demonstrating the effect of diet on change in health outcomes [3]. Randomized 
control trials are the gold standard intervention study design [103]. In order to reduce attrition 
and to ensure all participants receive some treatment of care, a randomized active comparator 
study can be used [104,105]. For active comparator designs, the comparison group is assigned 
a diet that is known to be beneficial but is different from the primary intervention diet 
[63,104,105]. In HDLS, the healthful diet assigned to the active comparator group was a 
euenergetic DASH diet. 
The analysis of Shape Up! Adults, detailed in Chapter 5 of this dissertation, was a cross-
sectional study. Cross-sectional studies can be used to describe population characteristics, for 
surveillance, evaluate adherence to dietary guidelines, and to examine the association 
between diet and disease [3]. In a cross-sectional study, measurements are collected on a 
group of participants at a single point in time [3]. This study design is relatively fast and 
inexpensive because of the one-time measurement of exposure and disease [106]. Measuring 
diet and disease at the same time is also a limitation as there is no temporality [106]. 
Consequently, causality between an exposure and health outcomes can not be determined by 
cross-sectional studies [106]. However, information provided from cross-sectional studies is 
useful for planning cohort and intervention studies [106], and these studies can used to 
support causality between diet and disease [3,107].  
Anthropometric methods are commonly used in nutrition research, as they are relatively 
inexpensive and simple to administer [108]. In the MEC HEI-2015 study, anthropometric data 
were used to calculate and control for BMI in mortality analyses. In HDLS and the Shape Up! 
Adults study, anthropometric measures were used to assess the effect of dietary patterns on 
health outcomes.  
In order to collect accurate anthropometric measures, the International Society for the 
Advancement of Kinanthropometry (ISAK) protocols should be followed [109,110]. In the 
literature, anthropometric measures used as predictors of VAT include waist hip ratio, BMI, 
waist circumference [111,112], and more recently, the waist-to-height ratio (WHtR) [112]. 
Using a combination of both BMI and waist circumference is the most accepted method to 
approximate VAT [113]. In research assessing the association between dietary patterns and 
VAT, waist circumference has most commonly been used as the surrogate measure of VAT 
[75]. It has been noted that VAT correlates more strongly with waist circumference in men vs. 
women adults, and white vs. Asians [114]. These differences need to be taken into 




DXA is a laboratory-based method used to measure VAT, and was the method adopted 
in both the HDLS and Shape Up! Adults study. Magnetic resonance imaging (MRI) and 
computed tomography (CT) are considered the “gold standard” for measuring VAT, 
[111,115,116]; however, with advances in DXA, DXA-based VAT has become an acceptable 
measure [75]. Both MRI and CT provide high-resolution cross-sectional scans and measures 
of SAT, VAT, bone, muscle, and viscera [109,117]. MRI does not expose participants to 
radiation; however, they are expensive and take a relatively long time to perform [109,117]. 
CT scans do expose participants to radiation; therefore, they are not suitable for children and 
pregnant women [109,117]. New DXA-based methods of measuring VAT strongly correlates 
with CT and MRI and can be performed more efficiently and with a low exposure of radiation 
to both the participant and examiner [116,118]. After the DXA scan, software allows for the 
calculation of VAT [118]. For example, VAT in the L4-L5 region can be estimated by 
calculating the difference between total body fat and subcutaneous adipose tissue (SAT) [118]. 
The limitation of this method is DXA can underestimate VAT in lean individuals and 
overestimate VAT in individuals with high VAT levels [118,119]. Experts encourage the 
continued use of DXA-based measures in VAT research [75]. 
VAT is a biomarker for risk of CVD, type 2 diabetes, certain cancers, and mortality [120-
125]. A biomarker is a measure of normal biological processes, and can be used to measure 
biochemical or physiological response, the clinical endpoint, or risk of the clinical endpoint 
[126]. In HDLS and the Shape Up! Adults study, VAT was used to estimate the effect of dietary 
patterns on health outcomes. Biomarkers should be relatively easy and non-invasive to obtain, 
and they are useful to show the short term effect of an intervention [126]. In the case of VAT, 
researchers can monitor change in VAT over a shorter time frame, versus following 
participants until the onset of disease/death [76,127]. Often it is better to use more than one 
biomarker to provide a more thorough assessment [126]. For example, in addition to VAT, 
other biomarkers of metabolic dysfunction monitored in HDLS and Shape Up! Adults 
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The Healthy Eating Index-2015 (HEI-2015) was created to assess conformance of dietary 
intake with the Dietary Guidelines for Americans (DGA) 2015–2020. We assessed the 
association between the HEI-2015 and mortality from all-cause, cardiovascular disease 
(CVD), and cancer in the Multiethnic Cohort (MEC). White, African American, Native 
Hawaiian, Japanese American, and Latino adults (n > 215,000) from Hawaii and California 
completed a quantitative food-frequency questionnaire at study enrollment. HEI-2015 scores 
were divided into quintiles for men and women. Radar graphs were used to demonstrate 
how dietary components contributed to HEI-2015 scores. Mortality was documented over 
17–22 years of follow-up. Hazard ratios (HRs) and 95% confidence intervals (CIs) were 
computed using Cox proportional hazards models. High HEI-2015 scores were inversely 
associated with risk of mortality from all-cause, CVD, and cancer for men and women (p-
trend <0.0001 for all models). For men, the HRs (CIs) for all-cause, CVD, and cancer 
comparing the highest to the lowest quintile were 0.79 (0.76, 0.82), 0.76 (0.71, 0.82), and 0.80 
(0.75, 0.87), respectively. For women, the HRs were 0.79 (0.76, 0.82), 0.75 (0.70, 0.81), and 0.84 
(0.78, 0.91), respectively. These results, in a multiethnic population, demonstrate that 
following a diet aligned with the DGAs 2015–2020 recommendations is associated with lower 
risk of mortality from all-cause, CVD, and cancer. 
 
3.2 Introduction 
Dietary pattern analysis is a relatively new method to quantify diet quality, monitor 
changes in population-based diet quality, and assess the relationships between diet quality 
and health-related outcomes [1–4]. Analyses of individual nutrients and foods are still 
important; however, as we consume foods in combination, the synergistic effect of food on 




dietary recommendations in the form of patterns, which may be easier for the general public 
to interpret and follow [5].  
Dietary indices are important tools used to assess dietary patterns. They may be derived 
from theoretically based scoring systems or a priori approaches, which are guided by 
evidence-based research [2]. For example, the Healthy Eating Index (HEI) is constructed to 
reflect the evidence-based recommendations of the Dietary Guidelines for Americans (DGA) 
and to evaluate conformance to these recommendations [6–9]. Every five years the Dietary 
Guidelines Advisory Committee reviews current nutrition research and provides an Advisory 
Report to the United States Department of Agriculture (USDA) and Health and Human 
Services (HHS) [4,10]. Guided by this report, the USDA and HHS publish the Dietary 
Guidelines for Americans (DGA), which provide evidence-based food and beverage 
recommendations to the public [4,10]. Since the implementation of the original HEI in 1995, 
development and application of successive HEIs to assess and monitor dietary status have 
been ongoing [3,6,11]. The HEI-2005 introduced density-based scoring standards, which were 
continued in the HEI-2010 and HEI-2015. Additional changes to scoring standards were 
implemented between each new HEI to reflect updates in the DGA [3,12,13]. 
To add to the evidence for using dietary patterns to guide dietary advice, the National 
Cancer Institute (NCI) initiated the Dietary Patterns Methods Project (DPMP) [13–15]. This is 
a collaborative project between three large cohort studies, including the NIH-AARP Diet and 
Health Study (AARP) [16,17], the Multiethnic Cohort Study (MEC) [18,19] and the Women’s 
Health Initiative Observational Study (WHI-OS) [20,21]. These groups adopted overlapping 
and complementary research questions and conducted standardized diet analysis using four 
dietary indices, including the HEI-2010, the Alternative Healthy Eating Index-2010 (AHEI-
2010), the alternate Mediterranean Diet (aMED), and the Dietary Approaches to Stop 
Hypertension (DASH) [15]. A summary of the results revealed that men and women with 
higher quality diets (higher index scores) were at significantly lower risk (11–28%) of death 
from all-causes, cardiovascular disease (CVD), and cancer compared to people with lower 
quality diets (lower index scores) [15]. This was true for mortality assessments made with each 
dietary index, with the exception of women from the WHI-OS cohort, where the AHEI-2010 
score was not associated with cancer death [15]. 
The HEI-2015 was introduced to reflect the DGA 2015–2020 [12]. The HEI-2015 is 
comprised of 13 components and the maximum HEI score is 100 points [12]. There are nine 
adequacy components (foods to eat enough of) including Total Fruits, Whole Fruits, Total 
Vegetables, Greens and Beans, Whole Grains, Dairy, Total Protein Foods, Seafood and Plant 
Proteins, and Fatty Acids. There are four moderation components (foods to limit) including 
Refined Grains, Sodium, Added Sugars, and Saturated Fats. Most components are scored on 
a density basis, that is, amounts per 1000 kcal of intake [12]. The Fatty Acids component is 
scored using the ratio of poly- and mono-unsaturated fatty acids (PUFAs and MUFAs) to 
saturated fatty acids (SFAs), and Added Sugars and Saturated Fats are scored as a percentage 
of total energy intake. The key differences between the HEI-2010 and the HEI-2015 include 
the scoring for legumes and the Empty Calories component. In the HEI-2010, legumes were 
allocated into two components and have expanded into four components with the HEI-2015, 
including Total Vegetables, Greens and Beans, Total Protein Foods, and Seafood and Plant 
Proteins [12]. In the HEI-2015, the Empty Calories single component was replaced with the 




Empty Calories component score; instead, the energy (kcal) from alcohol is now added to the 
total energy intake per day [12].  
To assess the efficacy of the new HEI score, the AARP, MEC, and the WHI-OS each 
completed a standardized mortality assessment using the HEI-2015. The aim of this study is 
to examine the association between the HEI-2015 and mortality from all-cause, CVD, and 
cancer in the MEC, which represents a large cohort of adult men and women from five distinct 
ethnic groups residing in Hawaii and Los Angeles (LA). 
 
3.3 Methods 
3.3.1 Study Population 
The MEC is a large prospective cohort study developed to investigate the relationship 
between diet and health-related outcomes among African American, Latino, Japanese 
American, Native Hawaiian, and white men and women [18]. Hawaii and the LA basin have 
large multiethnic populations; therefore, participants were recruited from these areas between 
1993 and 1996. A detailed report of the MEC study design and implementation has previously 
been published [18]. Briefly, inclusion criteria were men or women, 45–75 years and living in 
Hawaii or LA at cohort entry. Driver’s license files were the primary resource used to identify 
potential participants. Secondary resources included voter registration and Medicare files. 
The final sample included over 215,000 individuals, who identified as African American 
(16.2%), Latino (21.2%), Japanese American (26.4%), Native Hawaiian (6.7%), white (23%) or 
other ancestry (6.5%). Socio-demographic, anthropometric, health history, physical activity 
and dietary intake information were collected at cohort entry using a 26-page self-
administered questionnaire (Qx1). The institutional review boards at the University of Hawaii 
and the University of Southern California approved the study. 
 
3.3.2 Dietary Assessment and Calculation of the Healthy Eating Index-2015 (HEI-2015) 
All participants were provided with the Qx1 written in English, and Latinos were 
provided English and Spanish language versions [18]. A detailed description of the 
development and validation of the Qx1 is published elsewhere [18,22]. The Qx1 included a 
quantitative food-frequency questionnaire (QFFQ), developed to be suitable for the five main 
ethnic groups in the study [18]. The QFFQ was validated and calibrated in each ethnic-sex 
group [22]. Dietary intake over the last year was assessed using 182 questions. Questions were 
grouped into key categories, e.g., meats, bread items, and alcoholic and other beverages. The 
frequency of consumption was assessed using ordinal categories ranging from “never or 
hardly ever” to “4 or more times a day”. Serving sizes were also assessed using categories 
with the format varying by food. Images of different portion sizes were provided to help 
participants estimate the serving size of some food items, e.g., stir-fried beef. For other food 
items, three different written serving size options were provided without images, e.g., ½ hot 
dog, 1 hot dog, 2 hot dogs or more. A customized multiethnic food composition database was 
developed for the MEC [18,19,23]. This database was used to calculate food groups according 
to the MyPyramid Equivalents Database (MPED) [24,25]. The MPED is a system developed 
by the USDA to help researchers examine dietary data in terms of MyPyramid food groups 
(e.g., total vegetables, added sugars). Dietary intakes using the MyPyramid food groups were 
calculated from the QFFQ by summing each participant’s daily servings across the food items. 




program code to calculate HEI-2015 scores was created specifically for the DPMP by the NCI 
to insure harmonization in coding across the cohorts participating in the DPMP project [14]. 
3.3.3 Healthy Eating Index-2015 (HEI-2015) Scoring 
The HEI provides a score for diet quality and not diet quantity. For example, the index 
can provide information on the quality of the food consumed, but not whether an individual 
is meeting his or her nutrient requirements [13]. A quality versus quantity approach was 
chosen because it allows for the comparison of scores between age and sex groups [13]. An 
overview of HEI-2015 components and scoring standards can be found in Table 3.1. The HEI-
2015 aligns with and reflects the changes between the 2010 DGA and 2015–2020 DGA [12]. 
The HEI-2010 and HEI-2015 have the following features in common: adequacy and 
moderation components, the same adequacy components, most components scored on a 
density basis, and standards for recommendations based on the least restrictive standards, 
e.g., least restrictive sodium recommendations [12]. As previously mentioned, scoring 
standards for legumes and the Empty Calories component have changed. Also, energy from 
alcohol consumed is now added to total energy intake per day for HEI-2015, which is used as 
the denominator for density values. This change results in a lower HEI-2015 score for an 
individual who consumes alcohol compared to an individual with the same diet who does 
not. For example, for the Total Fruits component, computed as (Total Fruits in cup equivalents 
per day/energy intake per day) × 1000 kcal) [13], will have a larger denominator for the 
individual who consumes alcohol, thereby decreasing the Total Fruits component score and 
HEI-2015 score.  
To achieve the maximum HEI-2015 score of 100 points, an individual would need to score 
maximum points on all components. For each component, intakes closer to the DGA 
recommendations increase the score. Therefore, to achieve a perfect HEI-2015 score, 
individuals need to have a high intake of foods that count toward the adequacy components 
and a low intake of foods that count toward moderation components (moderation 
components are scored inversely). Scores between the minimum and maximum standards for 





















Table 3.1 Healthy Eating Index-2015 (HEI-2015) component scoring standards using standardized cup and 




Standard for Maximum 
Scores 3 
Standard for Minimum of 
Zero 
Adequacy    
Total Fruits 4 5 ≥0.8 cup No Fruits 
Whole Fruits 5 5 ≥0.4 cup No Whole Fruits 
Total Vegetables 6 5 ≥1.1 cup No Vegetables 
Greens & Beans 6 5 ≥0.2 cup No Greens and Beans 
Whole Grains 10 ≥1.5 oz No Whole Grains 
Dairy 7 10 ≥1.3 cup No Dairy 
Total Protein Foods 6,8 5 ≥2.5 oz No Protein Foods 
Seafood & Plant Proteins 6,8 5 ≥0.8 cup No Seafood & Plant Proteins 
Fatty Acids 9 10 (PUFAs + MUFAs)/SFAs ≥ 2.5 (PUFAs + MUFAs)/SFAs ≤ 1.2 
Moderation    
Refined Grains 10 ≤1.8 oz ≥4.3 oz 
Sodium 10 ≤1.1 g ≥2.0 g 
Added Sugars 10 ≤6.5% of energy ≥26% of energy 
Saturated Fats 10 ≤8% of energy ≥16% of energy 
1 Scoring standards are expressed as cup and ounce equivalents from the MyPyramid Equivalents 
Database (MPED), whereby 1 oz = 28.3 g and 1 cup = 225 mL. 2 Intakes between the minimum and 
maximum standards are scored proportionately. 3 All standards represent amounts per 1000 kcal, 
except for Fatty Acids, Added Sugars and Saturated Fats. 4 Includes 100% fruit juice. 5 Includes all 
forms expect juice. 6 Includes legumes (beans and peas). 7 Includes all milk products, such as fluid 
milk, yogurt, cheese and fortified soy beverages. 8 Includes seafood, nuts, seeds, and soy products 
(other than beverages). 9 Ratio of poly- and mono-unsaturated fatty acids (PUFAs and MUFAs) to 
saturated fatty acids (SFAs). 
3.3.4 Case Ascertainment 
Deaths were identified by using state death files and the National Death Index. Deaths 
from CVD were identified and classified as International Classification of Diseases, Ninth 
Revision (ICD9) codes 390–448 or International Classification of Diseases, Tenth Revision 
(ICD10) codes I00–I78 and G45 [26,27]. Cancer deaths were identified by using ICD9 codes 
140–209 or ICD10 codes C00–C96 [26,27]. All-cause mortality included CVD and cancer deaths 
as well as deaths from other causes, including accidents and suicides. All death files were 
current as the closure dates of 31 July 2015 for participants in Hawaii and 31 March 2015 for 
participants in LA. Participants with no recorded deaths as of these closure dates were 
censored. 
 
3.3.5 Statistical Analysis 
Analyses were limited to 70,170 men and 86,634 women who identified with one of the 
five main MEC ethnic groups (white, African American, Japanese American, Native 
Hawaiian, and Latino) (excluding n = 13,992), had valid dietary assessment information 
(excluding n = 8263); and had no previous history of cancer, heart attack, or stroke at baseline 
(excluding n = 36,723). The association of all-cause, CVD, and cancer mortality with HEI-2015 
was modeled separately for men and women through Cox regression using years since study 
entry as the time metric. Cox regression was run for all ethnic groups combined and for each 
ethnic group separately. To assess if any one particular component was driving the association 
of HEI-2015 with mortality outcomes, we examined separate Cox models for HEI-2015, 




the HEI-2015 was also modelled on the MEC sample with 17,012 fewer mortality cases from 
the follow-up period of the HEI-2010 mortality analysis [19]. Sensitivity analysis with the 
same number of cases as the previous study [19] was performed to compare the difference 
between HEI-2010 and HEI-2015, and so that any observed differences would not be 
influenced based on the additional mortality cases. For CVD and cancer models, study 
participants who died of other causes were censored at the time of death. The following self-
reported covariates were included in all models: age at study entry and energy intake as 
continuous variables, history of diabetes (yes or no), ethnicity (as indicator variables), weekly 
hours of moderate-to-vigorous physical activity (<2.5 or ≥2.5 hours/week), smoking (current 
smoker, past smoker, or never smoked), education (<12, 12, 13–15, or ≥16 years) as a proxy of 
socioeconomic status, marital status (married or not married), and hormone-replacement 
therapy (HRT) (yes or no (women only)). BMI (in kg/m2) was categorized as ≤24.9, 25–29.9, or 
≥30 using self-reported height and weight. The HEI-2015 does not have a unique component 
for alcohol; therefore, models were further adjusted for alcohol intake in the past year as a 
continuous variable. All variables included as continuous measures had no missing values. 
Education, marital status, smoking, BMI, and weekly hours of moderate to vigorous physical 
activity had missing values; thus, each of these variables were modeled with a separate 
missing value category. Missing values ranged from <1% to 2.3% of the total sample. Separate 
models were fit for men and women with all ethnic groups combined. Total HEI-2015 scores 
and HEI-2015 with one component removed were divided into quintiles. HRs and 95% 
confidence intervals (CIs) were calculated for each quintile using the lowest quintile as a 
reference category. Wald’s chi square statistic was used to evaluate the linear trend on the 
basis of the median dietary score within each quintile. The proportional hazards assumption 
for Cox models was verified by plotting scaled Schoenfeld’s residuals against the time to the 
event [28]. Mean HEI-2015 scores by ethnic group and sex were compared using ANOVA. 
Given the ANOVA results were statistically significant for both men and women, post hoc 
analysis was undertaken using Scheffe’s multiple comparisons procedure. 
Radar graphs were constructed to provide a visual representation of how men and 
women in quintile 1 and quintile 5 obtained their overall HEI-2015 scores [29]. Each axis on a 
radar graph represents a unique component score. Component scores were graphed as 
percentages, e.g., a Total Fruits score of 4/5 was graphed as 80%. A perfect HEI-2015 score 
(100% for each component) would be displayed as a line around the border of the radar graph. 
All descriptive analyses were conducted with IBM SPSS Statistics version 23 software (IBM 
Corp., Armonk, NY, USA), all statistical modeling was conducted with SAS version 9.4 
software (SAS Institute Inc., Cary, NC, USA), and radar graphs were created using Microsoft 
Excel 2013 (Microsoft Corp, Redmond, WA, USA). All p values were 2-sided, and p < 0.05 was 
defined as statistically significant. 
 
3.4 Results 
3.4.1 Participant Characteristics  
A total of 51,442 mortality cases were documented (26,376 men and 25,066 women) over 
17–22 years of follow-up (Table 3.2). Of these cases, 17,662 deaths were from CVD (9130 men 
and 8532 women) and 14,778 were from cancer (7812 men and 6966 women). Compared to 
men and women in quintile 1 (lowest diet quality), participants in quintile 5 (highest diet 
quality) on average were older at the time they completed the Qx1, had a lower BMI, lower 




also contained a larger proportion of people with diabetes, those who never smoked, and 
those who graduated from college, compared to quintile 1. Among both men and women, 
there were higher proportions of Japanese American, Latino, and Native Hawaiian 
participants in quintile 1 compared to quintile 5, and a higher proportion of white and African 
American participants in quintile 5 compared to quintile 1. There was a lower proportion of 
married women in quintile 5 than in quintile 1, and a higher proportion of married men in 
quintile 5 than in quintile 1. A higher proportion of women in quintile 5 were users of 
hormone-replacement therapy, compared to all other quintiles. Mean HEI-2015 scores by sex 
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Table 3.2 Descriptive characteristics of participants (n = 156,804) in the Multiethnic Cohort by quintiles of Healthy Eating Index-2015 (HEI-2015) scores. 
 Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Men (n = 70,170)      
HEI-2015 scores, range 17.9–56.1 56.2–62.1 62.2–67.5 67.6–74.0 74.1–98.7 
Mean HEI-2015 score *** 50.7 59.4 64.9 70.7 79.6 
N 14,034 14,034 14,035 14,033 14,034 
Mortality, n cases 5003 5177 5321 5355 5520 
Cardiovascular disease 1708 1740 1864 1894 1924 
Cancer 1566 1598 1572 1561 1515 
Age at time of death, years 1 74.4 ± 9.6 75.9 ± 9.4 77.0 ± 9.2 77.9 ± 9.1 79.3 ± 8.6 
Age at time of questionnaire, years 1,*** 56.8 ± 8.6 58.3 ± 8.7 59.4 ± 8.7 60.0 ± 8.7 61.1 ± 8.6 
Ethnicity, % of row      
Japanese American (n = 21,239) 24.1 21.5 20.0 17.8 16.6 
Latino (n = 17,595) 20.7 23.1 22.8 19.8 13.7 
White (n = 17,330) 14.9 16.3 18.0 23.0 28.0 
African American (n = 9014) 15.1 17.0 19.2 21.7 26.9 
Native Hawaiian (n = 4992) 27.0 20.9 18.7 17.2 16.3 
Body mass index (kg/m2) 1,*** 26.9 ± 4.5 26.9 ± 4.3 26.8 ± 4.2 26.6 ± 4.1 26.1 ± 3.8 
Energy intake, kcal 1,*** 2479 ± 1158 2552 ± 1220 2524 ± 1181 2448 ± 1107 2256 ± 978 
Physical activity, h/week 1,2,*** 1.2 ± 1.5 1.3 ± 1.6 1.4 ± 1.5 1.4 ± 1.5 1.5 ± 1.5 
History of diabetes, % with diabetes *** 8.4 10.0 11.4 11.7 12.5 
Smoking, % who never smoked *** 24.3 28.0 30.6 33.8 37.7 
Education, % graduated from college *** 23.9 26.2 28.6 33.3 38.5 
Marital status, % married 74.5 76.3 77.7 76.8 75.2 
Women (n = 86,634)      
HEI-2015 scores, range 23.5–59.8 59.9–66.3 66.4–71.8 71.9–78.0 78.1–99.8 
Mean HEI-2015 score *** 53.8 63.3 69.2 74.9 83.0 
N 17,327 17,326 17,328 17,327 17,326 
Mortality, n cases 4603 4809 5020 5119 5515 
Cardiovascular disease 1493 1637 1747 1782 1873 
Cancer 1398 1365 1385 1353 1465 




Age at time of questionnaire, years *** 56.4 ± 8.6 58.2 ± 8.7 59.3 ± 8.7 60.1 ± 8.8 61.5 ± 8.5 
Ethnicity, % of row      
Japanese American (n = 24,785) 21.1 21.5 20.1 19.0 18.3 
White (n = 20,653) 15.8 16.6 19.7 22.9 25.0 
Latina (n = 18,756) 25.4 24.1 21.2 17.0 12.4 
African American (n = 16,072) 15.0 17.0 19.3 22.3 26.5 
Native Hawaiian (n = 6368) 26.1 20.8 18.8 17.8 16.5 
Body mass index (kg/m2) *** 27.1 ± 6.2 26.7 ± 5.8 26.5 ± 5.6 26.1 ± 5.4 25.5 ± 5.2 
Energy intake, kcal *** 2052 ± 1068 2038 ± 1023 2003 ± 967 1956 ± 915 1865 ± 817 
Physical activity, h/week 2,*** 1.0 ± 1.2 1.0 ± 1.3 1.1 ± 1.3 1.2 ± 1.3 1.3 ± 1.3 
History of diabetes, % with diabetes *** 8.2 9.3 9.8 9.5 10.1 
Smoking, % never smoked *** 50.5 55.8 56.5 57.9 58.7 
Education, % graduated from college *** 18.7 21.3 23.9 27.4 31.3 
Marital status, % married * 59.1 60.9 60.5 59.4 57.6 
Hormone replacement therapy, % users *** 37.4 42.7 46.1 49.2 53.1 
*** p value < 0.001 for independent sample t-test between quintile 1 and quintile 5 for quantitative variables and test of proportions for discrete variables 
collected at baseline. 1 Mean ± SD (all such values). * p value < 0.05 between quintile 1 and quintile 5, for test of proportions for discrete variables 
collected at baseline. 2 Represents self-reported weekly hours of moderate to vigorous physical activity. 
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3.4.2 Mortality Analysis 
For men and women, participants in quintile 5 were at lower risk of all-cause, CVD, and 
cancer mortality compared to participants in quintile 1 (Table 3.3). For men, the quintile 1: 
quintile 5 HRs (95% CIs) for all-cause, CVD, and cancer for were 0.79 (0.76, 0.82), 0.76 (0.71, 
0.82), and 0.80 (0.75, 0.87), respectively. For women, the HRs (95% CIs) were 0.79 (0.76, 0.82), 
0.75 (0.70, 0.81), and 0.84 (0.78, 0.91), respectively. With every increase across quintiles of 
diet quality, there was a decrease or no change in risk of death from all-cause, CVD, and 
cancer for both men and women. The change in risk from all-cause and CVD mortality 
between quintile 1 and quintile 5 was similar for men and women. For cancer mortality, 
quintile 1: quintile 5 HR results supported a 20% reduction in risk of death for men 
compared to women, who had a 16% lower risk. 
In men, when stratified by ethnicity, a protective effect was seen for quintile 1: quintile 
5 for all-cause, CVD, and cancer mortality among the white, African American, and Japanese 
American groups, with all HR ≤ 0.83 (Appendix E). Latino men in quintile 1: quintile 5 had 
a reduced risk of all-cause and cancer mortality with HRs of 0.88 and 0.79, respectively, and 
a null association for CVD mortality. For Native Hawaiian men there was a null association 
for all mortality outcomes and for the tests for trend. In women, when stratified by ethnicity, 
a protective effect for all-cause, CVD, and cancer mortality was observed for white women 
in quintile 1: quintile 5 with HRs of 0.66, 0.63, and 0.71, respectively (Appendix F). African 
American and Japanese American women in quintile 1: quintile 5 had a reduced risk of all-
cause and CVD mortality, with HR ≤ 0.72 for African American women and HR ≤ 0.87 for 
Japanese American women. African American and Japanese American women in quintile 1: 
quintile 5 had a null association for cancer mortality. Latino women in quintile 1: quintile 5 
had a reduced risk of all-cause and cancer mortality, with HR ≤ 0.92, and a null association 
for CVD morality. There was a null association for all mortality outcomes for Native 
Hawaiian women and for the tests for trend. CVD mortality among Latino women, and 
cancer mortality among the African American and Japanese American women did not have 
significant tests for trend. The test for trend was statistically significant for the majority of 
the relationships tested. 
Removing any one of the 13 components from the HEI-2015 score did not substantially 
change the association of the index with mortality outcomes for both men and women 
(Figure 3.1 and Appendix B-D). Removing the Refined Grains component (component 10) 
changed the quintile 1: quintile 5 HR for men from 0.79 (0.76, 0.82) to 0.75 (0.72, 0.78) for all-
cause mortality, 0.76 (0.71, 0.82) to 0.73 (0.68, 0.78) for CVD mortality, and 0.80 (0.75, 0.87) to 
0.74 (0.68, 0.79) for cancer mortality. Repeating the same concept with the Saturated Fats 
component (component 13) changed the quintile 1: quintile 5 HR for men from 0.79 (0.76, 
0.82) to 0.82 (0.78, 0.85) for all-cause mortality, 0.76 (0.71, 0.82) to 0.80 (0.74, 0.85) for CVD 
mortality, and 0.80 (0.75, 0.87) to 0.84 (0.78, 0.91) for cancer mortality. These were the largest 
changes seen and yet these HRs were still relatively close. When the HEI-2015 scoring 
standards were applied to the MEC sample with fewer mortality cases from the follow-up 
period of the HEI-2010 mortality analysis [19], similar associations with mortality risk were 
observed. The quintile 1: quintile 5 HRs were 0.78 (0.75, 0.82), 0.78 (0.72, 0.84), and 0.80 (0.73, 
0.87) for all-cause, CVD, and cancer mortality, respectively, for men and 0.79 (0.75, 0.84), 





Table 3.3 Hazard ratios (HR) (95% confidence intervals (CI)) for all-cause, cardiovascular disease (CVD), and cancer mortality according to quintiles of 









Mortality 1  
HR (95% CI) 
CVD Deaths 
n 
CVD Mortality 1  
HR (95% CI) 
Cancer 
Deaths n 
Cancer Mortality 1  
HR (95% CI) 
Men 2,3         
Quintile 1 14,034 5003 252,098  1.00 1708 1.00 1566 1.00 
Quintile 2 14,034 5177 250,512 0.93 (0.90, 0.97) 1740 0.90 (0.84, 0.96) 1598 0.97 (0.90, 1.04) 
Quintile 3 14,035 5321 250,072  0.89 (0.85, 0.92) 1864 0.88 (0.82, 0.94) 1572 0.91 (0.85, 0.98) 
Quintile 4 14,033 5355 250,974 0.85 (0.81, 0.88) 1894 0.84 (0.78, 0.90) 1561 0.88 (0.82, 0.95) 
Quintile 5 14,034 5520 252,489 0.79 (0.76, 0.82) 1924 0.76 (0.71, 0.82) 1515 0.80 (0.75, 0.87) 
Women 
3,4 
        
Quintile 1 17,327 4603 327,551 1.00 1493 1.00 1398 1.00 
Quintile 2 17,326 4809 327,362 0.92 (0.89, 0.96) 1637 0.93 (0.87, 1.00) 1365 0.93 (0.86, 1.00) 
Quintile 3 17,328 5020 325,938 0.87 (0.84, 0.91) 1747 0.88 (0.82, 0.95) 1385 0.90 (0.83, 0.97) 
Quintile 4 17,327 5119 326,802  0.82 (0.79, 0.86) 1782 0.83 (0.77, 0.89) 1353 0.84 (0.78, 0.91) 
Quintile 5 17,326 5515 325,836 0.79 (0.76, 0.82) 1873 0.75 (0.70, 0.81) 1465 0.84 (0.78, 0.91) 
1 p-trend < 0.0001 for all models. 2 Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, energy, ethnicity, 
education, marital status, smoking, weekly hours of moderate to vigorous physical activity, and alcohol intake. 3 Quintile 1 is lowest score and 
quintile 5 is highest score, HEI ranges shown in Table 3.2 4 Adjusted for self-reported covariates; age at study entry, body mass index, history of 
diabetes, energy, ethnicity, education, marital status, smoking, physical activity, hormone replacement therapy, and alcohol intake. 




Figure 3.1 Quintile 1: quintile 5 hazard ratios (HR) and 95% confidence intervals (CI) for 
all-cause, cardiovascular disease (CVD) and cancer mortality for Healthy Eating Index-
2015 (HEI-2015) scores with one component removed for men and women in the 
Multiethnic Cohort. Diamond shapes represent HR for mortality by (A) all-cause (purple), 
(B) CVD (red) and (C) cancer (blue) for men and women, as per results shown in Table 3.3 
Smaller dots represent HR for HEI-2015 with one component removed. When excluded, 
the component is labeled as: (1) Total Fruits, (2) Whole Fruits, (3) Total Vegetables, (4) 
Greens and Beans, (5) Whole Grains, (6) Dairy, (7) Total Protein Foods, (8) Seafood and 
Plant Proteins, (9) Fatty Acids, (10) Refined Grains, (11) Sodium, (12) Added Sugars, (13) 
Saturated Fats. All models were adjusted for self-reported covariates; age at study entry, 
body mass index, history of diabetes, energy, ethnicity, education, marital status, smoking, 
weekly hours of moderate to vigorous physical activity, and alcohol intake. All models for 
women were also adjusted for hormone replacement therapy. 
 
3.4.3 Radar Graphs 
Figure 3.2 displays radar graphs which can be used to visualize the range of intakes 
among the components. A perfect HEI-2015 total score (100% for each component) would 
be displayed as a line around the border of the radar graph. The median component scores 
for men in quintile 1 (the lowest quality diet group) were 50% or less for the adequacy 
components of Total Fruits, Whole Fruits, Greens and Beans, Whole Grains, and Dairy, as 





3.2A). For Total Vegetables (an adequacy component) and Saturated Fats (a moderation 
component), the median component scores in quintile 1 for men were between 50% and 80%. 
Seafood and Plant Proteins, and Total Protein Foods (adequacy components), and Added 
Sugars (a moderation component) were all above 80%. The lowest median component scores 
for men in quintile 5 were Dairy (41%), Fatty Acids (78%) and Sodium (59%). All other 
median component scores for men in quintile 5 were over 84%. The median component 
scores for women in quintile 1 were 50% or less for Total Fruits, Whole Grains, Dairy, Fatty 
Acids, Refined Grains, and Sodium (Figure 3.2B). The median component scores in quintile 
1 for women were between 50% and 80% for Whole Fruits, Total Vegetables, Greens and 
Beans, and Saturated Fats, and over 80% for Total Protein Foods, Seafood and Plant Proteins, 
and Added Sugars. The lowest median component scores for women in quintile 5 were 
Dairy (51%), Fatty Acids (79%), and Sodium (63%). All other median component scores for 
women in quintile 5 were over 95%. Patterns of the median component scores were similar 
for men and women in quintile 1 and in quintile 5, e.g., Total Protein Foods scored the 
highest and Dairy scored the lowest for men and women in both quintiles. Women had 
higher median scores for each component, with the exception of men having higher median 
component scores for Seafood and Plant Proteins, Fatty Acids, Sodium, and Saturated Fats 
in quintile 1. Comparing the total HEI-2015 median scores between the sexes for quintile 1 







Figure 3.2 Total median scores and radar graphs of median component scores for (A) men 




Comparing those with the lowest quality diets to those with the highest quality, the 
reduction in risk of mortality from all-cause, CVD, and cancer was 21%, 24%, and 20%, 
respectively, for men and 21%, 25%, and 16%, respectively, for women. In the HEI-2010 
mortality analysis with the MEC, the reduction in the risk of mortality from all-cause, CVD, 
and cancer was 25%, 26%, and 24%, respectively, for men, and 21%, 23%, and 11%, 
respectively, for women [19]. Therefore, HRs have slightly improved for women and 
marginally lowered for men between the HEI-2015 and HEI-2010 mortality analyses with 
the MEC. When the HEI-2015 scoring standards were applied to the MEC sample with fewer 
mortality cases, from the follow-up period of the HEI-2010 mortality analysis, the HR results 
were also very similar. The reduction in risk of mortality from all-cause, CVD, and cancer 







women. For the DPMP, standardized mortality assessments were also conducted with the 
HEI-2010 and the WHI-OS, and AARP cohorts. The HEI-2010 mortality analysis with the 
WHI-OS was conducted with 63,115 US women, of whom 83% identified as white [21,30]. 
The results of this study showed a reduction in risk between quintile 1: quintile 5, with HRs 
of 24%, 22%, and 23% for all-cause, CVD, and cancer mortality, respectively. The HEI-2010 
mortality analysis for the AARP contained 242,321 men and 182,342 women from six US 
states and over 90% of participants identified as white [17,31]. The same mortality analysis 
applied to the AARP showed a reduction in risk of 22%, 15%, and 24% for all-cause, CVD, 
and cancer mortality, respectively, for men and 23%, 21%, and 18%, respectively, for women. 
The results from the HEI-2015 mortality analysis with the MEC and the HEI-2010 mortality 
analysis with the WHI-OS and AARP are very similar, more so than the mortality results 
from the HEI-2010 analyses with the MEC. For example, the reduction in risk of cancer 
mortality for women in the MEC, WHI-OS, and AARP were 11%, 23%, and 18%, 
respectively, using the HEI-2010. The reduction in risk of cancer mortality for women in the 
MEC changed to 16% in the HEI-2015 analysis. A recent meta-analysis on the association 
between the HEI-2005/HEI 2010, AHEI, and DASH and health outcomes for both men and 
women had similar findings to this HEI-2015 analysis with the MEC [32]. Consistency 
between the HEI-2010 analyses and this HEI-2015 analysis reinforces the use of HEI as an 
assessment of diet quality. 
The analysis that removed one component at a time did not change the protective 
association of the remaining HEI components. Therefore, no one HEI component made an 
independent significant contribution to the total score (Figure 3.1). The Saturated Fat 
component did distinguish itself, as its removal changed the HRs slightly towards the null 
for all three mortality outcomes among men only. Previous versions of the HEI included 
Saturated Fat as part of the empty calories component comprised of solid fat, added sugars, 
and alcohol [3]. The HEI-2015 offers the first opportunity to evaluate the Added Sugars and 
Saturated Fat components independently, however alcohol is now part of total energy 
intake. Removal of the Added Sugars component had no influence on moving the hazard 
ratios. On the other hand, the component whose removal consistently changed the HRs 
away from the null was Refined Grains for all-cause mortality, CVD mortality, and cancer 
mortality among men only, although this shift was minor and did not change the overall 
results. The by-component models using HEI-2010 among the members of the AARP cohort 
reported the unexpected finding of an increase in risk for all-cause mortality among men 
and women with higher scores for the Refined Grain component (indicating lower 
consumption) [16]. Future analysis might consider reconciling these observations across the 
HEI-2010 and HEI-2015 and the cohorts involved in the DPMP. These results support and 
reinforce the multidimensionality of the HEI and the representation of diet quality using a 
wide array of components. 
Higher diet quality was associated with improved mortality outcomes in this analysis 
among a multiethnic population of men and women. All of the HEI-2015 components 
contributed to the association of diet quality and mortality. Given this, dietary components 
needing improvement for people with the lowest quality diets could be emphasized in 
public health messages. The components with the largest differences in median scores 
between quintile 1 and quintile 5 were identified as Total Fruits, Whole Fruits, Greens and 
Beans, Whole Grains, and Refined Grains for men and Total Fruits, Whole Grains, and 
Refined Grains for women (Figure 3.2). The results of the present analysis suggest increasing 





people with the lowest quality diets. Data from the 2007-2010 National Health and Nutrition 
Examination Survey (NHANES) reported that men and women 31 years and older in the US 
do not meet the requirements for fruits, vegetables, and whole grains and exceed the 
recommended intake of refined grains [4,33]. The message on increasing the intake of fruits, 
vegetables, and whole grains to improve health outcomes is consistent with results from 
both the MEC and NHANES [4,33].  
The components with the lowest median scores were the same for people in quintile 1 
and quintile 5. These components were Dairy, Fatty Acids, and Sodium, with median scores 
of less than 50%. Improving scores for Dairy, Fatty Acids, and Sodium components may 
help to improve mortality outcomes for people with the lowest quality diets. The current 
mortality analysis does not provide evidence on whether increasing Dairy, Fatty Acids, and 
Sodium component scores for people with the highest quality diets will offer any additional 
protection. The DGA reports, on average, that adults in the US are not achieving their 
recommended intakes of dairy and oils, and average intakes of saturated fats and sodium 
are met or exceeded [4]. The MEC results and the DGAs support evidence that people with 
low quality diets should increase their intakes of these foods to improve health outcomes 
[4,33]. The current dietary guidelines also promote replacing SFAs with PUFAs to reduce 
CVD-related deaths and decreasing sodium intake to reduce CVD events [4]. Based on this 
evidence from the DGAs and the MEC, people with the highest quality diets may have 
improved mortality outcomes if they meet recommended intakes of SFAs, PUFAs, and 
sodium.  
The median component scores for men and women in the MEC in quintile 1 and quintile 
5 were at 100% (a perfect score) for the Total Protein Foods component. Similarly, results 
from NHANES 2007–2010 support that mean intakes of meat, poultry, and eggs for adults 
31 years and older are at recommended levels for women and at or above recommended 
levels for men [4,33]. The standard for a perfect score for Total Protein Foods is ≥2.5 oz per 
1000 kcal per day. There is no upper limit for Total Protein Foods using this scoring 
standard; therefore, we do not know if consuming more than 2.5 oz of Total Protein Foods 
per 1000 kcal per day further improves or worsens mortality outcomes. Also, we do not 
know if consuming Total Protein Foods in excess replaces intake of foods found in the other 
12 components, which would lower these component scores. Having no upper limit for 
component scoring standards may be a limitation of the HEI.  
The median component scores for quintile 1 and quintile 5 for Added Sugars for men 
and women in the MEC were each above 88%. In comparison, the average intake of added 
sugar for adults in NHANES were all above the recommended maximum limit [4,33]. 
Previous research on the MEC found that Japanese Americans had the greatest percentage 
of people who met the DGA recommendations for added sugars [34,35]. The MEC has a 
large proportion of Japanese Americans (26.4%), which may explain why median 
component scores for Added Sugars indicate a low intake in the MEC compared to excessive 
average intakes in NHANES. For the Seafood and Plant Proteins component, the median 
scores among the MEC men and women in both the 1st and 5th quintiles were above 80%. 
Results reported from NHANES 2007-2010 indicated intakes of nuts, seeds, and soy 
products were at or above recommended intakes among adults, whereas seafood intakes 
were below recommendations [4,33]. Previous research shows that Native Hawaiians and 
Japanese Americans in the MEC have more servings of fish per day than other ethnic groups 





intake may contribute to the median component scores of over 80% for Seafood and Plant 
Proteins.  
The overall mean HEI-2015 score among men and women in the MEC, as estimated 
using the FFQ, was 65 and 69, respectively. Among men, Native Hawaiian men had the 
lowest score at 63 compared to African American and white men, with scores of 67. For 
women, the range was 71 among African American and white women to 67 among Native 
Hawaiian women. At the time of this paper, no published information about HEI-2015 
scores among adults or children had been published. For any comparison, HEI-2015 scores 
derived from a FFQ would be preferable, as was done by Liese et al. [15]. Although the mean 
scores by ethnic group were almost all statistically significantly different, the range of scores 
was small, i.e., four points for both men and women. An examination of component scores 
between ethnic groups to further explore variation in dietary exposures is warranted. 
Identifying the characteristics of people with the lowest quality diets may help to 
further tailor nutrition education messages. Comparing the results across the WHI-OS, 
AARP, and MEC cohorts, college graduates were more likely to be classified as having a 
higher quality diet based on HEI-2010 [16,21]. In the AARP and MEC cohorts, women had 
slightly higher diet quality scores than men [16]. For both men and women in the MEC, a 
higher percentage of Japanese Americans, Native Hawaiians, and Latinos were in quintile 1 
and a higher percentage of whites and African Americans were in quintile 5. The WHI-OS 
cohort is comprised of women and similar to the women in the MEC cohort, there was a 
higher percentage of whites in quintile 5 compared to quintile 1 and a higher percentage of 
Hispanic women in quintile 1 compared to quintile 5 [21]. In the WHI-OS, a greater 
percentage of Black women were in quintile 1 compared to quintile 5, which is in contrast 
to the MEC, where a larger proportion of Black women were in quintile 5 [21]. Thus, the 
quality of diet within any one group may vary by geographic area.  
Of note, the highest versus the lowest HEI-2015 scores were consistently more 
protective for white and African Americans. The development of the HEI is guided by 
evidence-based research, and nutrition research is dominated by studies conducted among 
white and African American participants [36–39]. This may account for why the HEI-2015 
performs better for white and African Americans. In this analysis, Native Hawaiian men 
and women had a null association between HEI-2015 quintile 1: quintile 5 and all-cause, 
CVD, and cancer mortality. Native Hawaiians have the lowest sample size compared to all 
other ethnic groups in the MEC. Therefore, the power for the analyses of diet quality and 
mortality outcomes in Native Hawaiians may not be large enough to draw significant 
findings. Latino men and women also had null associations between HEI-2015 quintile 1: 
quintile 5 and CVD mortality. Latinos in the US have the lowest rate of CVD compared to 
other ethnic groups [40]. These rates are mimicked in this current analysis, with Latino men 
and women making up 25% and 22% of this MEC sample, respectively, but having the 
second lowest rate of CVD mortality behind Native Hawaiians. Therefore, the relatively 
lower rate of CVD mortality in Latino men and women may be contributing to the null 
association between diet quality and CVD mortality. The associations between the HEI-2015 
and mortality outcomes by ethnic group in the MEC are similar to those found in the HEI-
2010 mortality analysis with the MEC [19]. 
A limitation of this study was the use of a food frequency questionnaire (FFQ) to collect 
dietary information at baseline, which could introduce bias [22]. However, this QFFQ was 
validated and calibrated in each ethnic-sex group and the correlations between the QFFQ 





limitation was dietary data only being assessed once at baseline; therefore, this analysis was 
not able to capture the influence of dietary changes on mortality outcomes. In addition, all 
demographic and anthropometric variables were self-reported, and we cannot rule out 
whether other factors not measured and controlled for, could have affected mortality 
outcomes; e.g., access to health care. Participants in the MEC were recruited from Hawaii 
and LA; therefore, results of this study may not be generalizable outside of these areas. 
Lastly, measurement error is an important consideration relevant to all self-reported 
behavioral variables. The simple models used to examine predictive validity do not address 
measurement error; however, efforts are underway to do so for future analyses. 
The strengths of this study include the use of a large multiethnic sample that was 
followed prospectively for over 17 years and the use of a comprehensive QFFQ that was 
designed to capture ethnic specific foods, allowing for this multiethnic comparison. In 
addition, covariate data at baseline were collected for almost every participant, permitting 
the adjustment for multiple, salient risk factors. This study also applied the same 
standardized regression analysis previously used in diet quality and mortality analysis by 
the DPMP. Using this standardized approach allows comparisons to be made between the 
present study and previous and future DPMP analyses of dietary indices and mortality 
outcomes. For example, once finalized, comparisons can be made between the MEC, the 
WHI-OS and the AARP mortality analysis with the HEI-2015. 
 
3.6 Conclusions 
In summary, people in the MEC with higher HEI-2015 scores had a reduction in risk of 
all-cause, CVD, and cancer mortality. Updates to component scoring between the HEI-2010 
and HEI-2015 do not appear to have affected the balance of the scoring system, and mortality 
analysis results were robust between studies that used either index. Increasing intake of 
whole fruits, vegetables, whole grains, MUFA, PUFA and reducing intake of refined grains, 
sodium, and saturated fats may improve dietary patterns and mortality outcomes for people 
with the poorest quality diets. Improving intake as a whole versus any single food group 
appears to be most beneficial in reducing risk for mortality. The HEI-2015 is a useful means 
by which to measure diet quality.  
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4.1 Abstract 
Intermittent energy restriction combined with a Mediterranean diet (IER+MED) has shown 
promise to reduce body fat and insulin resistance. In the Multiethnic Cohort Adiposity 
Phenotype Study, Japanese Americans had the highest visceral adipose tissue (VAT) when 
adjusting for total adiposity. We conducted this pilot study to demonstrate feasibility and 
explore efficacy of following IER+MED for 12 weeks to reduce VAT among East Asians in 
Hawaii. Sixty volunteers (aged 35–55, BMI 25–40 kg/m2, VAT ≥ 90 cm2 for men and ≥ 80 
cm2 for women) were randomized to IER+MED (two consecutive days with 70% energy 
restriction and 5 days euenergetic MED) or an active comparator (euenergetic Dietary 
Approaches to Stop Hypertension (DASH) diet). Participants and clinic staff (except 
dietitians) were blinded to group assignments. IER+MED had significantly larger 
reductions in DXA-measured VAT and total fat mass (−22.6 ± 3.6 cm2 and −3.3 ± 0.4 kg, 
respectively) vs. DASH (−10.7 ± 3.5 cm2 and −1.6 ± 0.4 kg) (p = 0.02 and p = 0.005). However, 
after adjusting for total fat mass, change in VAT was not statistically different between 
groups; whereas, improvement in alanine transaminase remained significantly greater for 
IER+MED vs. DASH (−16.2 ± 3.8 U/L vs.–4.0 ± 3.6 U/L, respectively, p = 0.02). Attrition rate 
was 10%, and participants adhered well to study prescriptions with no reported major 
adverse effect. Results demonstrate IER+MED is acceptable, lowers visceral and total 
adiposity among East Asian Americans, and may improve liver function more effectively 







Excess adiposity contributes to an increased risk of cardiovascular disease, type 2 
diabetes, and at least 13 cancers, including postmenopausal breast, endometrium, liver, 
gallbladder, pancreas, thyroid, kidney and colon cancer [1,2]. Visceral adiposity more so 
than subcutaneous adiposity is associated with the cardiovascular and metabolic 
consequences of obesity [3,4]. Higher visceral adipose tissue (VAT) levels result in increased 
circulating proinflammatory cytokines and adipokines, and a decrease in protective 
adipokines [4–8]. Also, non-alcoholic fatty liver disease (NAFLD) and steatohepatitis 
(NASH) have emerged as common liver diseases due to excess adiposity and are associated 
with type 2 diabetes, metabolic syndrome, and liver cancer [9]. 
Asians and Asian Americans are at a higher metabolic risk from excess adiposity 
compared to whites and other racial/ethnic populations [10]. In the Multiethnic Cohort 
Adiposity Phenotype Study (MEC-APS), conducted in Hawaii and California, we observed 
Japanese Americans preferentially store excess fat as VAT over subcutaneous adipose tissue 
(SAT) and also have higher levels of liver fat compared to participants of African American, 
Latino, Native Hawaiian or white ancestry after adjusting for total adiposity [11]. Consistent 
with this observation, among 23,830 men in the MEC over the median follow-up of 16.6 
years, Japanese Americans showed a stronger association of higher body mass index (BMI) 
with the risk of hepatocellular carcinoma (HCC; relative risk (RR) for a 5 kg/m2 increase in 
BMI = 1.77) compared to African American, Latino, Native Hawaiian, and white men (RRs 
ranging 0.78–1.34) [12]. Other studies comparing Asians or Asian Americans to whites also 
found a higher prevalence of visceral obesity, NAFLD and metabolic syndrome [13,14], 
suggesting this group may benefit from an intervention aimed at reducing adiposity, 
especially VAT. 
While energy restriction is the most common strategy for weight loss and visceral fat 
reduction [15], long-term adherence to continuous energy restriction (CER) is known to be 
difficult [16], and intermittent energy restriction (IER) has emerged as a promising 
alternative to CER [17]. IER includes periods of marked energy restriction (typically 60–75% 
below estimated energy requirements) on at least one day but no more than six days per 
week, interspersed with periods of normal or ad libitum energy intake [17–21]. In particular, 
Harvie et al. suggested combining two consecutive days of IER with five days of a 
Mediterranean (MED) type diet to promote satiety and high-quality nutrition [17,22]. The 
MED diet is primarily a plant-based diet rich in olive oil, olives, fruits, vegetables, whole 
grains, legumes and nuts with moderate amounts of dairy products (principally cheese and 
yogurt), fish, poultry, red wine, and limited amounts of red meat [23–25]. Adherence to a 
MED diet was also promoted for the management of NAFLD in joint clinical practice 
guidelines issued by the European Associations for the Study of Liver (EASL), Diabetes 
(EASD) and Obesity (EASO) [26]. These guidelines also recommended patients with 
NAFLD restrict energy intake, lose weight if overweight or obese, and incorporate aerobic 
exercise or resistance training [26]. Consistently, in the MEC-APS, we observed following a 
high-quality diet, e.g., a high MED index score, was inversely associated with adiposity, 
including VAT and liver fat as assessed by magnetic resonance imaging (MRI)[27]. Thus, 
adopting IER combined with a MED diet on the non-restricted days may help to reduce 
VAT, and assist with controlling other ectopic fat stores.  
The primary aim of the present study was to finalize and implement a protocol for an 





adapted IER and MED combined diet (IER+MED) to reduce VAT among East Asian 
Americans. Secondary aims were to evaluate study retention and protocol adherence, and 
changes in total adiposity and metabolic risk biomarkers. East Asian women and men were 
also prioritized for this study as their traditional and acculturated East Asian diets are 
dissimilar compared to the IER+MED diet. Therefore, limiting enrollment to men and 
women of East Asian ancestry for participation in this pilot study allowed full attention to 
be directed to adapting their diets. 
 
4.3 Materials and Methods 
4.3.1 Study Design and Participants 
The Healthy Diet and Lifestyle Study (HDLS) pilot was a two-arm randomized trial 
conducted between September 2016 and October 2017 at the University of Hawaii Cancer 
Center (UHCC) to demonstrate the feasibility of a nutritional intervention aimed at reducing 
visceral adiposity in East Asian middle-aged adults. This study included two clinic visits 
before the intervention (an eligibility visit and a baseline visit approximately one week apart 
(1.25 ± 1.2 weeks)), a 12 week intervention phase, a final clinic visit at Week 12, and a 6-
month post-intervention telephone interview. Participants who responded to the study 
promotions, were first screened over the telephone to assess the inclusion criteria of East 
Asian ancestry (Japanese, Chinese, or Korean), residence in Honolulu County, body mass 
index (BMI) between 25 and 40 kg/m2, ages 35 to 55 years, and no serious health issues. 
Exclusion criteria included; smoking tobacco products or marijuana in the past two years, 
taking thyroid medication, prescription medication or insulin for type 1 or type 2 diabetes, 
anti-estrogen medication (women), anti-androgen medication (men), substantial change of 
weight of more than ± 10 kg in the past six months, following a special diet (e.g., vegan), or 
alcohol intake >15 drinks per week for men or >10 drinks per week for women. Ethnicity 
was self-reported and at least two biological grandparents of pure East Asian ancestry were 
required. Those screened as eligible were scheduled for an eligibility visit, which consisted 
of a fasting blood draw, anthropometric measurements, questionnaires (characteristics, 
medical history, medication list, physical activity), a whole-body dual energy X-ray 
absorptiometry (DXA) scan, and training participants how to complete a mobile food record 
(mFR™) [28–31] to capture images with their mobile device of foods/beverages before and 
after each eating occasion over 4 contiguous days. Final eligibility was determined based on 
general good health, normal blood count and biochemistry profile, and DXA-derived 
visceral fat area at L4-L5 intervertebral region ≥ 90 cm2 for men or ≥ 80 cm2 for women to 
target at-risk individuals for visceral obesity based on VAT distribution in the MEC-APS 
study [11]. The baseline clinic visit involved randomizing participants into the IER+MED 
group or the active comparator DASH group, education of diet and physical activity 
prescriptions, and reviewing information from mFRs™collected between the eligibility and 
baseline visits. During the final clinic visit, measurements taken at baseline were repeated.  
The enrollment goal was to recruit 70 persons to achieve a final sample of 50 persons to 
account for an attrition rate of ~23%, as reported in past studies [22]. Participants were 
recruited through advertisements in local newspapers, on radio stations, television news, 
social media, and email list-servs, and through distribution of brochures and flyers. A total 
of 820 people responded to the study promotions and of these, 760 people were excluded 





reimbursement for time and travel, each participant received a $50 gift card at the eligibility 
visit, $50 at the baseline clinic visit, and $50 at the final clinic visit, totaling $150 in gift cards 
to a state-wide supermarket chain. Participants were provided their whole-body DXA, BMI, 
and blood biochemistry panel results after the baseline and final clinic visits. All study 
procedures were approved by the University of Hawaii Institutional Review Board and 
written informed consent was obtained from all study participants.  
 
Figure 4.1 Consort diagram. 
 
4.3.2 Randomization and Masking 
Randomization was implemented within strata defined by sex and VAT levels (above 
or below 150 cm2) and was blocked to ensure balance in assignment over the course of the 
study [32,33]. Stratified blocked randomization schedules were created by biostatisticians 
not involved in the intervention [33]. The assignments were printed and placed in opaque 
sealed envelopes with consecutive numbering and unique colors by strata. During the 
baseline clinic visit, research dietitians provided the participants with the next four 
consecutive envelopes in the appropriate stratum. The participant then selected and opened 





had been blinded to the group assignment. The participants (men, n = 18; women, n = 42) 
were randomized equally into either the intervention group or the DASH group. 
Recruitment and clinic staff were blinded to group assignments until after the 6-month post-
intervention telephone interview. The current study was promoted as a healthy diet and 
lifestyle study, and study diets were identified as Diet 1 (for IER+MED) or Diet A (for DASH) 
to reduce any influence of familiarity with IER, MED or DASH diets.  
 
4.3.3 Diet and Physical Activity Prescriptions 
The intervention group was prescribed an IER+MED diet for 12 weeks. The IER 
component entailed a 70% energy restriction for two consecutive days with 34%, 33% and 
33% of energy from protein, carbohydrate, and fat intakes, respectively. For the remaining 
five days per week, a euenergetic MED diet that met estimated energy requirements (EER), 
was prescribed with 25%, 45%, and 30% of energy from protein, carbohydrate, and fat, 
respectively. This regimen would achieve an overall energy restriction of 20% per week [22]. 
Participants self-selected which two consecutive days of the week to follow the IER protocol, 
and were asked to keep to those same two days throughout the study.  
The active comparator group was prescribed a euenergetic DASH diet, which met EER, 
for 12 weeks, with 20%, 53%, and 30% of energy from protein, carbohydrate, and fat, 
respectively. An active comparator was used, instead of an inactive control, because all 
participants were at risk of poor metabolic conditions and would likely benefit from dietary 
support [34,35]. DASH was chosen as the comparator diet, as its regimen is broadly 
recognized as a healthful diet [36,37]. The DASH diet is rich in fruit, vegetables, low-fat dairy 
products, whole grains, and limits total fat, saturated fat and sodium [36,37]. All participants 
were advised to limit their alcohol intake, and the IER+MED group were restricted to zero 
alcoholic beverages on IER days. Increases in moderate to vigorous physical activity have 
been documented using accelerometers in past dietary interventions among intervention 
and control groups [38]. Therefore, to reduce confounding due to physical activity, we 
recommended both groups walk up to one hour per day, up to five days a week. The 
IER+MED group was encouraged to exercise on MED days only. EER for participants were 
determined based on their baseline body weight using the equations as published in the 
Dietary Reference Intakes (DRI) for energy for men and women 19 years and older [39]. The 
physical activity coefficient for men and women was assigned using the typical daily living 
activity descriptions from the DRI Calculator for Healthcare Professionals [40]. Information 
on hours in light, moderate and strenuous activity was estimated using the baseline physical 
activity questionnaire, which allowed dietitians to select an appropriate physical activity 
coefficient for each participant. 
Both groups received an equal amount of planned dietitian guidance at baseline and 
during the intervention, although participants were encouraged to contact dietitians with 
any questions. The baseline face-to-face dietary consultation (45–60 minutes) with one of the 
three trial dietitians at the UHCC included instructions on how to follow their respective 
diet and physical activity plan. All participants received personalized diet booklets, 
individualized food lists and menus, and trackers to help them follow their plans at home. 
The IER+MED materials were originally developed and tested by Harvie et al. amongst 
white women in the UK [22,41]. Therefore, the food lists and menus were modified to 
provide examples of foods and beverages more commonly available in Hawaii, e.g., papaya, 





designed in 100 kcal increments, e.g., 1500 kcal, 1600 kcal, 1700 kcal. For example, 
participants with an EER of 2030 kcal were assigned an energy allotment rounded to the 
closest 100 kcal, i.e., 2000 kcal. If randomized to the IER+MED group, the energy allotment 
would have been 2000 kcal on MED days and 600 kcal on IER days. As an example, a food 
group prescription on MED days for the 2000 kcal plan was 8 carbohydrate servings, 8–14 
protein servings, 7 fat servings, 3 dairy servings, 6 vegetable servings, and 4 fruit servings, 
and a maximum of three nutrient-poor treats of ≤ 150 kcal per week. On IER days, the 
primary restrictions were energy and carbohydrate, and a 600 kcal plan was comprised of 
2–12 protein servings, 2 fat servings, 3 dairy servings, 5 vegetables servings and 1 fruit 
serving. If randomized to the DASH group, using the same example as above, the diet 
prescription for a 2000 kcal plan was 6–8 grain servings, 4–5 fruit servings, 2–3 dairy 
servings, 6 meat, poultry, or fish servings, 4–5 nuts, seeds, or legumes servings, 2–3 fats or 
oils servings, a maximum sodium intake of 2300 mg per day, and 5 or less sweets and added 
sugars servings per week. The personalized diet booklets detailed the amounts for servings 
of each food group and provided examples of types of foods to choose from within each 
food group. To support the dietary counseling, study dietitians underwent training in 
behavioral change strategies using the Body and Soul program [42–44]. In particular, the 
training focused on motivational interviewing techniques, ensuring the dietitians practiced 
reflective listening and provided positive affirmations rather than relying heavily on 
persuasion or advice giving [42–44]. Dietitians contacted participants at Weeks 1, 2, 3, 4, 6, 
8 and 10, primarily by telephone, and met in person with participants during the final clinic 
visit, to assess participants’ compliance to the intervention plans and guide positive 
behavioral change. 
 
4.4.4 Study Measurements 
Dietary intakes were assessed using the mFR™ completed at baseline, between Weeks 
5–6, and at Week 11. The mFR™ is designed to capture images of foods/beverages before and 
after each eating occasion and allows for automatic uploading of images to a secure cloud-
based server when in 3G/4G/Wi-Fi range [28–31]. During the eligibility visit, the mFR™ app 
was loaded onto each participant’s mobile device by a study dietitian. Participants were 
trained on how to use the mFR™ and provided with a fiducial marker (a small reference 
device of known dimensions and colors) to include in images [30,31]. All participants were 
asked to use the mFR™ over four contiguous days including at least one weekend day to 
capture a baseline mFR™ between the eligibility and baseline clinic visits. After the baseline 
clinic visit, participants in the IER+MED group were asked to keep mFRs™ of their two IER 
days bookended by two MED days, e.g., MED-IER-IER-MED at Weeks 5–6 and Week 11. 
Participants in the DASH group were asked to keep to the same recording days as their 
baseline record for recording their Weeks 5–6 and Week 11 mFRs™. Images from the mFR™ 
were reviewed in person with a dietitian at the baseline and the final clinic visits, and over 
the phone at Week 6. All participants were willing to download the app, except five could 
not due to owning an incompatible phone (n = 3), full phone memory (n = 1), or phone 
lacking features to run app (n = 1). Consequently, these five participants completed written 
records [45,46]. Data entry of before and after images of food and beverages followed the 
methods by Kerr et al [29,47]. Briefly, dietitians underwent analyst training before entering 
the food and beverage data into RapidCalc, a dietary data entry program developed at 





images. This task was completed with the assistance of a fiducial marker [50] for size 
estimation, and an additional foods questionnaire (completed by participants at baseline) to 
help identify occluded foods, e.g., type of milk in tea or coffee. A priori, only dietary records 
with at least two days of recording and at least one eating occasion captured on each day 
were to be included in the analysis. 
Clinic measures were taken at baseline and Week 12. Anthropometric, body 
composition, fasting bloods, and blood pressure measures were collected using the same 
protocol as Lim et al [11]. Briefly, whole-body composition was determined by DXA 
(Hologic Discovery A fan-beam densitometer, Hologic Inc. (Bedford, MA, USA) using APEX 
3.3). Fat mass and lean mass were estimated for the whole body, trunk, arms, and legs, from 
which skeletal muscle mass was derived [51,52,53]. For VAT and SAT outcomes, we used 
visceral and subcutaneous fat area estimates for L4-L5 derived from DXA parameters. 
Trained technicians obtained measurements of height, weight, and circumferences of the 
waist and hip. Fasting blood samples were processed at the UHCC and analyzed at the 
UHCC Analytical Biochemistry Shared Resource Laboratory for plasma levels of total 
cholesterol, high-density (HDL and low-density (LDL) cholesterol, glucose, insulin, alanine 
transaminase (ALT), and aspartame transaminase (AST). Blood pressure in the left arm was 
measured in a sitting position after 20 minutes of rest using a digital monitor (Omron HEM-
907XL, Omron Healthcare, Inc. (Lake Forest, IL, USA)). Physical activity levels (PALs) were 
assessed at baseline using a physical activity questionnaire previously validated for the 
MEC [54]. The questionnaire was designed to reflect average physical activity per day 
completed in the preceding year, including moderate-to-vigorous activity [54]. The baseline 
physical activity questionnaire was modified for the Week 12 visit, with participants being 
asked to recall physical activity in the preceding week. 
During the telephone calls at Weeks 1, 2, 3, 4, 6, 8 and 10, and the in person visit at Week 
12, participants in the IER+MED group self-reported how many IER days they had 
successfully completed in the most recent week, i.e., 0, 1, or 2 days. All participants were 
also asked, “How well have you been following your diet plan? On a scale of zero to ten 
with zero being not at all, four being somewhat, and ten being following the plan very well, 
where would you place yourself?” and “How well have you been following your physical 
activity plan? On a scale of zero to ten with zero being not at all, four being somewhat, and 
ten being following the plan very well, where would you place yourself?”. Participants were 
also encouraged to report any minor or major adverse effects experienced during the study 
(e.g., adverse reactions associated with performing DXA, phlebotomy, or from following the 
diet). 
 
4.4.5 Six-Month Post-Intervention Telephone Interview 
At 6 months post-intervention, participants who completed the study were interviewed 
over the telephone. These calls were conducted by trained recruitment staff not involved in 
the 12-week intervention counseling. Quantitative questions included current weight, still 
following the intervention diet plan (yes/no) and extent (same, better, not as well), 
willingness to follow the prescribed diet longer than 3 months (yes/no), and interest in 
nutrition/food preparation classes (yes/no). Open-ended qualitative questions related to 
current health issues, physical activity, description of type of diet currently being followed, 
and suggestions on how the study could be improved were also asked. This paper 






4.4.6 Statistical Analysis  
Continuous variables are reported as means ± SDs or SEMs, and categorical variables 
are reported as counts and percentages. The analysis followed an intention-to-treat-
analyses, where all individuals were analyzed in a randomization group, regardless of 
compliance. A linear mixed model was fit for each outcome. This model uses of all available 
data to estimate the treatment effects over time using maximum likelihood estimation under 
a missing-at-random assumption [55,56]. The model included an indicator variable for 
intervention group (IER+MED vs. DASH), indicator variable for time (Week 12 vs. baseline, 
or Weeks 5–6 vs. baseline and Week 11 vs. baseline for diet), and interaction terms between 
group and time. The F test was used to assess the intervention effect, defined as the contrast 
of change in IER+MED minus change in DASH. Outcome variables included: dietary 
intakes, body measurements, biomarkers, and physical activity. The following comparisons 
were made across time points: Week 12 vs. baseline for body measurements, physical 
activity, and biomarkers, and Weeks 5–6 vs. baseline, Week 11 vs. baseline, and Weeks 5–6 
vs. Week 11 for diet. No transformations of the outcomes were needed to meet model 
requirements as values for change over time were approximately normal and 
homoscedastic. To test the specific effects of the IER+MED intervention on VAT and 
biomarkers independent of those on total adiposity, additional models were run adjusting 
for concurrent total fat mass. Model-predicted adjusted means at each time point for each 
group were computed. Diet data are represented as group mean daily intakes. For DASH, 
the mean across four food record days were taken, while for the IER+MED group, means 
were computed by IER and MED days and then an overall average was computed, 
weighting the IER mean by 2 and the MED mean by 5. Per protocol analyses, changes in diet 
and body measurements were also conducted only among those completing the 
intervention (i.e., had a Week 12 assessment). For per protocol analyses, diet data were also 
reported separately for IER and MED days. To verify the reported change in energy intake 
over time, for both study groups, the expected weight change at 12 weeks was compared to 
measured weight change at Week 12. An energy deficit of 500 to 1000 kcal/day is estimated 
to result in a weight loss of 0.45 to 0.90 kg/week [57,58]. The average difference per day 
between energy intakes at baseline and Week 11 was estimated as the average of the change 
from baseline to Weeks 5–6 and the change from Weeks 5–6 to Week 11, which were 
calculated from a mixed model of energy on time, for both groups. The average change in 
weight in pounds was then calculated as the estimated change in energy per day from 
baseline to Week 11 converted to pounds of weight loss as [change in energy/500] x 12 
weeks. A 95% confidence interval for change in weight was computed by converting the 
limits of a 95% confidence interval for change in energy. 
Alcohol, vitamin and mineral intake, and the proportion of participants meeting the US 
estimated average requirement (EAR) for vitamin and mineral intake at baseline, Weeks 5–
6 and 11 are reported for both groups. Statistical significance was defined as p < 0.05. Data 
were analyzed using SAS version 9.4 software (SAS Institute Inc., Cary, NC, USA) and IBM 







4.5.1 Study Population 
The stratified randomized sampling was successful, with men and women being 
distributed evenly between groups, and participants with high (< 150 cm2) and very high (≥ 
150 cm2) VAT being distributed almost equally between groups (Table 4.1). After 12 weeks, 
four participants dropped out of the IER+MED group and two out of the DASH group; 
therefore, 87% (n = 26) of participants in the IER+MED group and 93% (n = 28) in the DASH 
group completed the study (Figure 4.1). One participant from the IER+MED group dropped 
out due to not being able to adhere to the diet and the other five participants dropped out 
for reasons unrelated to the study (e.g., work, medical reasons). There were no major 
adverse effects reported during the intervention.  
 
Table 4.1 Randomization and baseline characteristics of study participants by the intermittent 
energy restriction combined with a Mediterranean diet (IER+MED) and dietary approaches to stop 
hypertension (DASH) groups. 
Variable 
Randomization Group 
IER+MED (n = 30) DASH (n = 30) 
Men 9 9 
Visceral adipose tissue category (%)   
High (90 < 150 cm2) 6 (67%) 6 (67%) 
Very high (≥ 150 cm2) 3 (33%) 3 (33%) 
Women 21 21 
Visceral adipose tissue category (%)   
High (80 < 150 cm2) 13 (62%) 14 (67%) 
Very high (≥ 150 cm2) 8 (38) 7 (33%) 
Characteristics (Men and Women)   
Age (years) 48.4 ± 4.7 46.2 ± 5.4 
Height (m) 1.6 ± 0.1 1.6 ± 0.1 
Weight (kg) 79.3 ± 12.5 81.0 ± 12.5 
Visceral adipose tissue area (cm2) 134.6 ± 6.4 135.3 ± 6.4 
Body mass index (kg/m2) 30.5 ± 3.5 30.8 ± 3.3 
Moderate or vigorous physical activity (hours/day) 1.6 ± 0.2 1.4 ± 0.3 
Ethnicity (%)   
Chinese 23.3 6.7 
Japanese 56.7 63.3 
Korean 10.0 13.3 
Mixed Asian 10.0 16.7 
Data are presented as mean ± standard deviation (SD) or number (%). IER+MED: Intermittent energy 
restriction combined with a Mediterranean diet. DASH: Dietary Approaches to Stop Hypertension 
diet. 
4.5.2 Intervention Adherence  
The IER+MED participants completed 90.6% of the allocated IER days. Ninety six 
percent of these IER days were completed as two consecutive IER days and the remainder 
completed at least one IER day per week. For the IER+MED group, the mean self-rated 
compliance to the diet prescription and the self-rated compliance to the physical activity 
prescription were 7.7 at Week 1, Week 6, and Week 12 using the scale of 0–10. For the DASH 
group, the respective self-rated compliance rates were 6.7, 6.8, and 6.4 for diet and 6.4, 7.3, 
and 6.9 for physical activity. Data from the physical activity questionnaires support there 
being no significant change in physical activity from baseline to Week 12 for within the 





respectively, p = 0.49) and the DASH group (1.39 ± 0.22 to 1.27 ± 0.22 hours of moderate or 
vigorous activity/day, p = 0.58) or between groups (p = 0.91). Both groups met the physical 
activity recommendations at the beginning and end of the intervention. 
Overall, there was a 23% decrease in mean daily energy intake for the IER+MED group 
from baseline (1,590 kcal) to Weeks 5–6 (1227 kcal), and a 28% decrease between baseline 
and Week 11 (1152 kcal) (Table 4.2). Mean energy allotment for the IER days was 692 kcal 
(range 540 to 960 kcal). Estimated mean energy intakes on IER days were 960 kcal at Weeks 
5–6 and 929 kcal at Week 11 (Appendix B). For the MED days, the mean energy allotment 
was 2307 kcal (range 1800 to 3200 kcal). Estimated mean energy intakes on MED days were 
1222 kcal at Week 5–6 and 1144 kcal at Week 11. For the DASH group, energy intake 
decreased by 22% between baseline (1803 kcal) and Weeks 5–6 (1414 kcal) and by 16% 
between baseline and Week 11 (1507 kcal) as seen in Table 4.2. Mean energy allotment was 
2300 kcal (range 1800 to 3400 kcal). 
The prescriptions for percentage energy from protein, carbohydrates and total fats for 
the IER+MED group were approximately 28%, 42%, and 31%, respectively (weighted for 
two IER days and five MED days). By Week 11, participants in this group increased their 
percentage energy from protein from 18.7% to 25.7%, almost matching the prescription of 
28%. The mean percentage energy from carbohydrates decreased from 44.8% to 35.1% which 
was lower than the goal of 42%. Percentage energy from total fats increased from 36.6% to 
40.2%, as compared to the recommended of 31%. When examined as absolute intake, 
participants in the IER+MED decreased their mean intakes of total fats from 64.7 g at baseline 
to 51.8 g at Week 11, and their mean intakes of carbohydrates from 180 g to 103 g. Since the 
drop in grams of carbohydrates was proportionally larger than the drop in total fats, 
percentage of energy from carbohydrates decreased and percentage energy from total fats 
increased. For the DASH group the recommended percentage energy from protein, 
carbohydrates and total fats was 20%, 53%, and 30%, respectively. By Week 11, the DASH 
group increased percentage energy from protein from 17.3% to 18.9%, with the goal of 
reaching 20%. At baseline, percentage energy from carbohydrates and total fats were 44.1% 
and 38.3%, respectively, and did not significantly change by Week 11. Assessing absolute 
intakes, mean carbohydrate intakes dropped from 198 g to 169 g and mean intakes of total 
fats decreased from 77.6 g to 62.7 g. Total energy intake also decreased by Week 11; 
therefore, the drop in grams of carbohydrates and total fats consumed did not affect 
percentage of energy from these macronutrients. For both the IER+MED and DASH groups 
there were no significant changes in total energy (kcal); percentage energy from total 
protein, fat, or carbohydrate; and grams of protein, fat, or carbohydrate consumed between 
Weeks 5–6 and Week 11. In per protocol analyses, similar patterns were seen (Appendix B). 
At Week 11, and only among the IER+MED group, reductions in calcium, thiamin, and 
folate intakes were observed, as well as, the proportion of participants meeting the EAR for 
calcium, thiamin, and folate (Appendix I-J). A more detailed description of alcohol and 
micronutrient intake and proportion of participants meeting the EAR for micronutrients can 






Table 4.2 Dietary intake assessed using 4-day mobile food records (mFR™) captured by participants 
in the IER+MED group (n = 30) and the DASH group (n = 30) across three time points 1. 
Variable Baseline Weeks 5–6 p 2 Week 11 p 3 
Energy (kcal)      
IER+MED 4 1590 ± 078 1227 ± 085 <0.0001 1155 ± 077 <0.0001 
DASH 1803 ± 111 1414 ± 096 0.001 1507 ± 100 0.001 
Protein (g)      
IER+MED 73.0 ± 3.6 74.9 ± 5.0 0.692 72.7 ± 4.2 0.946 
DASH 76.5 ± 4.6 66.1 ± 4.8 0.055 70.6 ± 4.7 0.128 
Protein (% energy)      
IER+MED 18.7 ± 0.7 24.9 ± 1.0 <0.0001 25.7 ± 1.1 <0.0001 
DASH 17.3 ± 0.6 18.7 ± 0.5 0.115 18.9 ± 0.5 0.011 
Carbohydrate (g)      
IER+MED 180 ± 11 115 ± 10 <0.0001 103 ± 09 <0.0001 
DASH 198 ± 13 160 ± 12 0.013 169 ± 12 0.008 
Carbohydrate (% energy)      
IER+MED 44.8 ± 1.5 37.3 ± 1.6 <0.0001 35.1 ± 1.6 <0.0001 
DASH 44.1 ± 1.2 44.8 ± 1.1 0.650 45.2 ± 1.3 0.418 
Total fat (g)      
IER+MED 65 ± 4 53 ± 5 0.015 52 ± 4 0.001 
DASH 78 ± 6 57 ± 4 <0.0001 63 ± 5 0.001 
Total fat (% energy)      
IER+MED 36.6 ± 1.1 39.1 ± 1.4 0.140 40.2 ± 1.2 0.014 
DASH 38.3 ± 1.1 36.7 ± 1.1 0.183 36.8 ± 1.3 0.234 
Saturated fatty acids (% energy)      
IER+MED 11.5 ± 0.4 11.1 ± 0.6 0.560 11.6 ± 0.6 0.854 
DASH 11.7 ± 0.5 11.0 ± 0.4 0.092 11.8 ± 0.5 0.830 
Monounsaturated fatty acids (% energy)      
IER+MED 13.6 ± 0.4 15.0 ± 0.6 0.055 15.9 ± 0.6 0.001 
DASH 14.5 ± 0.5 13.6 ± 0.5 0.111 13.9 ± 0.6 0.357 
Polyunsaturated fatty acids (% energy)      
IER+MED 8.4 ± 0.5 9.6 ± 0.5 0.093 8.8 ± 0.5 0.426 
DASH 9.0 ± 0.5 9.0 ± 0.6 0.994 7.7 ± 0.4 0.093 
Dietary fiber (g)      
IER+MED 13.0 ± 1.0 12.8 ± 0.9 0.874 11.9 ± 1.0 0.297 
DASH 13.4 ± 1.1 14.1 ± 1.3 0.661 13.7 ± 1.0 0.814 
Data are presented as mean/day ± standard error of the mean (SEM). IER+MED: 
Intermittent energy restriction combined with a Mediterranean diet. DASH: Dietary 
Approaches to Stop Hypertension diet.1 All data analyzed using an intention-to-treat 
approach with a linear mixed model for all 60 participants. 2 Within group difference from 
baseline to Weeks 5–6. 3 Within group difference from baseline to Week 11. 4 Weighted for 










4.5.3 Changes in Anthropometric, DXA, and Biomarker Measurements at Week 12 
Both the IER+MED and the DASH groups experienced significant reductions in all 
anthropometric and DXA measurements from baseline to Week 12 (Table 4.3). Between 
groups, the IER+MED group had a significantly greater loss of weight, BMI, waist 
circumference, hip circumference, percentage body fat, fat mass, muscle mass, total lean 
body mass, VAT, and SAT compared to the DASH group (Table 4.3). These decreases in 
anthropometric and DXA measures were close to double for the IER+MED group compared 
to the DASH group and over three times the amount for change in SAT. In the IER+MED 
group, approximately 73% of participants lost 5% or greater of their weight and 27% of 
participants lost 10% or greater of their weight. In the DASH group, these were 32% and 7%, 
respectively. Per protocol analyses, showed similar results for change in anthropometric and 
DXA measurements between and within groups (Appendix K). After adjusting for 
concurrent total fat mass, change in VAT was no longer significantly different between 
groups (IER+MED −8.6 ± 3.1 cm2 vs. DASH −3.7 ± 2.6 cm2, p = 0.188). The VAT/SAT ratio did 
not change significantly for either group between baseline and Week 12 (Table 4.3). Based 
on the average difference per day between energy intakes at baseline and Week 11, and the 
guidelines of an energy deficit of 500 to 1,000 kcal/day is estimated to result in a weight loss 
of 0.45 to 0.90 /week, the expected mean (95% CI) weight loss for the IER+MED group at 
Week 12 was 5.1 (2.5–7.8) kg. Actual mean weight loss at Week 12 was 5.9 kg; therefore, fell 
within the expected range. For the DASH group, expected mean weight loss at Week 12 was 
3.6 (0.2–6.9) kg. Actual weight loss was 3.3 kg; therefore, also fell within the expected range. 
All fasting blood biomarkers (total and LDL cholesterol, triglycerides, insulin, ALT, and 
AST), except HDL cholesterol, and systolic and diastolic blood pressure significantly 
improved in the IER+MED group, whereas only triglycerides, insulin, and blood pressure 
improved in DASH (Table 4.4). Only the improvement in ALT was significantly greater in 
the IER+MED group compared to the DASH group (p = 0.04), which was maintained after 























Table 4.3 Baseline, Week 12, and change in anthropometric measures within and between the 
IER+MED group (n = 30) and DASH group (n = 30) 1. 
Variable Baseline Week 12 p 2 Change p 3 
Weight (kg)      
IER+MED  79.3 ± 2.2 73.4 ± 2.2 <0.0001 −5.9 ± 0.7 0.007 
DASH 81.0 ± 2.2 77.8 ± 2.2 <0.0001 −3.3 ± 0.6  
Body mass index (kg/m2)      
IER+MED 30.5 ± 0.6 28.3 ± 0.6 <0.0001 −2.2 ± 0.2 0.002 
DASH 30.8 ± 0.6 29.6 ± 0.6 <0.0001 −1.2 ± 0.2  
Waist circumference (cm)      
IER+MED 100.3 ± 1.6 93.3 ± 1.6 <0.0001 −6.9 ± 0.8 0.026 
DASH 100.7 ± 1.6 96.2 ± 1.6 <0.0001 −4.5 ± 0.7  
Hip circumference (cm)      
IER+MED 107.7 ± 1.3 102.5 ± 1.3 <0.0001 −5.3 ± 0.5 0.021 
DASH 107.3 ± 1.3 103.9 ± 1.3 <0.0001 −3.4 ± 0.5  
Body fat (%)       
IER+MED 33.4 ± 1.2 31.3 ± 1.2 <0.0001 −2.0 ± 0.4 0.021 
DASH 33.0 ± 1.2 32.1 ± 1.2 0.023 −0.8 ± 0.4  
Fat mass (kg)      
IER+MED 26.4 ± 1.1 23.1 ± 1.1 <0.0001 −3.3 ± 0.4 0.005 
DASH 26.4 ± 1.1 24.9 ± 1.1 <0.0001 −1.6 ± 0.4  
Muscle mass (kg)       
IER+MED 21.9 ± 0.9 20.8 ± 0.9 <0.0001 −1.1 ± 0.2 0.013 
DASH 22.3 ± 0.9 21.8 ± 0.9 0.005 −0.5 ± 0.2  
Total lean body mass (kg)       
IER+MED 52.6 ± 1.8 50.4 ± 1.8 <0.0001 −2.3 ± 0.4 0.040 
DASH 54.3 ± 1.8 53.1 ± 1.8 0.002 −1.2 ± 0.4  
Visceral adipose tissue area (cm2)       
IER+MED 134.6 ± 6.4 112.0 ± 6.5 <0.0001 −22.6 ± 3.6 0.022 
DASH 135.3 ± 6.4 124.5 ± 6.5 0.003 −10.7 ± 3.5  
Subcutaneous adipose tissue area (cm2)       
IER+MED 373.1 ± 16.2 324.9 ± 16.4 <0.0001 −48.2 ± 6.4 <0.0001 
DASH 359.0 ± 16.2 344.0 ± 16.3 0.018 −15.0 ± 6.1  
VAT/SAT ratio 4      
IER+MED 0.38 ± 0.02 0.36 ± 0.02 0.157 −0.01 ± 0.01 0.825 
DASH 0.39 ± 0.02 0.37 ± 0.02 0.076 −0.01 ± 0.01  
Data are presented as mean ± standard error of the mean (SEM). IER+MED: Intermittent 
energy restriction combined with a Mediterranean diet. DASH: Dietary Approaches to Stop 
Hypertension diet. 1 All data analyzed using an intention-to-treat approach with a linear 
mixed model for all 60 participants. 2 Within group difference from baseline to Week 12. 3 
Between group difference (IER+MED vs. DASH) from baseline to Week 12. 4 Ratio of visceral 






Table 4.4 Baseline, Week 12, and change in metabolic risk biomarkers within and between the 
IER+MED group (n = 30) and the DASH group (n = 30) 1. 
Variable Baseline Week 12 p 2  Change p 3 
Cholesterol (mg/dL)       
IER+MED  237.0 ± 10.3 219.5 ± 10.3 0.009 −17.4 ± 6.4 0.356 
DASH 250.0 ± 10.0 240.9 ± 10.0 0.149 −9.1 ± 6.2  
HDL cholesterol (mg/dL)      
IER+MED 38.1 ± 2.4 39.6 ± 2.4 0.396 1.5 ± 1.8 0.610 
DASH 32.1 ± 2.3 34.9 ± 2.3 0.110 2.8 ± 1.7  
LDL cholesterol (mg/dL)      
IER+MED 178.5 ± 9.2 164.5 ± 9.2 0.019 −14.0 ± 5.8 0.585 
DASH 188.6 ± 9.1 179.1 ± 9.1 0.104 −9.5 ± 5.8  
Triglycerides (mg/dL)      
IER+MED 101.9 ± 26.2 77.1 ± 26.2 0.004 −24.8 ± 8.2 0.809 
DASH 165.5 ± 25.2 143.5 ± 25.2 0.008 −22.0 ± 7.9  
Alanine transaminase (U/L)      
IER+MED 33.8 ± 3.2 20.1 ± 3.2 0.001 −13.8 ± 3.7 0.038 
DASH 19.5 ± 3.1 16.6 ± 3.1 0.419 −2.9 ± 3.6  
Glucose (mg/dL)      
IER+MED 104.3 ± 4.2 102.2 ± 4.2 0.374 −2.1 ± 2.4 0.928 
DASH 104.9 ± 4.1 102.5 ± 4.1 0.294 −2.4 ± 2.3  
Aspartame transaminase (U/L)       
IER+MED 23.8 ± 1.8 18.1 ± 1.8 0.012 −5.7 ± 2.2 0.179 
DASH 18.9 ± 1.7 17.3 ± 1.7 0.462 −1.6 ± 2.1  
Insulin (mU/L)      
IER+MED 13.9 ± 1.7 8.8 ± 1.7 <0.001 −5.1 ± 1.2 0.134 
DASH 14.6 ± 1.6 12.0 ± 1.6 0.027 −2.5 ± 1.7  
Systolic blood pressure (mm Hg)      
IER+MED 133.2 ± 2.5 124.3 ± 2.7 <0.001 −9.0 ± 2.5 0.345 
DASH 133.4 ± 2.5 127.7 ± 2.6 0.024 −5.7 ± 2.4  
Diastolic blood pressure (mm Hg)      
IER+MED 84.2 ± 1.7 77.5 ± 1.8 <0.001 −6.7 ± 1.5 0.124 
DASH 86.2 ± 1.7 82.8 ± 1.8 0.021 −3.4 ± 1.4  
Data are presented as mean ± standard error of the mean (SEM). IER+MED: Intermittent 
energy restriction combined with a Mediterranean diet. DASH: Dietary Approaches to Stop 
Hypertension diet. 1 All data analyzed using an intention-to-treat approach with a linear 
mixed model for all 60 participants. 2 Within group difference from baseline to Week 12. 3 
Between group difference from baseline to Week 12. 
4.5.4 Six-month Post-Intervention Telephone Interview 
Among participants completing the 6-month post-intervention telephone interview, for 
the IER+MED group there was no significant change in body weights measured at Week 12 
and self-reported at 6 months post study (Table 4.5). For the DASH group there was a 
significant increase in body weights (p = 0.03). During the post-intervention telephone call, 
both the IER+MED and DASH groups reported physical activity of over 3.5 hours/week 
(mean). In addition, 71.4% of participants in the IER+MED group, compared to 88.0% in the 
DASH group, reported they were able to follow the prescribed diet longer than three months 
after the study finished (Table 4.5). The mean amount of time participants could follow the 





group. In addition, almost two-thirds, 66.7%, of participants in the IER+MED group were 
still following their diet prescription at the time of the post-intervention telephone call, with 
6.7% reporting they were still following the diet protocol the same as they were when 
completing the study. For the DASH group, 44.0% of participants were still following their 
diet prescription at the time of the post-intervention telephone call and 25.0% reported they 
were still following the diet protocol the same as during the study.  
 
Table 4.5 Self-reported data collected during the 6-month post-intervention telephone interview for 
participants in the IER+MED group (n = 22) and the DASH group (n = 26), who completed the 
intervention. 
Variable IER+MED DASH 
Weight (kg) 75.5 ± 2.7 77.9 ± 3.2 
Change in weight between Week 12 1 and 6-month post-intervention (kg) 2 1.0 ± 3.8  1.1 ± 2.1* 
Physical activity (hours/week) 3.8 ± 0.4 3.6 ± 0.6 
Able to follow the diet prescription for longer than 3 months (%)   
No 28.6 12.0 
Yes 71.4 88.0 
If yes, for how many more months? 5.0 ± 0.6 3.6 ± 0.5 
Still following the diet prescription (%)   
No 33.3 56.0 
Yes 66.7 44.0 
If yes, following the diet the same, better, not as well, or other (%)   
Same 6.7 25.0 
Better 0.0 0.0 
Not as well 80.0 66.7 
Same and not as well 13.3 0.0 
Other 0.0 8.3 
Would nutrition classes and/or food preparation classes been helpful (%)   
No 13.6 24.0 
Yes 86.4 76.0 
Data are presented as mean ± standard deviation (SD) or number (%). IER+MED: 
Intermittent energy restriction combined with a Mediterranean diet. DASH: Dietary 
Approaches to Stop Hypertension diet. 1 Weight measured at Week 12 visit. 2 Analyses 
completed using paired samples t-tests. * p ≤ 0.03. 
4.6 Discussion 
This is the first known pilot study to evaluate the effectiveness of a culturally adapted 
IER+MED vs. an active comparator (DASH diet) to reduce DXA measured VAT among East 
Asian Americans. This study was also unique in that the mFR was used to capture dietary 
intake. Despite the IER+MED diet being different to traditional and acculturated Asian diets, 
participants complied well to prescriptions. For both study arms, the recommendations, 
which appeared most difficult to achieve were those for carbohydrate and fat, with 
percentage of energy from carbohydrates being consistently lower than recommended and 
percentage of energy from total fats being consistently higher. Despite reductions in energy 
intake, the proportion of fiber in the diet, for the IER+MED and DASH groups, was higher 
at Week 12 than baseline. Both study groups had significant reductions in VAT, weight, and 
total adiposity. Although loss of VAT was greater in IER+MED than in DASH, this appeared 





difference after adjusting for concurrent total fat mass. For IER+MED, we observed general 
improvements in metabolic risk biomarkers, particularly in total and LDL cholesterol, 
triglycerides, ALT, AST, insulin, systolic and diastolic blood pressure. Only the reduction in 
ALT was significantly greater in IER+MED vs. DASH, a difference maintained after 
adjusting for concurrent total fat mass. This indicates a potentially greater benefit of 
IER+MED on liver function, compared to a healthful dietary pattern [59]. The observed 
results were not due to differences in physical activity as both groups reported similar levels 
of physical activity at the beginning and end of the intervention, and these levels met the 
physical activity recommendations. This pilot study demonstrated that an IER+MED vs. 
DASH intervention can be successfully conducted with East Asian Americans, and with a 
low attrition rate of 10%. 
Consistent with our results, other IER trials involving two energy restricted days as 
consecutive or non-consecutive restricted days (termed “5:2”[55]) have reported high study 
retention and protocol adherence [22,55,60,61]. Attrition rates range from 4.2% to 23% 
[22,55,60,61], which supports observations of participants being able and willing to complete 
“5:2” trials. In the “5:2” study by Harvie et al, a study arm was prescribed a 70% energy 
restriction for two consecutive days and 5 non-restricted days following a euenergetic MED 
diet [22]. Over three months, participants in the IER study arms in the Harvie et al trial 
completed 74–76% of their two IER days, indicating high study compliance [22]. Similarities 
between the current study and the Harvie et al. trials were energy intake was higher than 
prescribed on IER days, and energy and carbohydrate intakes were lower than prescribed 
on non-restricted days [22]. This highlights that participants do well at completing their IER 
days, but may need extra support with meeting their energy and carbohydrate 
prescriptions. Results from the current study also support previous findings that 
participants do not over eat on non-restricted days [18,22]. Harvie et al [22] hypothesized 
that the reduced intake on non-restricted days could be due to behavioral aspects of 
following IER (e.g., IER made participants more aware of habitual intakes, and increased 
awareness of appetite and hunger). Also, for both groups, dietitians promoted consuming 
high quality unprocessed diets on euenergetic days, which may have resulted in 
participants consuming less energy than prescribed [62]. As part of the post-intervention 
follow up call, the majority of participants from both groups reported nutrition classes 
and/or food preparation classes would have been helpful. Incorporating nutrition classes 
and/or food preparation classes may be a useful strategy to improve compliance to dietary 
prescriptions [63]. 
We observed no preferential loss of VAT in the IER+MED group compared to the DASH 
group after adjusting for concurrent total fat mass. The results of this analysis could be 
clinically true if the DASH group was able to lose similar amounts of fat mass to the 
IER+MED group and maintain this loss. However, results suggest that IER+MED is easier to 
follow than the euenergetic DASH, and weight loss easier to maintain. For example, self-
rated dietary compliance scores were higher for IER+MED (7.7 at Weeks 1, 6 and 12) 
compared to DASH (6.7, 6.8, and 6.4, respectively), and at 6-months post-intervention 66.7%, 
of the IER+MED group vs. 44.0% of the DASH group reported still following their diet 
prescriptions. In addition, between the Week 12 visit and the 6-month post-intervention 
telephone interview, amongst participants completing the call, self-reported weight 
suggested that weight loss was maintained in the IER+MED group and that weight 
increased in the DASH group. These results are promising as CER is known to be difficult 





VAT data were not collected at 6-months post intervention; however, given the self-
report of weight maintenance, it is likely that loss of VAT was also maintained in the 
IER+MED group [15]. The only known “5:2” IER trial to assess the effect of IER on VAT is 
the HELENA trial carried out over 50 weeks [55]. This trial found that IER did not exert 
stronger effects on VAT loss than CER [55]; however, their trial incorporated two non-
consecutive restriction days. Incorporating two consecutive vs. non-consecutive restriction 
days may have differing effects on health outcomes. The former may likely produce higher 
reductions on insulin resistance and percentage body fat [22,55]. Therefore, further long 
term studies are needed to assess the effects of “5:2” trials with 2 consecutive restriction days 
on VAT. The IER+MED and DASH groups reduced VAT proportionally to their change in 
total adiposity and the difference between groups may be due to the difference in energy 
intakes. Diets limited in sodium and more in line with the DASH diet, have been associated 
with lower VAT [27,64], which likely contributed, along with the observed decrease in 
energy intake, to the loss of VAT in the DASH group. These improvements in VAT may 
explain the lack of significant difference between groups in most metabolic risk biomarkers. 
The greater improvement in ALT in the IER+MED group vs. the DASH group is important 
as ALT is a biomarker for NAFLD [59]. Significant reductions in ALT in the IER+MED group 
even after adjusting for change in total adiposity suggest improvements in liver function, 
beyond that obtained by VAT reduction alone [59]. However, liver fat measurement e.g., by 
abdominal MRI scans are needed to confirm this. The decrease in ALT when following 
IER+MED is consistent with the European guidelines for NAFLD, which recommend 
following a MED diet and energy restriction to improve NAFLD [26]. 
For the IER+MED group, there was a reduction in dietary calcium, thiamin, and folate 
intakes, and in the proportion of participants meeting the EAR for calcium, thiamin, and 
folate. Past “5:2” studies have also reported reductions in micronutrients [22,61]; for 
example, Harvie et al expressed concern about lower intakes of calcium, iron, zinc, vitamins 
A and D and fiber in the IER groups [22]. Previous “5:2” trials, have prescribed a healthful 
diet [22,55] or recommended participants follow their usual diet [60,61] on non-restricted 
days. Given the large energy deficit on restricted days, prescribing a balanced diet on non-
restriction days along with a nutritional supplement may help to limit any possible 
deficiencies. In the current study, blood measurements to assess nutritional deficiencies 
were not completed. Across “5:2” trials, including the current study, there were no reported 
serious adverse effects [22,55,61]. 
The strengths of the design for the current study include the stratified random design, 
the inclusion of an active comparator, blinding of participants and study staff (other than 
dietitians) to group allocations, the ethnic/racial tailoring of the intervention prescriptions, 
and providing the same physical activity recommendations for both study arms. Another 
strength was the low attrition rate, which added to the validity and reliability of study 
results. The reliability is evident from the similarity in results between the intention-to-treat 
analyses using all participants (n = 60) and the per protocol analyses using only participants 
who completed the study (n = 54). Additional strengths were the use of the mFR™ for 
assessing dietary intake, which was used to help generate responses to study promotions, 
encourage adherence during the intervention, and allowed the intervention dietitians to 
monitor dietary intakes in real time [28–30,65], and the novel use of DXA to measure VAT. 
Limitations of the current pilot study include the small sample size, which may have 
limited statistical power to show small differences between groups. Also, the possible 





among people with overweight or obesity [66,67]. However, weight loss achieved by 
participants in the IER+MED and DASH groups corresponded well to the average change 
in daily energy intake between baseline and Week 11, indicating at the group level, the 
dietary data was collected and analyzed accurately [57,58]. Another limitation is that results 
from the 6-month post-intervention telephone interview may not be representative of the 
study sample due to not all participants responding and the self-reported nature of the 
information collected. There have been limited studies comparing DXA-based VAT 
measures with CT or MRI and, in the few studies reported, the DXA results overestimated 
VAT, particularly in individuals with higher VAT levels [68–70]. 
 
4.7 Conclusions 
In summary, this randomized pilot study, testing the effects of IER+MED vs. an active 
comparator DASH diet on VAT levels, was successfully conducted among a relatively small 
sample of East Asian Americans in Hawaii. Despite the prior belief among the investigators 
that the IER+MED diet would be challenging to adopt among East Asian Americans, the 
participants complied well to the culturally adapted study prescriptions and the attrition 
rate was low. Visceral adiposity, as well as total fat mass and ALT, were reduced to a greater 
extent in the IER+MED diet group than in the DASH diet group, possibly because the 
observed decrease in energy intake was greater in the IER+MED group. Within groups, 
changes in VAT may have resulted from changes in macronutrient intakes. IER+MED was 
superior to DASH in improving ALT since this improvement was not explained by the 
greater reduction in total fat mass. The results of this pilot study are promising, and further 
studies addressing a larger sample of men and women are needed to confirm the 
effectiveness of the IER+MED diet on change in VAT, and its possible beneficial effect on 
liver fat, in the short term and long term. 
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5.1 Abstract 
Visceral adiposity, more so than overall adiposity, is associated with chronic disease and 
mortality. Known determinants of visceral adiposity include age, sex, ethnicity, and diet 
quality. There is little research exploring the association between diet quality and visceral 
adiposity among a multiethnic adult population. This cross-sectional analysis examined 
the association between diet quality (Healthy Eating Index-2010 (HEI-2010) scores) and 
DXA-based visceral adipose tissue (VAT), overall adiposity, and blood-based biomarkers 
of metabolic risk. 540 adults (18-80 y; white, African American, Asian, Latino, Native 
Hawaiian or Other Pacific Islander) were recruited across 3 sites (Honolulu County, San 
Francisco, and Baton Rouge) for the Shape Up! Adults study. Whole-body DXA, 
anthropometry, fasting blood draw, and questionnaires (food frequency, physical activity, 
demographic characteristics) were completed. Linear regression was used to assess the 
association between HEI-2010 tertiles and VAT in all participants and age-specific strata, 
overall adiposity, and blood-based biomarkers while adjusting for known confounders. 
For the study sample, VAT, BMI, body fat percentage, total body fat, trunk fat, insulin, and 
insulin resistance were inversely related to diet quality (all p values < 0.004). When 
stratified by age, diet quality was inversely associated with VAT/SAT (subcutaneous 
adipose tissue) among participants 40<60 y (p < 0.008), and with VAT among participants 
60<80 y (p < 0.006). Higher quality diet was associated with lower VAT, overall adiposity, 
and insulin resistance among this diverse sample of men and women ranging 18-80 y. More 
specifically, adherence to a high-quality diet may preferentially promote storage of SAT 
vs. VAT in adults 40<60 y, and minimize VAT accumulation in adults 60<80 y. This study 








Excessive abdominal adiposity is known to be more harmful than lower body adiposity 
[1-4]. In particular, higher levels of visceral adiposity are associated with greater risk of 
cardiovascular disease [5], type 2 diabetes [6,7], certain cancers [8-10] and mortality [11-13]. 
Determinants of visceral adipose tissue (VAT) include age [2,4,14], sex [1,2,4], physical 
activity [4,15], ethnicity [2,4], alcohol intake [16], and diet [4,17-19]. With advancing age, 
there are increases in VAT for both men and women across ethnic groups [14]. Ethnic/racial 
heterogeneity has been found to influence the propensity for VAT storage over 
subcutaneous adipose tissue (SAT) [20,21]. In the Multiethnic Cohort Adiposity Phenotype 
Study (MEC-APS), relative to total body fat, VAT was highest in Japanese Americans, lowest 
in African Americans, and intermediate for Native Hawaiians, Latinos, and whites [21]. For 
the effect of diet on VAT, researchers have reported higher intakes of medium-chain 
triglycerides, dietary fiber, calcium, and/or phytochemicals may be associated with lower 
VAT levels, and following a high quality dietary pattern is inversely related to VAT [17,18]. 
Among 1,861 participants 58-74 years of age in the MEC-APS study, results demonstrated 
adherence to a high quality diet (e.g., higher Healthy Eating Index-2010 (HEI-2010) score) 
was associated with lower adiposity, in particular VAT [18]. Studying the effects of 
individual foods on health is important; however, analyses using the whole diet captures 
the synergistic effects of nutrients on health outcomes [22]. Further research is needed to 
examine the effect of diet quality on VAT amongst a multiethnic group across adulthood. 
Given there are no official clinical guidelines for the prevention and treatment of VAT, such 
research may help to inform and tailor interventions targeting loss of VAT.  
The primary aim of this analysis was to assess the association between diet quality as 
defined by the HEI-2010 score and dual X-ray absorptiometry (DXA)-based VAT among a 
cross-sectional sample of multiethnic adults 18-80 years of age in the US. The secondary 
objectives were to explore the relationships between diet quality, overall adiposity, and 
metabolic risk biomarkers.  
 
5.3 Study Participants and Methods 
5.3.1 Study Population 
Shape Up! Adults (NIH R01 DK109008) is a cross-sectional study aiming to recruit 720 
adults (ages 18-80 y) within predetermined strata by sex, age (18<40, 40<60, 60<80 y), BMI 
(<18.5, 18.5-24.9, 25-29.9, ≥30 kg/m2), ethnicity (white, African American, Latino, Asian, 
Native Hawaiian, or Other Pacific Islander), and geographic location (San Francisco, CA, 
Baton Rouge, LA, or Honolulu County, HI). The Shape Up! Adults study began in October 
2016 and the estimated completion date is September 2020. Currently, data are available for 
540 participants (75% of the anticipated study sample), which was used for the current 
analysis. Given this is a secondary analysis, the sample size was predetermined. 
Participants were recruited by convenience sampling [23] at three sites, the Pennington 
Biomedical Research Center (PBRC) (n = 311), University of California San Francisco (UCSF) 
(n=173), and University of Hawaii Cancer Center (UHCC) (n = 56) via flyers, news 
broadcasts, health fairs, and word of mouth. Eligible participants were identified as 
ambulatory individuals who met the study strata requirements. Exclusion criteria included 
current pregnancy, missing limbs, non-removable metal in the body (e.g., joint 
replacements), and a history of body-altering surgery (e.g., liposuction). Those screened as 





responded to the study promotions. Of these, 6,403 people were excluded because they did 
not meet the eligibility criteria, study strata was full, or refusal to participate (Figure 5.1).  
 
5.3.2 Study Measurements 
Study preparations included fasting for at least 8 hours (water and prescription 
medication were allowed). Anthropometric measures, whole-body DXA, a fasting blood 
draw, and a characteristics questionnaire were completed in the clinic at each site. A self-
administered food frequency questionnaire (FFQ) and physical activity questionnaire (PAQ) 
were completed at the clinic (n = 524) or at home (n = 16). As reimbursement for time and 
travel, each participant received a $50 gift card. Participants were provided with their 
whole-body DXA, BMI, and blood biochemistry panel results. All participants provided 
informed consent, and the study protocol was approved by the Institutional Review Boards 
(IRB) at PBRC (PBRC, IRB study #2017-10, FWA #00006218), UCSF (UCSF, IRB #16-20197), 
and the University of Hawaii Office of Research Compliance (UH ORC, CHS #24282). 
Dietary data were collected using the standard format of the Diet History Questionnaire 
II (DHQ II) (Diet History Questionnaire, Version 2.0. National Institutes of Health, 
Epidemiology and Genomics Research Program, National Cancer Institute. 2010). The DHQ 
II is a FFQ consisting of 134 food items and 8 dietary supplement questions to capture intake 
in the past year and typical portion sizes [24,25]. Diet*Calc software (Diet*Calc Analysis 
Program, Version 1.5.0. National Cancer Institute, Epidemiology and Genomics Research 
Program. October 2012.), developed by the National Cancer Institute (NCI), is linked with 
the DHQ II Nutrient Database (DHQ Nutrient Database. dhq2.database.092914.csv. 
National Cancer Institute, Epidemiology and Genomics Research Program) and allows for 
DHQ II data to be analyzed [24]. The DHQ II Nutrient Database is comprised of information 
from the U.S. Department of Agriculture's (USDA) Food and Nutrient Database for Dietary 
Studies (FNDDS), USDA's MyPyramid Equivalents Database, and the Nutrition Data 
System for Research (NDS-R) [26-28]. Study staff transferred the DHQ II into Research 
Electronic Data Capture (REDCap), a secure web-based application for building and 
managing online surveys and databases, and participants completed the DHQ II online. 
Participants were instructed to ask study staff for assistance with the DHQ II if needed. For 
the small number of participants who preferred to complete the DHQ II at home, 
instructions were emailed on how to access and complete the DHQ II remotely. Once 
completed, data were downloaded from REDCap and analyzed using the Diet*Calc 
program for computation of total energy, nutrients, bioactive components and food groups. 
The Diet*Calc results file and SAS code, available through NCI [29], were used to calculate 
HEI-2010 total scores.  
The HEI-2010 is a diet quality index and measures compliance to the 2010 Dietary 
Guidelines for Americans [30]. Higher HEI-2010 scores reflect greater adherence to these 
dietary guidelines [30]. The HEI-2010 scoring system is a 100-point scale comprised of 12 
components worth 5-20 points each, including 9 adequacy components (foods to eat enough 
of) and 3 moderation components (foods to limit) [30]. Adequacy components include Total 
Fruit, Whole Fruit, Total Vegetables, Greens and Beans, Whole Grains, Dairy, Total Protein 
Foods, Seafood and Plant Proteins, and Fatty Acids [30]. Moderation components include 
Refined Grains, Sodium, and Empty Calories (kcal from solid fats, alcohol, and added 
sugars) [30]. The scoring system primarily uses a density based approach (i.e., per 1000 kcal), 





component and for the Fatty Acids component, a specified ratio is used for poly- and 
monounsaturated fatty acids to saturated fatty acids. Collectively these specified scoring 
mechinisms across the components allow common scoring standards to be used [31].  
The Godin-Shephard leisure-time physical activity questionnaire (GSLTPAQ) was used 
to collect data on physical activity level [32]. Questions from the GSLTPAQ were added to 
the end of the online REDCap DHQ II. Briefly, the GSLPAQ consists of three questions, and 
asks in a typical week, how many times more than 15 minutes of strenuous, moderate, and 
mid/light exercise is performed [32]. Answers to the strenuous and moderate activity 
questions can then be used to determine if participants are insufficiently active or active. A 
characteristic questionnaire collected data on sex, age, and ethnicity. Participants who 
identified as multiple ancestries selected the ethnicity with which they identified the most. 
DXA and anthropometric measures were collected using an adaptation of the protocol 
described by Ng et al. [33]. In the current study, two whole-body DXA scans were completed 
and results averaged. Each participant underwent two whole-body DXA scans with 
repositioning on either a Hologic Horizon/A system at UCSF or a Hologic Discovery/A 
system at PBRC and at UHCC (Hologic Inc., Marlborough, MA, USA). Participants were 
scanned according to the manufacturer’s guidelines. All DXA scans were centrally analyzed 
at UHCC by a single certified technologist using Hologic Apex 5.5 software. Output from 
DXA included regional and whole-body percentage body, fat mass, lean soft tissue mass, 
and mean VAT and SAT for L1-L5. DXA cross calibration phantoms were circulated 
between all sites and calibration equations derived to remove systematic bias in all bone and 
soft tissue results. Anthropometric measures of waist circumference (WC) and hip 
circumference (HC) were collected using a flexible measuring tape according to the standard 
protocol from National Health and Nutrition Examination Survey (NHANES) [34]. 
Measurements were recorded in triplicate to the nearest 0.1 cm and results averaged. If a 
measurement differed by greater than 1 cm, a fourth measurement was taken and the closest 
three measurements averaged. 
A whole blood fasting sample of 40 ml was collected from each participant. Blood 
samples were placed on ice and processed within 4 hours into plasma, serum, whole blood, 
and buffy coat components, following which they were stored at -80°C at each study site 
until analysis. Complete blood counts were analyzed at the respective clinic sites. 
Biochemical analyses of all lipid and blood chemistry profiles were performed at PBRC. 
Serum chemistry panels were assayed through the use of a DXC600 instrument (Beckman 
Coulter, Inc.; Brea, CA). Insulin was measured by immunoassay on an Immulite 2000 
platform (Siemens Corporation; Washington, DC). 
5.3.3 Statistical Methods 
Of the 540 participants, analyses were limited to the 468 participants (men, n = 204, 
women, n = 264) who completed the study (excluding n = 4) with accurate DXA scans 
(excluding n = 36), and plausible dietary assessment information (excluding n = 32) (Figure 
5.1).  
Diet quality was scored using the HEI-2010 and total scores were divided into three 
tertiles, with the highest tertile (T3) representing the highest diet quality and the lowest 
tertile (T1) the lowest diet quality. Physical activity level (insufficiently active and active) 
was calculated using data from the GSLTPAQ, according to standard protocol [32]. Briefly, 
answers to questions on strenuous, and moderate exercise were multiplied by 9 and 5, 





corresponding to health contribution, the total score was split into two groups, with a score 
of ≤23 representing insufficiently active, and ≥24 denoting active [32]. Forty-nine 
participants had missing physical activity data, and were included in analyses in a missing 
category.  
For analysis of the primary outcome, general linear model (GLM) was used to estimate 
covariate-adjusted mean values for DXA-based VAT by HEI-2010 tertiles [18]. Linear trends 
were estimated to assess dose-response relations of VAT across HEI-2010 tertiles. The same 
approach was applied to analyze the data stratified by age groups (18<40, 40<60, 60<80 y) to 
assess if associations seen in the whole sample were present within age strata. Linear trends 
were also used to assess dose-response relations in VAT between age groups (18<40, 40<60, 
60<80 y) within each HEI-2010 tertile. Logistic regression was applied to estimate odds ratios 
(OR) and 95% CI between diet quality tertiles and high VAT (>100 cm2). This VAT cut-off 
was applied as previous literature has found DXA-based VAT of approximately 100 cm2 or 
greater to be associated with risk of obesity-related disorders in Asian populations [35,36]. 
Given there is no known cutoff for high DXA-based VAT amongst a multiethnic group, 
additional ORs were explored with VAT cutoffs of 90 cm2, and 110 cm2 to 200 cm2 in 10 cm2 
increments. GLM, linear trend between HEI-2010 tertiles, and the OR models for VAT were 
adjusted for age, total body fat, and total energy intake (log-transformed) as continuous 
variables; gender, ethnicity (white, African American, Asian, other (including NHOPI and 
Latino)), physical activity level (insufficiently active, active, and missing), alcohol (<14g/day, 
≥14g/day of ethanol) as categorical variables [18]. Linear trends for VAT between age 
groups, by HEI-2010 tertiles, adjusted for the same covariates, excluding age. To evaluate 
effect modification by ethnicity, logistic regression was applied with an interaction term 
between diet quality and ethnicity. 
Secondary analyses explored relationships between diet quality and anthropometric 
measures (BMI, WC, HC, and waist-hip ratio (WHR)), DXA-based measures (body fat 
percentage, total body fat, lean mass, SAT, VAT/SAT, and trunk fat), and blood based 
biomarkers (total cholesterol, HDL, LDL, triglycerides, glucose, insulin, HbA1c, and alanine 
transaminase (ALT)) applying the same methods as above. Most models were adjusted for 
total body fat, with the exception of models for BMI, total body fat, or body fat percentage. 
Participants with a missing blood or anthropometric measure were removed from the 
analysis for that outcome measure, and added back into the dataset for remaining analyses. 
Statistical significance was defined as P <0.05. Data were analyzed using IBM SPSS Statistics 
















Figure 5.1 Flow diagram for the Shape Up! Adults study (NIH RO1DK109008) as of this publication.  
 
5.4 Results 
Due to the stratified recruitment, the study sample contained almost an equal number 
of men (43.6%) and women (56.4%) (Table 5.1) with a mean age of 45.6 ± 16.6 y. The 
distribution of participants in the age groups 18<40, 40<60, and 60<80 y, was 41.9%, 32.3%, 
and 25.9%, respectively, with the number of participants in the 18<40 y category being 
significantly higher than the other two age categories. Overall, 39.1% of participants 
identified as predominately white, 26.9% African American, 23.3% as Asian, and 10.7% as 
Latino or NHOPI (Latino and NHOPI recoded as other). Across age strata, the proportion 
of participants was similar for each ethnic group.  
The mean HEI-2010 score was 67.2 ± 11.5 (range 28.9-90.3) with participants 60<80 y 
having significantly higher diet quality and participants 18<40 y scoring the lowest for diet 
quality. Consequently, the largest proportion of participants in HEI-2010 T3 (highest diet 
quality) were participants 60<80 y, and the largest proportion of participants in T1 (lowest 
diet quality) were those 18<40 y. For the whole study sample, mean VAT was 92.4 ± 58.5 
cm2, and between age group strata, participants 60<80 y had significantly higher VAT and 
























Table 5.1 Descriptive characteristics of participants (n = 468) in the Shape Up! Adults study by age groups. 
Characteristic All 18<40 y 40<60 y 60<80 y 
N, %*** 468 196 (41.9) 151 (32.3) 121 (25.9) 
Age, y, mean (± SD)*** 45.6 ± 16.6 28.7 ± 6.2 50.9 ± 6.2 66.5 ± 4.2 
Energy, kcal, median 
(IQR)*** 
1702 (1237-2452) 1838 (1359-2803) 1717 (1210-2545) 1609 (1005-1963) 
VAT, cm2, mean (± SD)*** 92.4 ± 58.5 62.7 ± 38.0 109.4 ± 62.4 119.3 ± 59.8 
HEI-2010, mean (± SD)*** 67.2 ± 11.5 64.9 ± 10.3 66.9 ± 11.5 71.1 ± 12.1 
HEI-2010, range 28.9-90.3 30.6-88.8 28.9-86.2 32.4-90.3 
HEI-2010 tertile1     
Tertile 1 *** 156 (33.3) 80 (40.8) 44 (29.1) 32 (26.5) 
Tertile 2 *** 156 (33.3) 75 (38.3) 58 (38.4) 23 (19.0) 
Tertile 3 * 156 (33.3) 41 (20.9) 49 (32.5) 66 (54.5) 
Sex     
Men*** 204 (43.6) 92 (46.9) 60 (39.7) 52 (43.6) 
Women*** 264 (56.4) 104 (53.1) 91 (60.3) 69 (56.4) 
Ethnicity     
White 183 (39.1) 71 (36.2) 57 (37.7) 55 (45.5) 
African American 126 (26.9) 49 (25.0) 42 (27.8) 35 (28.9) 
Asian 109 (23.3) 46 (23.5) 35 (23.2) 28 (23.1) 
Other *** 50 (10.7) 30 (15.3) 17 (11.3) 3 (2.5) 
BMI, kg/m2     
<25 194 (41.5) 80 (40.8) 60 (39.7) 54 (44.6) 
25<30 ** 154 (32.9) 69 (35.2) 45 (29.8) 40 (33.1) 
≥30 * 120 (25.6) 47 (24.0) 46 (30.5) 27 (22.3) 
Physical activity level     
Insufficiently active 148 (32) 49 (25) 52 (34) 47 (39) 
Active *** 271 (58) 135 (69) 80 (53) 56 (46) 
Missing 49 (10) 12 (6) 19 (13) 18 (15) 
1 n (% column) for all such values.  ***p value < 0.001 for analysis of variance between age groups (18<40, 40<60, 
60<80) for quantitative variables and test of proportions for discrete variables. **p value < 0.01 for test of 
proportions between age groups (18<40, 40<60, 60<80). *p value < 0.05 for test of proportions between age 






For the study sample, BMI, body fat percentage, total body fat, VAT, and trunk fat were 
inversely related to diet quality, with a significant trend across tertiles (Table 5.2). Within 
age groups; for participants 18<40 y, BMI, body fat percentage, total body fat, SAT, and trunk 
fat were inversely related to diet quality with a significant trend across tertiles. Unique to 
participants 40<60 y, VAT/SAT was inversely related to diet quality, with a significant trend 
across tertiles. For participants 60<80 y, BMI, body fat percentage, total body fat, and VAT 
were inversely related to diet quality with a significant trend across tertiles. Between age 
groups; among those with the highest diet quality, participants 18<40 y had significantly 
lower WC, WHR, body fat percentage, VAT, VAT/SAT, and trunk fat (Table 5.2) compared 
to participants 60<80 y, and the trend was significant across age groups. Also, among T3 
participants 18<40 y, HC and lean mass was significantly higher compared to participants 
60<80 y, with a significant trend across age groups. These patterns were similar among 
participants in T2 and T1, with the exception of body fat percentage for participants in T2, 
which did not significantly differ across age groups.  
For the study sample, participants with the highest diet quality had an OR of 0.39 (95% 
CI 0.25-0.62) for high VAT (defined as VAT over 100 cm2) compared to participants with the 
lowest diet quality (p = 0.04). The interaction with ethnicity in this model was not significant 
(p = 0.31). For the analysis of ORs with VAT cutoffs ranging from 90 cm2 to 200 cm2 in 
increments of 10 cm2, the lowest OR for T3 vs. T1 was 0.19, which corresponded to a VAT 
cutoff of 110 cm2. The odds of high VAT was significantly lower for participants in T3 
compared to T1 for almost all VAT cutoffs  except the VAT cutoffs of 140 cm2, 150 cm2, and 
180 cm2, where the ORs were not significant. 
For blood-based biomarkers (Table 5.3) among the total study sample, higher diet 
quality was inversely related to insulin and insulin resistance, with a significant trend across 
tertiles. Among participants 18<40 y and those 40<60 y, higher diet quality was inversely 
related to insulin and insulin resistance, with a significant trend across tertiles. Unique to 

























Table 5.2 Adjusted means (95% CI) for body measurements by Healthy Eating Index-2010 tertiles and age groups. 
Body measure1 HEI-2010 Tertiles All (n = 468) 18<40 y (n = 196) 40<60 y (n = 151) 60<80 y (n = 121) p-trend2 
  Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI  
BMI, kg/m2 T1 27.5 26.0-29.0 26.4 24.5-28.2 28.9 24.6-33.1 28.3 25.5-31.1 0.212 
 T2 27.6 26.0-29.0 26.2 24.4-28.0 29.8 26.1-33.5 25.6 22.7-28.6 0.547 
 T3 24.6 23.0-26.2 23.9 21.4-26.5 24.8 20.9-28.6 25.0 22.6-27.4 0.922 
 p-trend3 0.0024,5 0.0495 0.1104 0.0105  
WC, cm6 T1 93.1 91.9-94.4 88.6 86.9-90.3 98.2 95.5-100.9 94.8 91.3-98.3 0.0487 
 T2 92.4 91.2-93.6 88.8 87.1-90.5 95.1 92.7-97.4 95.2 91.4-98.9 0.0287 
 T3 92.6 91.3-94.0 88.6 86.2-91.0 96.8 94.4-99.3 94.4 91.3-97.6 0.0397 
 p-trend 0.542 0.987 0.401 0.825  
HC, cm6 T1 102.4 101.4-103.4 101.8 100.2-103.4 105.2 103.3-107.1 100.8 98.4-103.1 0.0117 
 T2 102.5 101.6-103.5 101.7 100.0-103.3 105.1 103.5-106.8 101.8 99.3-104.3 0.0207 
 T3 103.0 101.9-104.1 102.3 100.0-104.5 104.9 103.2-106.6 102.2 100.1-104.2 <0.0017,8 
 p-trend 0.307 0.644 0.773 0.209  
WHR6 T1 0.91 0.90-0.92 0.87 0.85-0.89 0.93 0.91-0.96 0.94 0.90-0.98 0.0017 
 T2 0.90 0.89-0.92 0.88 0.86-0.90 0.91 0.88-0.93 0.94 0.90-0.98 0.0207 
 T3 0.90 0.88-0.91 0.87 0.84-0.89 0.92 0.89-0.95 0.93 0.89-0.96 <0.0017 
 p-trend 0.134 0.835 0.441 0.417  
% body fat T1 29.1 27.8-30.4 26.9 24.9-28.9 29.3 26.7-32.0 31.5 28.1-34.9 0.0027 
 T2 28.5 27.2-29.8 25.6 23.6-27.6 31.3 28.9-33.6 27.7 24.1-31.4 0.092 
 T3 25.9 24.5-27.3 23.3 20.7-26.0 26.7 24.3-29.1 27.6 24.6-30.6 0.0137 
 p-trend <0.0014,5 0.0085 0.0984 0.0145  
Total body fat, kg T1 22.9 20.9-24.9 20.1 17.1-23.1 24.3 19.9-28.7 24.6 19.9-29.3 0.082 
 T2 22.1 20.1-24.0 19.1 16.1-22.1 25.6 21.8-29.4 19.6 14.6-24.6 0.979 
 T3 18.4 16.3-20.6 15.8 11.7-19.9 20.1 16.1-24.0 19.1 14.9-23.2 0.322 
 p-trend <0.0014,5 0.0335 0.1074 0.0115  
Lean mass, kg T1 54.3 53.1-56.0 54.6 52.2-57.1 57.2 54.6-59.8 52.2 49.0-55.4 0.0357 
 T2 54.7 53.3-56.2 56.1 53.7-58.6 55.4 53.1-57.7 51.6 48.1-55.0 <0.0017 
 T3 55.3 53.7-56.9 54.7 51.3-58.1 57.8 55.4-60.2 53.0 50.2-55.9 0.0097,8 
 p-trend 0.414 0.978 0.714 0.569  
SAT, cm2 T1 296 287-304 272 260-284 314 296-333 308 288-329 0.980 
 T2 295 287-303 271 259-282 318 302-334 311 289-333 0.191 
 T3 288 280-297 255 239-272 326 309-343 299 281-317 0.465 
 p-trend 0.168 0.0375 0.292 0.332  










 T2 96 90-102 63 56.0-69.2 117 104-131 117 98-136 <0.0017 
 T3 87 80-94 60 51.3-69.5 104 89-118 115 99-131 <0.0017,8 
 p-trend 0.0014,5 0.089 0.100 0.0065  
VAT, cm3 T1 529 495-563 354 320-389 620 541-700 718 627-810 <0.0017,8 
 T2 500 467-533 326 292-361 611 541-681 609 511-707 <0.0017 
 T3 455 419-492 315 267-362 541 467-614 600 518-681 <0.0017,8 
 p-trend 0.0014,5 0.089 0.100 0.0065  
VAT, g T1 489 458-521 328 296-360 574 500-647 665 580-749 <0.0017,8 
 T2 462 432-493 302 270-333 565 500-630 563 472-654 <0.0017 
 T3 421 387-455 291 247-335 500 432-568 555 479-630 <0.0017,8 
 p-trend 0.0014,5 0.089 0.100 0.0065  
VAT/SAT T1 0.4 0.3-0.4 0.3 0.2-0.3 0.4 0.4-0.5 0.4 0.4-0.5 <0.0017 
 T2 0.4 0.3-0.4 0.3 0.2-0.3 0.4 0.4-0.5 0.4 0.3-0.5 <0.0017 
 T3 0.3 0.3-0.4 0.3 0.3-0.4 0.3 0.3-0.4 0.4 0.4-0.5 <0.0017,8 
 p-trend 0.235 0.230 0.0084,5 0.571  
Trunk fat, kg T1 10.8 10.5-11.1 9.4 9.0-9.7 12.0 11.5-12.7 11.8 11.1-12.4 0.0097 
 T2 10.5 10.3-10.8 9.1 8.8-9.5 11.7 11.2-12.2 11.4 10.7-12.1 0.0027 
 T3 10.3 10.0-10.6 8.9 8.5-9.4 11.7 11.1-12.2 11.2 10.7-11.8 <0.0017 
 p-trend 0.0045 0.0525 0.258 0.096  
1General linear models (GLM) used to obtain adjusted means including adjustment for gender, race, physical activity level (PAL), age, alcohol, total energy intake, 
and total body fat. GLM for BMI, percentage body fat, and total body fat did not include adjustment for total body fat. 2GLM used to obtain trend by HEI-2010 
tertiles between age groups including adjustment for gender, race, PAL, alcohol, total energy intake, and total body fat. Trend test for BMI, percentage body fat, 
and total body fat did not include adjustment for total body fat. 3GLM used to obtain trend by age groups between tertiles; including adjustment for gender, race, 
PAL, age, alcohol, total energy intake, and total body fat. Trend test for BMI, percentage body fat, and total body fat did not include adjustment for total body fat. 
4Significant difference by GLM between HEI-2010 tertile 3 and HEI-2010 tertile 2. 5Significant difference by GLM between HEI-2010 tertile 3 and HEI-2010 tertile 
1. 6Missing values: 4 for waist circumference, hip circumference, and waist hip ratio. 7Significant difference by GLM between 60<80 and 18<40. 8Significant 
difference by GLM between 60<80 and 40<60. SAT: Subcutaneous adipose tissue. VAT: Visceral adipose tissue. WC: Waist circumference. WHR: Waist/hip ratio. 












All 18<40 y 40<60 y 60<80 y p-trend3 
  Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI  
HbA1c, % T1 5.4 5.3-5.5 5.1 5.0-5.3 5.6 5.3-5.9 5.6 5.4-5.9 <0.0014 
 T2 5.5 5.3-5.6 5.2 5.1-5.3 5.5 5.3-5.8 5.7 5.4-6.0 0.0084 
 T3 5.3 5.2-5.4 5.1 5.0-5.3 5.3 5.0-5.6 5.6 5.3-5.9 <0.0014,5 
 p-trend6 0.1117 0.850 0.063  0.722  
Insulin, uU/mL T1 13.0 11.6-14.5 11.3 9.4-13.1 14.7 12.0-17.5 14.7 10.2-19.1 0.177 
 T2 10.4 9.0-11.8 9.1 7.3-10.9 9.9 7.5-12.3 14.1 9.3-18.9 0.074 
 T3 9.2 7.6-10.7 7.8 5.3-10.3 8.5 6.0-11.1 12.4 8.5-16.3 0.0044,5 
 p-trend 0.0008 0.0058 <0.0018 0.275  
HOMA-IR T1 3.1 2.7-3.5 2.4 2.0-2.9 3.6 2.8-4.3 3.7 2.3-5.2 0.0214 
 T2 2.6 2.2-3.0 2.0 1.6-2.4 2.5 1.8-3.1 3.7 2.2-5.3 0.0224 
 T3 2.1 1.6-2.5 1.6 1.0-2.2 1.9 1.2-2.5 3.1 1.8-4.4 0.0014,5 
 p-trend <0.0018 0.0058 <0.0018 0.333  
Glucose, mg/dL T1 93.2 89.7-96.7 86.4 83.0-89.7 96.2 88.4-104.1 97.4 85.6-109.3 0.0344 
 T2 95.8 92.3-99.2 86.4 83.0-89.8 99.3 92.4-106.2 103.8 91.0-116.5 0.0084 
 T3 90.5 86.8-94.3 82.2 77.5-86.9 90.9 83.7-98.2 99.5 88.9-110.0 <0.0014,5 
 p-trend 0.2307 0.075  0.2667 0.715  
ALT, umol/L T1 25.9 23.5-28.3 24.8 20.3-29.4 25.4 21.8-29.0 25.9 21.0-30.9 0.773 
 T2 23.3 21.0-25.7 20.2 15.6-24.7 26.2 23.0-29.4 22.9 17.5-28.1 0.820 
 T3 24.1 21.5-26.7 21.2 14.9-27.5 26.6 23.3-30.0 23.9 19.5-28.3 0.752 
 p-trend 0.238 0.241 0.578 0.377  
Cholesterol, mg/dL T1 188.9 180.8-197.1 178.2 167.4-189.1 196.2 180.8-211.5 183.5 158.6-208.5 0.401 
 T2 193.4 185.3-201.4 180.8 169.9-191.6 203.3 189.8-216.8 192.1 165.3-218.8 0.363 
 T3 190.1 181.3-199.0 174.1 159.0-189.2 200.0 185.8-214.2 198.9 176.7-221.0 0.0174 
 p-trend 0.815 0.578 0.681 0.194  
HDL, mg/dL T1 59.2 56.5-61.9 54.1 50.0-60.0 62.5 57.2-67.9 62.0 54.8-69.1 0.0104 
 T2 61.9 59.2-64.5 60.6 56.7-64.6 62.1 57.5-66.8 63.7 56.0-71.3 0.622 
 T3 59.9 57.0-62.8 55.9 50.4-61.4 64.5 59.6-69.4 60.9 54.5-67.2 0.2975 
 p-trend 0.658 0.493 0.540 0.741  
LDL, mg/dL T1 110.5 104.4- 117.0 109.5 100.9-118.2 111.0 99.0-123.1 105.2 85.1-125.4 0.984 
 T2 111.6 105.3-118.0 106.0 97.4-114.6 118.4 107.7-129.1 106.0 84.4-127.6 0.7335 















 p-trend 0.805 0.611 0.763 0.180  
TG, mg/dL T1 108.0 95.7-120.2 103.9 86.4-121.3 110.8 82.7-138.9 104.1 75.3-132.9 0.977 
 T2 99.3 87.2-111.3 88.6 71.2-106.1 102.8 78.0-127.5 106.2 75.4-137.1 0.158 
 T3 95.7 82.5-108.9 80.0 55.9-104.2 103.7 77.7-129.8 97.7 72.2-123.2 0.0214 
 p-trend 0.114 0.0458 0.681 0.637  
1General linear models (GLM) used to obtain adjusted means including adjustment for gender, race, physical activity level (PAL), age, alcohol, total energy intake, 
and total body fat. 2Missing values: 4 for alanine transaminase, cholesterol, HDL, and glucose; 5 for triglycerides and HbA1c; 9 for LDL, and 8 for insulin and 
HOMA-IR. 3GLM used to obtain trend by HEI-2010 tertiles between age groups; including adjustment for gender, race, PAL, alcohol, total energy intake, and 
total body fat. 4Significant difference by GLM between 60<80 and 18<40. 5Significant difference by GLM between 60<80 and 40<60.6GLM used to obtain trend by 
age groups between tertiles; including adjustment for gender, race, PAL, age, alcohol, total energy intake, and total body fat.  7Significant difference by GLM 







In this cross-sectional analysis of multiethnic adults, diet quality for the whole sample was 
inversely related to VAT, overall adiposity, insulin, and insulin resistance. Among participants 
40<60 y, VAT/SAT was inversely related to diet quality, and among participants 60<80 y, VAT 
was lower for participants with the highest diet quality compared to the lowest diet quality. These 
results suggest following a higher quality diet may help to minimize VAT accumulation in adults 
18-80 y, in particular adults 60<80 y. In addition, following a higher diet quality may help to 
preferentially promote storage of SAT vs. VAT in adults 40<60 y. Participants 60<80 y had higher 
VAT/SAT, VAT, overall adiposity, and blood-based biomarkers for metabolic risk, than 
participants 18<40 y. Despite the effect of aging on VAT, diet quality appears to limit these effects.  
Differences in VAT levels by ethnicity [20,21] and by age [2,4,14] have previously been explored. 
The current analyses are novel as they include multiethnic participants with a wide age range, 
spanning 18-80 y. Splitting the sample by VAT of 100 cm2, a cut off for high risk of obesity-related 
disorders [35,36], demonstrated that those with higher diet quality may have lower odds of poor 
metabolic outcomes than those with lower quality diets. This hypothesis is supported by the 
inverse relationship between diet quality, insulin and insulin resistance.  
The significant association found between diet quality and VAT for participants 60<80 y is 
consistent with results from the MEC-APS (average age 69.2) [18]. To our knowledge, no 
published study has explored the relationship between VAT/SAT and diet quality among a 
younger multiethnic population. Thus, the results reported here may represent the first time a 
significant association has been reported among men and women 40<60 y. In this current analysis, 
participants 40<60 y in T3 (i.e., highest diet quality) had lower VAT and higher SAT compared to 
participants in T1, although these differences were not significant, probably due to the limited 
sample size. In comparison, in the Framingham Heart Study, among a larger sample of 2,926 
participants with a mean age of 50 ± 10 y, a significant inverse relationship was found between 
diet quality and VAT [37]. The non-significant relationship between diet quality and VAT, for 
participants 18<40 y, may be due to their relatively low levels of VAT. 
In this current study, an inverse relationship was found between diet quality and BMI, body fat 
percentage, and total body fat. These results are consistent with those found in MEC-APS with 
diet quality being inversely associated with BMI and total body fat [18]. Previous literature has 
reported that WC is highly correlated with abdominal adiposity, even more so than BMI [38,39]. 
In this current study, an inverse association was seen between diet quality, VAT, and BMI but not 
for WC. A systematic review of waist measurement sites for determining central adiposity 
highlighted that WC measures were more strongly correlated with VAT for men vs. women, and 
white vs. Asian adults [40]. Consequently, the sex and ethnicity mix of this current study sample 
may explain the null relationship between diet quality and WC.  
Diet quality among participants in this study appears to be higher than in the wider US 
population. Mean HEI-2010 scores for participants 18<40, 40<60, and 60<80 y were 64.9, 66.9, and 
71.1, respectively. According to the 2015 Dietary Guidelines Advisory Committee Report, the 
average HEI-2010 scores for people 19-30, 31-50, 51-70, and ≥71 y in the US were 50.5, 57.4, 61.6, 





sampling, which may explain the differences in these HEI-2010 scores. Similar to this current 
study, MEC-APS participants were recruited from Hawaii and Los Angeles through stratified 
sampling and comprised of; white, African American, Native Hawaiian, Japanese American, and 
Latino participants. The age range of MEC-APS participants was 60-77 years and the mean HEI-
2010 score was 72.7 [18]. These results closely match the 71.1 HEI-2010 score among the 
participants in the 60<80 y group in this current study. MEC-APS participants completed a FFQ 
validated for use among multiethnic populations that include Japanese-Americans [42]; whereas, 
the DHQ II FFQ has yet to be validated for Asian Americans [43-45]. The positive linear 
association between HEI-2010 scores and age in this current study is consistently seen in the 
literature among multiethnic groups [18,46]. This evidence supports the reliability of using the 
DHQ II for collection of dietary data among multiethnic populations, including Asian Americans. 
A strength of this study was the inclusion of DXA-based VAT measures. Computed tomography 
(CT) and MRI are considered the “gold standards” for measurement of VAT [47-49]. However, 
DXA-based VAT strongly correlates with CT and DXA can be performed with lower exposure of 
radiation to both the participant and examiner [49,50]. Additional strengths were the inclusion of 
an ethnic diverse population of adults 18-80 y, adjusting for known confounders, and the use of 
the criterion validated HEI-2010 dietary index for the assessment of diet quality [51]. A limitation 
was the sample size, which did not allow for stratification by sex and ethnicity. In addition, being 
a cross-sectional study, a causal relationship between diet quality and VAT cannot be derived. 
Due to the stratified recruitment, and convenience sampling, results of this study may not be 
representative of the US population [23]. The study size limited how many variables could be 
controlled for. Therefore, other factors not controlled for may have affected study results, e.g., 
smoking status, pharmacological agents, and menopausal status [4]. Previous research found that 
the DHQ underestimates energy and protein intake [52]; however, all participants were subjected 
to this bias. Administering the DHQ II through REDCap may have changed the user experience 
when completing the DHQ II; consequently, results may not align with previous validation of the 
DHQ. However, associations found between diet quality and VAT were as expected.  
In conclusion, despite the influence of sex, ethnicity and age on VAT, higher quality diet was 
associated with lower VAT, overall adiposity, and improved metabolic risk biomarkers, 
especially insulin and insulin resistance, amongst a multiethnic group ranging 18-80 y of age. In 
particular, following a higher quality diet may help to preferentially promote storage of SAT vs. 
VAT in adults 40<60 y and minimize VAT accumulation in adults 60<80 y. These results also 
highlight the importance of adults adhering to the 2010 Dietary Guidelines for Americans to help 
optimize health outcomes.  
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CHAPTER 6. CONCLUSIONS 
Findings from this dissertation demonstrate that following a healthy dietary pattern is 
associated with lower visceral adipose tissue (VAT), and a reduced risk of mortality from 
all-causes, cardiovascular disease (CVD), and cancer. In particular, intermittent energy 
restriction combined with a Mediterranean (IER+MED) diet, may help to lower VAT, and 
improve liver function. This is important given VAT is a risk factor for chronic disease and 
mortality, and the high prevalence of chronic disease in the US. Currently, there are no 
clinical guidelines for the prevention and management of VAT; therefore, this dissertation 
may help to build the evidence base needed to develop such guidelines. 
This chapter, Conclusions, will provide the aims, a summary, the limitations, and future 
directions for each of the three studies that make up this dissertation. 
 
6.1 Study One, Testing the Predictive Validity of the Healthy Eating Index-2015 in the 




The aim of this study was to examine the association between the Healthy Eating Index-
2015 (HEI-2015) and mortality from all-cause, CVD, and cancer in the Multiethnic Cohort 
(MEC), which represents a large cohort of adult men and women from five distinct ethnic 
groups residing in Hawaii and Los Angeles (LA). 
 
6.1.2 Summary  
This analysis of diet quality (HEI-2015 scores) and mortality outcomes among the MEC, 
demonstrates that closer compliance to the Dietary Guidelines for Americans (DGAs) 2015–
2020 is associated with a lower risk of mortality from all-cause, CVD, and cancer. Comparing 
those with the lowest quality diets (lowest HEI-2015 scores) to those with the highest quality 
(highest HEI-2015 scores), the reduction in risk of mortality from all-cause, CVD, and cancer 
was 21%, 24%, and 20%, respectively, for men and 21%, 25%, and 16%, respectively, for 
women. This study also reinforced the multidimensionality of the HEI and the 
representation of diet quality using a wide array of components. For example, removing one 
HEI component at a time from the survival analysis did not change the protective 
association of the remaining HEI components. Supporting the index goal of no one HEI 
component making a significant independent contribution to the total HEI-2015 score. This 
analysis also highlighted dietary changes that may help improve mortality outcomes for 
MEC participants with the lowest quality diets. The components with the most substantial 
differences in median scores between quintile 1 (lowest quality diets) and quintile 5 (highest 
quality diets) were identified as Total Fruits, Whole Fruits, Greens and Beans, Whole Grains, 
and Refined Grains for men and Total Fruits, Whole Grains, and Refined Grains for women. 
Also, the components with the lowest median scores were the same for people in quintile 1 





of less than 50%. Therefore, improving the intake of foods that fall into these components 
may help to reduce mortality risk. 
 
6.1.3 Limitations 
A limitation of this study was the use of a FFQ to collect dietary information at baseline, 
which could introduce bias, for example misreporting of dietary intake or foods often 
consumed not being available on the FFQ [1]. However, this FFQ was validated and 
calibrated in each ethnic-sex group, and the correlations between the FFQ and 24-hour 
dietary recalls were 0.55–0.74 for energy adjusted nutrients [1]. Another limitation was 
dietary data only being assessed once at baseline; therefore, this analysis was not able to 
capture the influence of dietary changes on mortality outcomes. Also, all demographic and 
anthropometric variables were self-reported, and we cannot rule out whether other factors 
not measured and controlled for, could have affected mortality outcomes; e.g., access to 
health care. Participants in the MEC were recruited from Hawaii and Los Angeles (LA); 
therefore, results of this study may not be generalizable outside of these areas. 
 
6.1.4 Future Directions  
In this study, the relationship between HEI-2015 scores and mortality outcomes was 
primarily explored for the whole study sample completing the FFQ. In a secondary analysis, 
where mortality outcomes were split by ethnicity, it was found that Native Hawaiian men 
and women had a null association between HEI-2015 quintile 1: quintile 5 and all-cause, 
CVD, and cancer mortality. Also, Latino men and women had null associations between 
HEI-2015 quintile 1: quintile 5 and CVD mortality. These null associations may be due to the 
relatively smaller sample size of Native Hawaiians in the MEC, and the low rate of CVD 
mortality among Latinos. However, future analyses among the MEC could further explore 
the relationship between HEI-2015 scores, HEI-2015 component scores, and mortality by 
ethnic group. These analyses may help to assess whether HEI indices, and the DGAs, require 
additional tailoring based on ethnicity. 
 
6.2 Study Two, Effects of Intermittent Energy Restriction Combined with a Mediterranean 
Diet on Reducing Visceral Adiposity: A Randomized Active Comparator Pilot Study 
 
6.2.1 Aim 
The primary aim of the present study was to finalize and implement a protocol for an 
intermittent energy restriction (IER) intervention to evaluate the effectiveness of a 
culturally adapted IER and MED combined diet (IER+MED) to reduce VAT among East 
Asian Americans. Secondary aims were to evaluate study retention and protocol 
adherence, and changes in total adiposity and metabolic risk biomarkers. 
6.2.2 Summary 
The Healthy Diet and Lifestyle Study (HDLS) is the first known pilot study to evaluate 
the effectiveness of a culturally adapted IER+MED vs. an active comparator (DASH diet) to 
reduce DXA measured VAT among East Asian Americans. Both study groups had 





in IER+MED than in DASH, this appeared to be due to the greater loss of total fat in 
IER+MED as there was no significant group difference after adjusting for concurrent total 
fat mass. The reduction in ALT was significantly greater in IER+MED vs. DASH, a difference 
maintained after adjusting for concurrent total fat mass. This indicates a potential benefit of 
IER+MED on liver function. Overall, this pilot study demonstrated that an IER+MED vs. 
DASH intervention could be successfully conducted with East Asian Americans, and with 
a low attrition rate of 10%. The low attrition rate may have been due to the use of the mFRTM 
to collect dietary information, which could have helped limit participant burden when 
completing a food record. Also, the use of motivational interviewing, and conducting 
participant follow-up calls over the telephone, may have helped to provide a supportive and 
flexible environment for participants, and contributed to the low attrition rate. 
 
6.2.3 Limitations  
Limitations of the HDLS pilot include the small sample size, which may have limited 
statistical power to show small differences between groups. Also, the possible misreporting 
of dietary intake, with underreporting of dietary intakes being common among people with 
overweight or obesity [2,3]. However, weight loss achieved by participants in the IER+MED 
and DASH groups corresponded well to the average change in daily energy intake between 
baseline and Week 11, indicating at the group level, the dietary data was collected and 
analyzed accurately [4,5]. Another limitation is that results from the 6-month post-
intervention telephone interview may not be representative of the study sample due to not 
all participants responding and the self-reported nature of the information collected. There 
have been limited studies comparing DXA-based VAT measures with CT or MRI and, in the 
few studies reported, the DXA results overestimated VAT, particularly in individuals with 
higher VAT levels [6-8]. 
 
6.2.4 Future Directions  
The results of HDLS are very promising. However, given this was a pilot study, and 
IER+MED is a novel area of research, there are many opportunities to build and expand on 
this research. For example, in HDLS, visceral adiposity, as well as total fat mass and alanine 
transaminase (ALT), were reduced to a greater extent in the IER+MED diet group than in 
the DASH diet group, possibly because the observed decrease in energy intake was greater 
in the IER+MED group. Future trials could be conducted where the energy deficit prescribed 
is the same for the IER+MED and active comparator groups. This would help to examine if 
it is energy restriction or specifically intermittent energy restriction influencing changes in 
health outcomes. Also, changes in VAT in the IER+MED group may have resulted from 
following a high protein low carbohydrate diet on restricted days, following a 
Mediterranean diet on non-restricted days, energy restriction, or a combination of these 
factors. Future IER+MED trials could include three studies arms being; IER+MED, 
euenergetic MED diet, or a continuous energy restricted MED diet to help determine 
whether the IER days, MED days, energy restriction, or a combination of these exposures 
effect changes in health outcomes. 
The greater improvement in ALT in the IER+MED group vs. the DASH group is 
important as ALT is a biomarker for non-alcoholic fatty liver disease (NAFLD) [9]. This 
highlights the potential benefit of IER+MED on liver function. However, liver fat 





confirm this. Given MRI are expensive and time-consuming to administer, research in this 
area could work towards developing less expensive methods for measuring liver fat and 
other ectopic fat stores, e.g., biomarkers and DXA-based measures for liver fat.  
Another area for future exploration is comparing the effect of consecutive vs. non-
consecutive IER days in IER+MED trials on VAT. The HELENA trial incorporated two days 
of IER per week, over 50 weeks, to assess the effects of IER on VAT [10]. This trial found that 
IER did not exert stronger effects on VAT loss than CER [10]; however, their trial 
incorporated two non-consecutive restriction days. Incorporating two consecutive vs. non-
consecutive restriction days may have differing effects on health outcomes. The former may 
likely produce higher reductions on insulin resistance and percentage body fat [10,11]. 
Given HDLS was a pilot study, the sample size was small and did not allow for 
stratification of analyses by sex. Therefore, further studies addressing a larger sample, with 
separate analyses for men and women, are needed to confirm the effectiveness of the 
IER+MED diet on change in VAT, and its possible beneficial effect on liver fat, in the short 
term and long term. 
 
6.3 Study Three, Diet Quality is Associated with Lower Visceral and Overall Adiposity 
Among a Multiethnic Adult Population 
 
6.3.1 Aims 
The primary aim of this cross-sectional study was to assess the association between diet 
quality as defined by the Healthy Eating Index-2010 (HEI-2010) score and dual X-ray 
absorptiometry (DXA)-based VAT among multiethnic adults 18-80 years of age in the US. 
The secondary objectives were to explore the relationships between diet quality, overall 
adiposity, and metabolic risk biomarkers.  
 
6.3.2 Summary  
 In this cross-sectional analysis of multiethnic adults in the Shape Up! Adults study, 
diet quality (HEI-2010 scores) for the whole group was inversely related to VAT, overall 
adiposity, insulin, and insulin resistance. Among participants 40<60 y, VAT/SAT was 
inversely related to diet quality, and among participants 60<80 y, VAT was lower for 
participants with the highest diet quality compared to the lowest diet quality. These results 
suggest following a higher quality diet may help to minimize VAT accumulation in adults 
18-80 y, in particular adults 60<80 y. Also, following a higher diet quality may help to 
preferentially promote storage of SAT vs. VAT in adults 40<60 y. Participants 60<80 y had 
higher VAT, subcutaneous adipose tissue (SAT), VAT/SAT, overall adiposity, and blood-
based biomarkers for metabolic risk than participants 18<40 y. Despite the effect of aging on 
VAT, diet quality appears to limit these effects.  
 
6.3.3 Limitations 
A limitation of this study was the sample size, which did not allow for stratification by 
sex and ethnicity. Also, being a cross-sectional study, a causal relationship between diet 
quality and VAT cannot be derived. Due to the stratified recruitment, and convenience 





other factors not controlled for may have affected study results, e.g., smoking status, 
pharmacological agents, and menopausal status [13]. Previous research found that the Diet 
History Questionnaire (DHQ) underestimates energy and protein intake [14]; however, all 
participants were subjected to this bias. Administering the DHQ II through REDCap may 
have changed the user experience when completing the DHQ II; consequently, results may 
not align with previous validation of the DHQ. However, associations found between diet 
quality and VAT were as expected.  
 
6.3.4 Future Directions 
The small sample size of this cross-sectional study did not allow for stratification of 
analyses by sex, and ethnicity, and limited the number of confounders that could be 
controlled for. The National Health and Nutrition Examination Survey (NHANES) has a 
substantially larger sample size, and provides data on diet quality [15] as well as DXA-based 
VAT measures [16]. VAT data is yet to be released; however, once available, NHANES data 
could be used to analyze the association between diet quality and VAT. These analyses 
could be stratified by sex and ethnicity, and adjust for an extensive number of confounders. 
This research may help provide further evidence in support of following a high quality diet 
to reduce VAT, and rationale for funding cohort and RCT studies in this area of research. 
Ultimately the aims are to build enough scientific evidence to determine causality between 
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APPENDIX A. Key papers reviewed for this dissertation 
Methods for collecting dietary intake data: mFR and FFQ studies central to this dissertation. 
mFR studies among adults 




Adolescents (n=78) and 
adults (n=57), aged 11-65 
years, West Lafayette, 
Indiana, USA 
Evaluate skills required to 
complete a mFR, and 
perceptions and preferences 
when completing a mFR 
-Majority of adults and adolescents had the 
skills to complete a mFR 
-Interactive training is necessary before 
completing mFR in community dwelling 
settings 
- Findings will help with age-specific 




Adolescents and young 
adults without Down 
syndrome (n= 244, aged 18-
30 years), or with Down 
syndrome (n=58, aged 12–30 
years), Perth, Western 
Australia.  
Assess the usability of the 
mFR among adolescents and 
young adults with Down 
syndrome 
-The mFR shows great promise as a feasible 
method of assessing diet in adolescents and 




Men and women (n=45, aged 
21–65 years), West Lafayette, 
Indiana, USA 
Test the accuracy of the mFR 
by comparing reported 
energy intake (rEI) to total 
energy expenditure (TEE) 
using the doubly labeled 
water (DLW) method. 
Usability was also assessed.  
-The accuracy of the mFR is comparable to 
traditional dietary records and other 
image-based methods.  
- The mFR was received well and usability 
was rated as easy 
The Multiethnic Cohort (MEC) FFQ and the Diet History Questionnaire II (DHQ-II) FFQ 
Study Population Objective/s Conclusion/s  




Latinos (n=649), 850 whites 
(n=850), men and women 
(aged 45-75 years), from 
Hawaii and Los Angeles 
apart of the Multiethnic 
Cohort study.  
Assess the performance of 
the dietary questionnaire 
used in a multiethnic cohort 
in a calibration substudy 
that compared diet reported 
from the questionnaire with 
24-hour dietary recalls 
Calibration and correlation results for 
nutrient densities and energy corrected 
nutrients were comparable with those 
reported by other groups, and highly 
satisfactory for energy-adjusted nutrients 
for all subgroups.  
Subar  et 
al 
(2001)[5] 
Men and women (n=1,640, 
aged 20-70 years) from a 
nationally representative 
sample in the USA.  
Validate and compare the 
DHQ with the Block and 
Willett FFQs 
The DHQ and the Block FFQ are better at 
estimating absolute intakes than the Willett 
FFQ, but after energy adjustment, all three 





 Men and women (n=623, 
aged 25 to 70 years) from 
Washington, DC, USA.  
Testing changes in a FFQ on 
the basis of cognitive theory 
and testing results in greater 
accuracy 
Accuracy of FFQ reporting can be 
improved by restructuring questions based 
on cognitive theory and testing 
Subar et al 
(2003)[7] 
Men and women (n=484, 
aged 40–69 years) from 
Montgomery County, 
Maryland, USA. 
Assess dietary measurement 
error using the FFQ, the 24-
hour dietary recall (24HR), 
doubly labeled water and 
urinary nitrogen. 
A greater percentage of men and women 
under-reported energy and protein intake 
when completing a FFQ vs. 24HR. Also, 
underreporting of total amount of energy 
and protein consumed was greater when 









Examining diet using dietary patterns: 
Mediterranean-style diet 
Study  Population Objective/s Dietary pattern 
examined 
Conclusion/s 
de Lorgeril et 
al (1994)[8] 
Men and women, 
(n= 605, less than 
70 years of age), in 
The Lyon Diet 
Heart Study, 
France.  
Assess the effects of the 
Lyon Diet Heart Study, 
which is a prospective, 
randomized, single-blinded, 
multi-clinic, secondary 
prevention trial aimed at 
reducing the risk of 
cardiovascular deaths by 
diet modification and 
recurrent myocardial 
infarction in survivors of a 
first myocardial infarction. 
Follow-up time 5 years. 
Follow-up time of this 
intermediate analysis was 
27 months.  
Patients were randomly 
assigned to the 
experimental or control 
group. Experimental 
group were advised to 
follow a Med-type diet.  
This intermediate 
analysis at 27 months of 
follow-up, 
demonstrated that the 
Mediterranean diet was 
more efficient than the 
control diet in 
secondary prevention 
of coronary events and 
death.  
Trichopoulou 
et al (1995)[9] 
Men and women 
(n=182, more than 
70 years old) 
across three Greek 
villages. 
To assess the influence of a 
specific dietary pattern 
(MED) on overall survival. 
An a priori index on the 
basis of eight 
component 
characteristics of the 
traditional common diet 
in the Mediterranean 
region.  
An a priori defined 
nutritional pattern 
which closely reflects 
the Greek version of the 
Mediterranean diet 
favorably affects life 
expectancy among 
elderly people 
de Lorgeril et 
al (1999)[10] 
Men and women, 
(n= 605, less than 
70 years of age) in 
The Lyon Diet 
Heart Study, 
France.  
Assess the relationships of 
dietary patterns and 
traditional risk factors with 
recurrence of myocardial 
infarction among 
participants in the Lyon 
Diet Heart Study at mean 
follow-up of 46 months.  
Patients were randomly 
assigned to the 
experimental or control 
group. Experimental 
group were advised to 
follow a Med-type diet. 
The protective effect of 
the Mediterranean 
dietary pattern was 





Men and women 
(n= 22,043, aged 
20-86 years) in 
Greece.   
Prospective study, 
investigating the 
relationship of the 
Mediterranean dietary 
pattern and the 
Mediterranean-diet score 
with overall mortality.  
The original MDS by 
Trichopoulou et al 
(2013), revised to 
include fish intake.  
Over a 44 month 
follow-up period, 
greater adherence to 
the traditional 
Mediterranean diet was 
associated with a 
significant reduction in 
total mortality. 
Fung et al 
(2005)[12] 
Women (n= 690, 
aged 43-69 years) 
in the Nurses' 
Health Study, 
USA.  
Assess the association 
between diet-quality scores 
and plasma concentrations 
of markers of inflammation 
and endothelial 
dysfunction. 
Healthy Eating Index 
(HEI), Alternate Healthy 
Eating Index (AHEI), 
Diet Quality Index 
Revised (DQI-R), 
Recommended Food 
Score (RFS), and the 
alternate Mediterranean 
Diet Index (aMED)  
Higher AHEI and 
aMED scores were 




endothelial dysfunction  
Estruch et al 
(2018)[13] 
Men and women 
(n= 7,447, 55 to 80 
years of age) at 
high 
cardiovascular 






Assess the relationship 
between the Med diet and 
major cardiovascular events 
(myocardial infarction, 
stroke, or death from 
cardiovascular causes). 
Randomized to one of 
three diets: a MED diet 
supplemented with 
extra-virgin olive oil, a 
MED diet supplemented 
with mixed nuts, or a 
control diet (advice to 
reduce dietary fat). 
The incidence of major 
cardiovascular events 
was lower among those 
assigned to a MED diet 
supplemented with 
extra-virgin olive oil or 
nuts than among those 







Study  Population Objective/s Dietary pattern 
examined 
Conclusion/s 
Appel et al 
(1997)[14] 
Men and women 
(n= 459, 22 years 
of age or older) 
with systolic 
blood pressures of 
less than 160 mm 
Hg and diastolic 
blood pressures of 
80 to 95 mm Hg, 
in the DASH trial.  
The Dietary Approaches to 
Stop Hypertension (DASH) 
trial was a multicenter, 
randomized feeding study. 
The aim was to test the 
effects of dietary patterns 
on blood pressure. 
For three weeks, 
participants were fed a 
control diet. They were 
then randomly assigned 
to receive for eight 
weeks 1) the control 
diet, 2) a diet rich in 
fruits and vegetables, or 
3) a “combination” diet 
rich in fruits, vegetables, 
and low-fat dairy 
products and with 
reduced saturated and 
total fat. Sodium intake 
and body weight were 
maintained at constant 
levels. 
A diet rich in fruits, 
vegetables, and low-fat 
dairy foods and with 
reduced saturated and 
total fat can 
substantially lower 
blood pressure. 
Sacks et al 
(2001)[15] 
Men and women 
(n=412, 22 years of 
age or older) 
whose blood 
pressure exceeded 
120/80 mm Hg 
Test the effect of different 
levels of dietary sodium, in 
conjunction with the 
Dietary Approaches to Stop 
Hypertension (DASH) diet.  
Participants were 
randomly assigned to 
eat either a control diet 
typical of intake in the 
United States or the 
DASH diet. Within the 
assigned diet, 
participants ate foods 
with high, intermediate, 
and low levels of 
sodium for 30 
consecutive days each, 
in random order. 
The reduction of 
sodium intake to levels 
below 100 mmol per 
day and the DASH diet 
both lower blood 
pressure substantially, 
with greater effects in 
combination than 
singly. 
Appel et al 
(2005)[16]  
Men and women 
(n=164, 30 years of 
age or older) with 
prehypertension 
or stage 1 
hypertension, in 
Boston, USA, in 
the Optimal 
Macronutrient 




To compare the effects of 3 
healthful diets, each with 
reduced saturated fat 
intake, on blood pressure 
and serum lipids 
Randomized, 3-period 
crossover design. A 
DASH diet rich in 
carbohydrates; a DASH 
diet rich in protein, 
about half from plant 
sources; and a DASH 
diet rich in unsaturated 
fat, predominantly 
monounsaturated fat.  
DASH with partial 
substitution of 
carbohydrate with 
either protein or 
monounsaturated fat 
can further lower blood 
pressure, improve lipid 
levels, and reduce 
estimated 
cardiovascular risk. 
Fung et al 
(2008)[17] 
Female nurses 
(n=88 517, aged 34 
to 59 years) 
without a history 
of cardiovascular 
disease or 
diabetes, USA.  
Assess the association 
between a DASH-style diet 
adherence score and risk of 
coronary heart disease 
(CHD) and stroke in 
women. 
A DASH score based on 
8 food and nutrient 
components (fruits, 
vegetables, whole 
grains, nuts and 
legumes, low-fat dairy, 
red and processed 
meats, sweetened 
beverages, and sodium) 
Adherence to the 
DASH-style diet is 
associated with a lower 
risk of CHD and stroke 
among middle-aged 
women during 24 years 
of follow-up. 
Healthy Eating Index 





Men and women 
(n=8,650, aged 2 




Evaluate the validity and 
reliability of the HEI-2005. 
Healthy Eating Index-
2005 (HEI-2005) 
The HEI-2005 is a valid 
measure of diet quality. 













al (2014) [19] 
Men and women 
(n=8,262, aged 2 







Evaluate the validity and 
reliability of the HEI-2010. 
Healthy Eating Index-
2010 (HEI-2010) 
This study supports the 
validity and the 
reliability of the HEI-
2010. 








(n=7,935), and the 
National Institutes 
of Health-AARP 
Diet and Health 
Study (n=422,928), 
USA. 
To evaluate the 






supportive of construct 
validity, reliability, and 
criterion validity of the 
HEI-2015.  
Intermittent energy restriction  
Study  Population Objective/s Dietary pattern 
examined 
Conclusion/s 





women (n=107), in 
the UK.  
To compare the feasibility 
and effectiveness of 
intermittent energy 
restriction (IER) with 
continuous energy 
restriction (CER) for weight 
loss, insulin sensitivity and 
other metabolic disease risk 
markers. 
Women were randomly 
assigned to 6 months of 
either the CER of 25% 
restriction below 
estimated requirements 
7 days/week or the IER 
of 25% restriction 
delivered as a VLCD for 
2 days/week with no 
restriction on the other 5 
days/week. 
IER is as effective as 
CER in regards to 
weight loss, insulin 
sensitivity and other 
health biomarkers and 
may be offered as an 
alternative equivalent 
to CER for weight loss 
and reducing disease 
risk. 
Harvie et al 
(2013)[22]  
Women (n=115, 
aged 20 to 69 
years) overweight 
with a family 
history of breast 
cancer, in the UK.  
Assess the effectiveness of 
three diets with respect to 
the change in insulin 
resistance, weight and 
adiposity, of an intermittent 
energy and carbohydrate 
restriction.  
Randomized to the 
MED diet with daily 
energy restriction 
(DER), or one of two 
intermittent energy and 
carbohydrate restriction 
(IECR) regimens, 
including one which 
allowed ad libitum 
protein and fat (IECR + 
PF). 
In the short term (4 
months), IECR is 
superior to DER with 
respect to improved 
insulin sensitivity and 
body fat reduction. 
Conley et al 
(2017)[23]  
Male war veterans 
(n=24, ages 55–75 
years) BMI ≥30 
kg/m2, in 
Australia.  
Determine whether the 5:2 
diet can achieve ≥5% weight 
loss and greater 
improvements in weight 
and biochemical markers 
than a standard energy-
restricted diet (SERD) in 
obese male war veterans. 
Randomized to 
consume either the 5:2 
diet or a SERD (2050 KJ 
(500 calorie) reduction 
per day) for 6 months. 
Results suggest that the 
5:2 diet is a successful 
but not superior weight 
loss approach in male 
war veterans when 
compared to a SERD.  
Schubel et al 
(2018)[24]  
Men and women 
(n=150, aged 35–
65), overweight 
and obese and 
nonsmokers, in 
the HELENA Trial 
in Germany.  
Test whether intermittent 
calorie restriction (ICR), 
operationalized as the “5:2 
diet,” has stronger effects 
on adipose tissue gene 
expression, anthropometric 
and body composition 
ICR, a CCR group, or a 
control group and 
participated in a 12-wk 
intervention phase, a 12-
wk maintenance phase, 
and a 26-wk follow-up 
phase. 
The effects of the “5:2 
diet” indicate that ICR 
may be equivalent but 
not superior to CCR for 
weight reduction and 






measures, and circulating 
metabolic biomarkers than 
continuous calorie 
restriction (CCR) and a 
control regimen. 
Carter et al 
(2018)[25]  
Men and women 
(n=137, ≥18 years 
of age) with type 2 
diabetes, BMI ≥27, 
in South Australia.  
To compare the effects of 
intermittent energy 
restriction (2 days per 
week) with those of 
continuous energy 
restriction (CER) on 
glycemic control and 
weight loss in patients with 
type 2 diabetes during a 12-
month period. 
Randomized 1:1 to 
parallel diet groups IER 
or CER for 12 months. 
 
IER is an effective 
alternative diet strategy 
for the reduction of 
HbA1c and is 
comparable with CER 
in patients with type 2 
diabetes. 
Quantifying the effect of dietary patterns on health outcomes: Mortality and visceral adiposity 
Dietary patterns and mortality amongst the NIH-AARP, WHI-OS, and MEC cohorts   




Men (n=214,284) and 
women (n=166,012) in the 
National Institutes of 
Health (NIH)-AARP 
cohort, USA.  
Examine the relationship of the 
Mediterranean dietary pattern to 
all-cause and cause-specific 
mortality in the NIH- AARP Diet 
and Health Study.  
Higher conformity with the 
Mediterranean dietary pattern has 
beneficial effects on risk of death from 
all causes, including deaths due to 
CVD and cancer.  
Reedy 
(2014)[27]  
Men and women 
(n=492,823) in the NIH-
AARP Diet and Health 
Study., USA.  
Examine the relationships 
between the HEI-2010, the AHEI-
2010, the aMED, and DASH, and 
all-cause mortality, and mortality 
from cardiovascular disease, and 
cancer.  
High adherence on each index was 
protective for all-cause mortality, CVD 




Participants (n=63,805) in 
the Women's Health 
Initiative Observational 
Study WHI-OS), USA.  
Examine the relationships 
between the HEI-2010, the AHEI-
2010, the aMED, and DASH, and 
all-cause mortality, and mortality 
from cardiovascular disease, and 
cancer.  
Having better diet quality (as assessed 
by HEI, AHEI, aMED, and DASH 
scores) was associated with lower all-
cause and CVD mortality risk. Higher 
HEI, aMED, and DASH (but not AHEI) 
scores were associated with lower risk 




Men and women 
(n=215,782) from the 
Multiethnic Cohort 
(MEC), USA.  
Examine the relationships 
between the HEI-2010, the AHEI-
2010, the aMED, and DASH, and 
all-cause mortality, and mortality 
from cardiovascular disease, and 
cancer. 
High adherence on each index was 
protective for all-cause mortality, CVD 
and cancer mortality. 
Fung 
 et al 
(2015)[30] 
All participants in the 
NIH-AARP (n=492,823), 
WHI-OS (n=63,805), and 
MEC (n=215,782) cohorts, 
USA.  
Synthesis of findings across the 
NIH-AARP, WHI-OS, and MEC 
cohort, for analyses that examined 
the relationships between the 
HEI-2010, the AHEI-2010, the 
aMED, and DASH, and all-cause 
mortality, and mortality from 
cardiovascular disease, and 
cancer. 
For all four indices, higher diet quality 
was significantly associated with a 
reduced risk of mortality from all-
causes, CVD, and cancer than lower 
diet quality. This finding was true, 
except for the AHEI-2010 and cancer 
mortality in WHI-OS women which 
was not significant. 
Dietary patterns and visceral adiposity  




Men and women, (n=1,861, 
58-74 years of age) from 
the Multiethnic Cohort 
(MEC), USA.  
Assess the relationship between 
HEI-2010, AHEI-2010, aMED, 
DASH and with adiposity 
measures, especially visceral 
adipose tissue (VAT) and 
nonalcoholic fatty liver (NAFL). 
Maintaining a high-quality diet during 
mid-to-late adulthood may prevent 
adverse metabolic consequences 




Sedentary men and 
women (n=278) with 
abdominal obesity or 
dyslipidemia 
Assess whether distinct lifestyle 
strategies can differentially affect 
specific body adipose depots 
The MED/low carbohydrate diet 
mobilizes specific ectopic fat depots, 
and exercise has an independent 
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APPENDIX B. Hazard ratios (HR) (95% confidence intervals (CI)) for all-cause mortality according to quintiles of Healthy 








HR (95% CI) 
Quintile 3 
HR (95% CI) 
Quintile 4      
  HR (95% CI) 
Quintile 5 
HR (95% CI) 
Men2      
Total Fruits 1.000 0.949 (0.912, 0.986) 0.886 (0.852, 0.922) 0.845 (0.813, 0.880) 0.793 (0.761, 0.825) 
Whole Fruits 1.000  0.928 (0.892, 0.965) 0.881 (0.847, 0.916) 0.842 (0.809, 0.876) 0.787 (0.756, 0.819) 
Total 
Vegetables 
1.000 0.942 (0.905, 0.980) 0.902 (0.867, 0.938) 0.850 (0.816, 0.884) 0.795 (0.763, 0.828) 
Greens & 
Beans 
1.000 0.942 (0.906, 0.980) 0.898 (0.863, 0.934) 0.854 (0.820, 0.889) 0.806 (0.774, 0.840) 
Whole Grains 1.000 0.941 (0.905, 0.979) 0.872 (0.838, 0.907) 0.843 (0.810, 0.877) 0.798 (0.767, 0.830) 
Dairy 1.000 0.944 (0.908, 0.982) 0.910 (0.875, 0.947) 0.844 (0.811, 0.878) 0.808 (0.776, 0.841) 
Total Protein 
Foods 
1.000 0.938 (0.902, 0.976) 0.898 (0.863, 0.934) 0.839 (0.806, 0.874) 0.793 (0.761, 0.825) 
Seafood & 
Plant Proteins 
1.000 0.944 (0.908, 0.982) 0.891 (0.857, 0.928) 0.845 (0.812, 0.879) 0.793 (0.761, 0.826) 
Fatty Acids 1.000 0.938 (0.902, 0.976) 0.893 (0.858, 0.929) 0.857 (0.823, 0.893) 0.805 (0.772, 0.839) 
Refined 
Grains 
1.000 0.903 (0.869, 0.939) 0.864 (0.831, 0.898) 0.816 (0.785, 0.849) 0.748 (0.719, 0.779) 
Sodium 1.000 0.923 (0.887, 0.960) 0.878 (0.844, 0.913) 0.849 (0.816, 0.883) 0.801 (0.769, 0.834) 
Added Sugars 1.000 0.934 (0.898, 0.972) 0.892 (0.858, 0.928) 0.843 (0.810, 0.878) 0.793 (0.761, 0.826) 
Saturated Fats 1.000 0.936 (0.899, 0.974) 0.908 (0.873, 0.945) 0.882 (0.847, 0.918) 0.816 (0.783, 0.851) 
Women3      
Total Fruits 1.000 0.917 (0.880, 0.955) 0.882 (0.847, 0.919) 0.821 (0.788, 0.853) 0.789 (0.757, 0.823) 
Whole Fruits 1.000  0.907 (0.870, 0.945) 0.882 (0.847, 0.919) 0.819 (0.786, 0.853) 0.789 (0.757, 0.823) 
Total 
Vegetables 
1.000 0.917 (0.880, 0.956) 0.875 (0.840, 0.912) 0.836 (0.802, 0.871) 0.792 (0.759, 0.825) 
Greens & 
Beans 
1.000 0.939 (0.901, 0.978) 0.882 (0.846, 0.919) 0.847 (0.812, 0.883) 0.804 (0.771, 0.838) 
Whole Grains 1.000 0.897 (0.861, 0.935) 0.864 (0.829, 0.900) 0.834 (0.801, 0.869) 0.778 (0.747, 0.811) 
Dairy 1.000 0.926 (0.889, 0.965) 0.887 (0.851, 0.924) 0.841 (0.807, 0.877) 0.792 (0.760, 0.826) 
Total Protein 
Foods 
1.000 0.930 (0.892, 0.969) 0.879 (0.844, 0.917) 0.838 (0.804, 0.874) 0.798 (0.765, 0.832) 
Seafood & 
Plant Proteins 
1.000 0.930 (0.892, 0.969) 0.879 (0.844, 0.916) 0.834 (0.800, 0.869) 0.799 (0.767, 0.834) 
Fatty Acids 1.000 0.935 (0.897, 0.974) 0.887 (0.851, 0.924) 0.837 (0.803, 0.873) 0.802 (0.769, 0.837) 
Refined 
Grains 
1.000 0.910 (0.874, 0.947) 0.864 (0.830, 0.900) 0.805 (0.772, 0.838) 0.771 (0.740, 0.804) 
Sodium 1.000 0.902 (0.866, 0.940) 0.844 (0.810, 0.879) 0.825 (0.792, 0.860) 0.774 (0.743, 0.807) 
Added Sugars 1.000 0.950 (0.912, 0.990) 0.888 (0.853, 0.926) 0.843 (0.808, 0.879) 0.804 (0.771, 0.839) 
Saturated Fats 1.000 0.934 (0.896, 0.973) 0.883 (0.847, 0.920) 0.834 (0.800, 0.870) 0.804 (0.771, 0.839) 
1p-trend < 0.0001 for all models. 2Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, 
energy, ethnicity, education, marital status, smoking, weekly hours of moderate to vigorous physical activity, and alcohol 
intake. 3Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, energy, ethnicity, 
education, marital status, smoking, weekly hours of moderate to vigorous physical activity, hormone replacement therapy, 










APPENDIX C. Hazard ratios (HR) (95% confidence intervals (CI)) for cardiovascular disease mortality according to quintiles 





HR           
Quintile 2 
HR (95% CI) 
Quintile 3 
HR (95% CI) 
Quintile 4   
 HR (95% CI) 
Quintile 5  
HR (95% CI) 
Men2      
  Total Fruits 1.000 0.916 (0.857, 0.980) 0.858 (0.803, 0.917) 0.830 (0.776, 0.888) 0.759 (0.709, 0.813) 
  Whole Fruits 1.000  0.878 (0.821, 0.939) 0.840 (0.785, 0.898) 0.829 (0.776, 0.886) 0.742 (0.693, 0.795) 
  Total    
  Vegetables 
1.000 0.903 (0.844, 0.966) 0.881 (0.823, 0.942) 0.845 (0.790, 0.904) 0.756 (0.706, 0.810) 
  Greens &  
  Beans 
1.000 0.907 (0.848, 0.970) 0.883 (0.826, 0.945) 0.852 (0.796, 0.912) 0.775 (0.723, 0.830) 
  Whole Grains 1.000 0.927 (0.867, 0.991) 0.870 (0.814, 0.930) 0.833 (0.779, 0.891) 0.769 (0.718, 0.823) 
  Dairy 1.000 0.937 (0.876, 1.002) 0.892 (0.835, 0.954) 0.837 (0.782, 0.895) 0.779 (0.727, 0.834) 
  Total Protein  
  Foods 
1.000 0.918 (0.857, 0.982) 0.890 (0.832, 0.952) 0.841 (0.786, 0.900) 0.766 (0.715, 0.821) 
  Seafood &     
  Plant Proteins 
1.000 0.925 (0.864, 0.990) 0.888 (0.830, 0.950) 0.855 (0.799, 0.915) 0.772 (0.720, 0.828) 
  Fatty Acids 1.000 0.925 (0.864, 0.990) 0.877 (0.819, 0.939) 0.863 (0.806, 0.924) 0.785 (0.732, 0.842) 
  Refined      
  Grains 
1.000 0.902 (0.844, 0.964) 0.848 (0.793, 0.907) 0.834 (0.780, 0.891) 0.730 (0.682, 0.782) 
  Sodium 1.000 0.899 (0.840, 0.962) 0.864 (0.807, 0.924) 0.867 (0.811, 0.927) 0.791 (0.739, 0.848) 
  Added Sugars 1.000 0.900 (0.841, 0.963) 0.864 (0.808, 0.924) 0.843 (0.788, 0.902) 0.758 (0.708, 0.812) 
Saturated Fats 1.000 0.927 (0.866, 0.993) 0.906 (0.846, 0.970) 0.884 (0.825, 0.947) 0.796 (0.742, 0.854) 
Women3      
  Total Fruits 1.000 0.921 (0.857, 0.988) 0.886 (0.825, 0.950) 0.818 (0.762, 0.879) 0.750 (0.698, 0.806) 
  Whole Fruits 1.000  0.923 (0.860, 0.992) 0.904 (0.842, 0.970) 0.820 (0.764, 0.881) 0.754 (0.702, 0.811) 
  Total  
  Vegetables 
1.000 0.947 (0.881, 1.017) 0.900 (0.838, 0.966) 0.831 (0.773, 0.893) 0.771 (0.717, 0.829) 
  Greens &  
  Beans 
1.000 0.965 (0.899, 1.037) 0.899 (0.836, 0.965) 0.839 (0.780, 0.902) 0.779 (0.725, 0.838) 
  Whole Grains 1.000 0.896 (0.834, 0.962) 0.874 (0.814, 0.938) 0.839 (0.782, 0.901) 0.734 (0.683, 0.788) 
  Dairy 1.000 0.946 (0.880, 1.017) 0.905 (0.843, 0.972) 0.850 (0.791, 0.913) 0.770 (0.716, 0.828) 
  Total Protein  
  Foods 
1.000 0.943 (0.878, 1.013) 0.876 (0.816, 0.941) 0.839 (0.781, 0.902) 0.763 (0.709, 0.820) 
  Seafood &  
  Plant Proteins 
1.000 0.977 (0.910, 1.050) 0.898 (0.836, 0.965) 0.838 (0.780, 0.901) 0.775 (0.720, 0.834) 
  Fatty Acids 1.000 0.957 (0.890, 1.028) 0.901 (0.839, 0.968) 0.845 (0.786, 0.908) 0.772 (0.718, 0.831) 
  Refined                      
  Grains 
1.000 0.902 (0.841, 0.967) 0.894 (0.834, 0.958) 0.777 (0.724, 0.834) 0.737 (0.686, 0.791) 
  Sodium 1.000 0.919 (0.856, 0.987) 0.871 (0.812, 0.935) 0.840 (0.783, 0.902) 0.728 (0.678, 0.782) 
  Added Sugars 1.000 0.976 (0.909, 1.048) 0.899 (0.837, 0.966) 0.840 (0.781, 0.903) 0.770 (0.716, 0.828) 
  Saturated Fats 1.000 0.956 (0.890, 1.028) 0.902 (0.840, 0.970) 0.830 (0.772, 0.893) 0.778 (0.723, 0.837) 
1p-trend < 0.0001 for all models. 2Adjusted for self-reported covariates;  age at study entry, body mass index, history of diabetes, 
energy, ethnicity, education, marital status, smoking, weekly hours of moderate to vigorous physical activity, and alcohol 
intake. 3Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, energy, ethnicity, 
education, marital status, smoking, weekly hours of moderate to vigorous physical activity, hormone replacement therapy, 










APPENDIX D. Hazard ratios (HR) (95% confidence intervals (CI)) for cancer mortality according to quintiles of Healthy Eating 







HR (95% CI) 
Quintile 3 
HR (95% CI) 
Quintile 4   
 HR (95% CI) 
Quintile 5  
HR (95% CI) 
Men2      
  Total Fruits 1.000 0.986 (0.919, 1.058) 0.930 (0.866, 0.999) 0.887 (0.825, 0.953) 0.815 (0.757, 0.878) 
  Whole Fruits 1.000  0.963 (0.897, 1.034) 0.944 (0.879, 1.013) 0.873 (0.812, 0.938) 0.811 (0.752, 0.873) 
  Total  
  Vegetables 
1.000 0.953 (0.888, 1.024) 0.929 (0.865, 0.998) 0.868 (0.808, 0.934) 0.811 (0.752, 0.874) 
  Greens &  
  Beans 
1.000 0.954 (0.888, 1.024) 0.928 (0.864, 0.997) 0.876 (0.815, 0.942) 0.816 (0.757, 0.880) 
  Whole Grains 1.000 0.930 (0.867, 0.998) 0.895 (0.834, 0.961) 0.863 (0.803, 0.927) 0.804 (0.747, 0.865) 
  Dairy 1.000 0.901 (0.839, 0.968) 0.922 (0.859, 0.989) 0.858 (0.799, 0.922) 0.807 (0.750, 0.869) 
  Total Protein  
  Foods 
1.000 0.962 (0.896, 1.032) 0.925 (0.861, 0.993) 0.863 (0.803, 0.929) 0.800 (0.742, 0.862) 
  Seafood &  
  Plant Proteins 
1.000 0.951 (0.886, 1.021) 0.923 (0.860, 0.992) 0.849 (0.789, 0.913) 0.807 (0.749, 0.870) 
  Fatty Acids 1.000 0.955 (0.890, 1.026) 0.931 (0.867, 1.000) 0.847 (0.787, 0.912) 0.812 (0.753, 0.876) 
  Refined        
  Grains 
1.000 0.869 (0.811, 0.932) 0.875 (0.816, 0.938) 0.828 (0.771, 0.889) 0.736 (0.684, 0.793) 
  Sodium 1.000 0.916 (0.853, 0.983) 0.922 (0.859, 0.989) 0.848 (0.789, 0.912) 0.825 (0.766, 0.888) 
  Added Sugars 1.000 0.975 (0.909, 1.046) 0.917 (0.854, 0.985) 0.858 (0.798, 0.923) 0.811 (0.753, 0.874) 
  Saturated Fats 1.000 0.971 (0.904, 1.043) 0.945 (0.879, 1.016) 0.907 (0.843, 0.976) 0.841 (0.780, 0.907) 
Women3      
  Total Fruits 1.000 0.978 (0.907, 1.055) 0.919 (0.852, 0.992) 0.849 (0.785, 0.918) 0.861 (0.796, 0.932) 
  Whole Fruits 1.000  0.946 (0.877, 1.020) 0.903 (0.837, 0.975) 0.841 (0.778, 0.910) 0.849 (0.785, 0.919) 
  Total  
  Vegetables 
1.000 0.922 (0.854, 0.995) 0.897 (0.832, 0.969) 0.837 (0.774, 0.905) 0.832 (0.769, 0.900) 
  Greens &  
  Beans 
1.000 0.932 (0.864, 1.006) 0.901 (0.835, 0.973) 0.862 (0.797, 0.931) 0.838 (0.774, 0.906) 
  Whole Grains 1.000 0.925 (0.858, 0.998) 0.901 (0.835, 0.972) 0.842 (0.779, 0.909) 0.837 (0.774, 0.904) 
  Dairy 1.000 0.933 (0.865, 1.007) 0.909 (0.842, 0.981) 0.849 (0.785, 0.918) 0.841 (0.778, 0.909) 
  Total Protein  
  Foods 
1.000 0.941 (0.872, 1.016) 0.916 (0.849, 0.988) 0.840 (0.777, 0.908) 0.849 (0.785, 0.918) 
  Seafood &     
  Plant Proteins 
1.000 0.928 (0.860, 1.002) 0.904 (0.837, 0.975) 0.839 (0.776, 0.907) 0.840 (0.777, 0.909) 
  Fatty Acids 1.000 0.953 (0.884, 1.028) 0.898 (0.832, 0.970) 0.824 (0.762, 0.891) 0.832 (0.769, 0.901) 
  Refined               
  Grains 
1.000 0.952 (0.884, 1.025) 0.872 (0.808, 0.941) 0.838 (0.776, 0.905) 0.823 (0.762, 0.890) 
  Sodium 1.000 0.908 (0.842, 0.979) 0.861 (0.798, 0.929) 0.849 (0.787, 0.917) 0.830 (0.769, 0.897) 
  Added Sugars 1.000 0.959 (0.889, 1.035) 0.902 (0.835, 0.974) 0.861 (0.796, 0.930) 0.839 (0.775, 0.908) 
  Saturated Fats 1.000 0.958 (0.888, 1.034) 0.933 (0.864, 1.008) 0.841 (0.777, 0.910) 0.858 (0.793, 0.929) 
1p-trend < 0.0001 for all models. 2Adjusted for self-reported covariates;  age at study entry, body mass index, history of diabetes, 
energy, ethnicity, education, marital status, smoking, weekly hours of moderate to vigorous physical activity, and alcohol 
intake. 3Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, energy, ethnicity, 
education, marital status, smoking, weekly hours of moderate to vigorous physical activity, hormone replacement therapy, 








APPENDIX E. Hazard ratios (HR) (95% confidence intervals (CI)) for all-cause, cardiovascular disease (CVD), and cancer 
mortality according to quintiles of Healthy Eating Index-2015 (HEI-2015) scores in men (n = 70,170) stratified by ethnicity in 

























HR (95% CI) 
Men1,2         
White         
Quintile 1 2573 979 45,703 1.003 322 1.003 293 1.004 
Quintile 2  2833 1033 50,771 0.88 (0.81, 0.96) 337 0.86 (0.73, 1.00) 320 0.94 (0.80, 1.11) 
Quintile 3  3113 1093 56,951 0.80 (0.73, 0.87) 376 0.80 (0.69, 0.94) 331 0.87 (0.74, 1.02) 
Quintile 4  3953 1336 72,705 0.76 (0.69, 0.82) 451 0.74 (0.64, 0.85) 421 0.86 (0.74, 1.01) 
Quintile 5  4858 1622 90,356 0.69 (0.64, 0.75) 527 0.65 (0.56, 0.75) 475 0.76 (0.66, 0.89) 
African 
American 
        
Quintile 1 1364 751 21,781 1.003 294 1.003 223 1.005 
Quintile 2  1531 842 24,716 0.92 (0.83, 1.01) 305 0.82 (0.70, 0.96) 269 1.03 (0.86, 1.23) 
Quintile 3  1734 917 28,177 0.88 (0.80, 0.97) 358 0.84 (0.72, 0.98) 268 0.94 (0.78, 1.13) 
Quintile 4  1960 1003 32,351 0.82 (0.75, 0.91) 383 0.78 (0.67, 0.91) 313 0.94 (0.79, 1.12) 
Quintile 5  2425 1198 41,436 0.71 (0.65, 0.79) 453 0.66 (0.57, 0.77) 343 0.79 (0.66, 0.94) 
Native  
Hawaiian 
        
Quintile 1 1344 485 23,921 1.006 186 1.006 154 1.006 
Quintile 2  1041 372 18,638 0.89 (0.78, 1.03) 123 0.74 (0.59, 0.94) 121 1.00 (0.78, 1.27) 
Quintile 3  934 344 16,480 0.93 (0.81, 1.07) 132 0.88 (0.70, 1.11) 104 1.00 (0.77, 1.30) 
Quintile 4  858 348 14,913 0.94 (0.81, 1.08) 129 0.83 (0.66, 1.05) 99 1.02 (0.78, 1.33) 
Quintile 5  815 350 14,276 0.98 (0.85, 1.13) 130 0.88 (0.69, 1.11) 95 1.03 (0.79, 1.35) 
Japanese 
American  
        
Quintile 1 5113 1567 94,659 1.003 496 1.004 514 1.005 
Quintile 2  4572 1598 83,057 0.96 (0.90, 1.03) 511 0.96 (0.85, 1.09) 482 0.96 (0.84, 1.08) 
Quintile 3  4238 1549 76,372 0.87 (0.81, 0.94) 481 0.83 (0.73, 0.94) 458 0.90 (0.80, 1.03) 
Quintile 4  3787 1447 68,387 0.84 (0.78, 0.90) 487 0.85 (0.75, 0.96) 406 0.87 (0.76, 1.00) 
Quintile 5  3529 1455 63,441 0.82 (0.76, 0.89) 477 0.81 (0.71, 0.93) 372 0.83 (0.72, 0.95) 
Latino         
Quintile 1 3640 1221 66,034 1.005 410 1.006 382 1.005 
Quintile 2  4057 1332 73,331 0.95 (0.87, 1.02) 464 0.98 (0.85, 1.12) 406 0.94 (0.82, 1.09) 
Quintile 3  4016 1418 72,093 0.94 (0.87, 1.01) 517 1.00 (0.87, 1.14) 411 0.92 (0.80, 1.06) 
Quintile 4  3475 1221 62,618 0.89 (0.82, 0.97) 444 0.94 (0.82, 1.07) 322 0.81 (0.70, 0.95) 
Quintile 5  2407 895 42,981 0.88 (0.80, 0.96) 337 0.95 (0.81, 1.10) 230 0.79 (0.67, 0.94) 
 1Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, energy, education, marital 
status, smoking, weekly hours of moderate to vigorous physical activity, and alcohol intake. 2Quintile 1 is lowest score and 











APPENDIX F. Hazard ratios (HR) (95% confidence intervals (CI)) for all-cause, cardiovascular disease (CVD), and cancer 
mortality according to quintiles of Healthy Eating Index-2015 (HEI-2015) scores in women (n = 86,634) stratified by ethnicity 

















CVD mortality1  






HR (95% CI) 
Women1,2         
White         
Quintile 1 3270 996 60,739 1.003 276 1.003 307 1.003 
Quintile 2  3430 964 64,502 0.85 (0.78, 0.93) 285 0.87 (0.74, 1.03) 280 0.85 (0.72, 1.00) 
Quintile 3  4066 1128 76,961 0.77 (0.71, 0.84) 379 0.87 (0.75, 1.02) 332 0.82 (0.70, 0.96) 
Quintile 4  4729 1269 90,655 0.71 (0.65, 0.78) 368 0.68 (0.58, 0.80) 356 0.74 (0.63, 0.87) 
Quintile 5  5158 1466 98,501 0.66 (0.60, 0.72) 438 0.63 (0.54, 0.74) 406 0.71 (0.61, 0.84) 
African 
American 
        
Quintile 1 2412 980 42,472 1.003 383 1.003 270 1.004 
Quintile 2  2720 1098 48,874 0.89 (0.81, 0.97) 454 0.92 (0.80, 1.05) 295 0.92 (0.78, 1.09) 
Quintile 3  3108 1272 55,071 0.85 (0.78, 0.93) 493 0.81 (0.71, 0.93) 359 0.97 (0.83, 1.14) 
Quintile 4  3578 1476 64,254 0.82 (0.75, 0.89) 627 0.86 (0.75, 0.98) 375 0.88 (0.75, 1.03) 
Quintile 5  4254 1681 77,482 0.72 (0.67, 0.79) 640 0.67 (0.59, 0.77) 474 0.90 (0.77, 1.05) 
Native  
Hawaiian 
        
Quintile 1 1662 435 31,071 1.004 132 1.004 147 1.004 
Quintile 2  1324 368 24,625 0.96 (0.83, 1.11) 123 0.97 (0.75, 1.25) 110 0.94 (0.73, 1.21) 
Quintile 3  1199 345 22,394 0.88 (0.76, 1.01) 110 0.85 (0.66, 1.11) 98 0.86 (0.66, 1.12) 
Quintile 4  1134 337 21,034 0.85 (0.73, 0.99) 124 0.93 (0.72, 1.21) 88 0.81 (0.61, 1.07) 
Quintile 5  1049 376 19,150 0.97 (0.83, 1.12) 126 0.95 (0.73, 1.23) 104 0.99 (0.75, 1.30) 
Japanese  
American  
        
Quintile 1 5227 1086 102,263 1.005 326 1.006 338 1.004 
Quintile 2  5335 1264 103,320 0.95 (0.88, 1.04) 422 1.02 (0.88, 1.18) 344 0.94 (0.81, 1.10) 
Quintile 3  4984 1291 95,993 0.93 (0.85, 1.01) 428 0.95 (0.82, 1.10) 346 0.96 (0.83, 1.13) 
Quintile 4  4697 1258 90,270 0.87 (0.80, 0.94) 400 0.84 (0.72, 0.98) 310 0.87 (0.74, 1.02) 
Quintile 5  4542 1338 86,923 0.87 (0.80, 0.95) 427 0.84 (0.73, 0.98) 321 0.90 (0.76, 1.06) 
Latina         
Quintile 1 4756 1106 91,007 1.006 376 1.004 336 1.007 
Quintile 2  4517 1115 86,042 0.95 (0.87, 1.03) 353 0.86 (0.74, 1.00) 336 1.01 (0.86, 1.17) 
Quintile 3  3971 984 75,519 0.89 (0.82, 0.98) 337 0.86 (0.73, 1.00) 250 0.82 (0.70, 0.97) 
Quintile 4  3189 779 60,590 0.85 (0.77, 0.93) 263 0.82 (0.70, 0.97) 224 0.89 (0.75, 1.06) 
Quintile 5  2323 654 43,781 0.92 (0.83, 1.02) 242 0.96 (0.81, 1.14) 160 0.83 (0.68, 1.01) 
1Adjusted for self-reported covariates; age at study entry, body mass index, history of diabetes, energy, education, marital 
status, smoking, physical activity, hormone replacement therapy, and alcohol intake.2Quintile 1 is lowest score and quintile 5 
is highest score, HEI ranges shown in Table 2. 3p for trend <0.0001, 4p for trend not significant, 5p for trend <0.001, 6p for trend 











APPENDIX G. Estimated mean and standard deviation of HEI-2015 total scores by ethnic group and sex, the Multiethnic 
Cohorta. 
Ethnic Group Men n Women **** n 
White 67.4 ± 10.4 * 17,330 70.5 ± 10.4 20,653 
African American 67.1 ± 10.4 * 9014 70.9 ± 10.3 16,072 
Native Hawaiian 63.2 ± 10.6 ** 4992 67.1 ± 10.9 6368 
Japanese American 63.7 ± 10.3 *** 21,239 68.3 ± 10.3 24,785 
Latino 63.8 ± 9.3 *** 17,595 66.5 ± 9.8 18,756 
Total group 65.0 ± 10.3 70,170 68.8 ± 10.4 86,634 
a Results based on responses to food frequency questionnaire. * p < 0.01 different from Native 
Hawaiian, Japanese American, Latino; ** p < 0.01 different from all others; *** p < 0.01 different from 
Native Hawaiian, African American, white. **** Among women, each ethnic group significantly 























APPENDIX H. Energy and macronutrient intake among participants completing the study, assessed using 4-day mobile 
food records (mFR™) captured by participants in the IER+MED group and DASH group over three time points 1. 
 Baseline Weeks 5-6 p 2 Week 11 p 3 
Energy (kcal)      
IER+MED 4 1590 ± 78 1167 ± 81 <0.001 1085 ± 65 <0.001 
IER 5  960 ± 81  929 ± 62  
MED 6  1222 ± 93  1144 ± 80  
DASH 1831 ± 115 1479 ± 91 0.004 1578 ± 93 0.003 
Protein (g)      
IER+MED 72.9 ± 3.7 75.3 ± 5.5 0.668 72.6 ± 4.6 0.964 
IER  70.6 ± 6.0  70.7 ± 5.3  
MED  75.0 ± 6.0  71.5 ± 5.2  
DASH 77.1 ± 4.8 69.3 ± 4.5 0.144 74.1 ± 4.3 0.380 
Protein (% energy)      
IER+MED 18.7 ± 0.7 25.8 ± 1.0 <0.001 26.8 ± 1.1 <0.001 
IER  29.5 ± 1.7  30.2 ± 1.4  
MED  24.7 ± 1.1  25.4 ± 1.2  
DASH 17.2 ± 0.7 18.9 ± 0.5 0.060 19.1 ± 0.5 0.002 
Carbohydrate (g)      
IER+MED 182 ± 12 107 ± 8 <0.001 92 ± 7 <0.001 
IER  70 ± 8  63 ± 4  
MED  119 ± 10  103 ± 10  
DASH 201 ± 13 168 ± 12 0.031 177 ± 12 0.023 
Carbohydrate (% energy)      
IER+MED 45.1 ± 1.5 36.4 ± 1.5 <0.001 33.9 ± 1.5 <0.001 
IER  28.7 ± 1.6  28.3 ± 1.8  
MED  39.2 ± 1.7  35.2 ± 2.0  
DASH 44.4 ± 1.3 44.8 ± 1.2 0.747 45.3 ± 1.4 0.497 
Total fat (g)      
IER+MED 64 ± 4 51 ± 4 0.012 49 ± 3 0.001 
IER  46 ± 5  45 ± 4  
MED  51 ± 5  52 ± 4  
DASH 79 ± 6 60 ± 4 0.001 66 ± 5 0.005 
Total fat (% energy)      
IER+MED 36.4 ± 1.2 39.2 ± 1.5 0.150 40.4 ± 1.3 0.015 
IER  43.4 ± 2.3  42.5 ± 1.7  
MED  37.4 ± 1.5  40.9 ± 2.1  
DASH 38.2 ± 1.2 36.4 ± 1.1 0.181 36.5 ± 1.3 0.232 
Saturated fatty acids (% energy)      
IER+MED 11.6 ± 0.5 11.1± 0.6 0.563 11.7 ± 0.6 0.830 
IER  11.2± 0.7  11.4 ± 0.6  
MED  10.9 ± 0.7  11.6 ± 0.8  
DASH 11.6 ± 0.5 10.8 ± 0.4 0.103 11.8 ± 0.5 0.789 
Monounsaturated fatty acids (% 
energy) 
     
IER+MED 13.5 ± 0.4 15.0 ± 0.7 0.065 16.0 ± 0.7 0.001 
IER  16.4 ± 1.0  17.2 ± 0.9  
MED  14.3 ± 0.7  16.9 ± 1.5  
DASH 14.4 ± 0.5 13.3 ± 0.5 0.081 13.7 ± 0.6 0.289 
Polyunsaturated fatty acids (% 
energy) 
     
IER+MED 8.2 ± 0.6 9.5 ± 0.6 0.104 8.7 ± 0.5 0.470 
IER  12.0 ± 1.3  9.8 ± 0.8  
MED  8.8 ± 0.6  8.5 ± 0.7  
DASH 9.1 ± 0.6 9.2 ± 0.6 0.859 7.8 ± 0.5 0.120 
Dietary fiber (g)      
IER+MED 13.0 ± 1.2 12.7 ± 1.0 0.799 11.7 ± 1.0 0.256 
IER  10.5 ± 0.9  9.3 ± 0.8  
MED  13.3 ± 1.1  12.8 ± 1.2  
DASH 13.5 ± 1.1 14.8 ± 1.3 0.420 14.3 ± 0.9 0.473 
Data are presented as mean/day ± standard error of the mean (SEM).   IER+MED: Intermittent energy restriction combined with a 
Mediterranean diet. DASH: Dietary Approaches to Stop Hypertension diet. 1 All data analyzed using a repeated measures mixed model for 
only the 54 participants who completed the study. 2 Within group difference from baseline to Weeks 5-6. 3 Within group difference from 
baseline to Week 11. 4 Weighted for five Mediterranean diet (MED) days and two intermittent energy restriction (IER) days. 5 IER days 






APPENDIX I. Alcohol and micronutrient intake among participants completing the study, assessed using 4-day mobile food records 
(mFR™) captured by participants in the IER+MED group and DASH group over three time points 1. 
 Baseline Weeks 5-6 Week 11 
Alcohol (g)    
IER+MED 2 1.5 ± 0.9 0.4 ± 0.3 0.3 ± 0.2 
IER 3  0.4 ± 0.3 0.1 ± 0.0 
MED 4  0.3 ± 0.3 0.3 ± 0.3 
DASH  2.9 ± 1.4 2.1 ± 1.5 0.6 ± 0.4 
Total retinol (µg)    
IER+MED 232 ± 17 209 ± 23 161 ± 21 
IER  164 ± 18 140 ± 14 
MED  219 ± 25 170 ± 22 
DASH   261 ± 27 267 ± 41 304 ± 36 
Alpha-tocopherol (mg)    
IER+MED 6 ± 0 6 ± 0 6 ± 1 
IER  6 ± 0 6 ± 0 
MED   6 ± 0 6 ± 1 
DASH   8 ± 1 6 ± 1 7 ± 1 
Total alpha carotene (µg)    
IER+MED 367 ± 89 586 ± 131 268 ± 63 
IER  679 ± 188 332 ± 88 
MED   528 ± 140 244 ± 79 
DASH   369 ± 82 484 ± 91 486 ± 116 
Vitamin C (mg)    
IER+MED 62 ± 9 81 ± 9 74 ± 8 
IER  81 ± 9 72 ± 8 
MED   79 ± 9 76 ± 9 
DASH   60 ± 7 60 ± 6 58 ± 5 
Thiamin (mg)    
IER+MED 1.3 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 
IER  0.8 ± 0.1 0.7 ± 0.1 
MED   1.0 ± 0.1 0.9 ± 0.1 
DASH   1.3 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 
Riboflavin (mg)    
IER+MED 1.5 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 
IER  1.3 ± 0.1 1.3 ± 0.1 
MED   1.5 ± 0.1 1.4 ± 0.1 
DASH   1.7 ± 0.2 1.5 ± 0.2 1.7 ± 0.1 
Niacin (mg)    
IER+MED 19 ± 1 18 ± 1 17 ± 1 
IER  16 ± 1 15 ± 1 
MED   18 ± 1 17 ± 1 
DASH   22 ± 2 17 ± 1 19 ± 1 
Vitamin B6 (mg)    
IER+MED 1.5 ± 0.1 1.6 ± 0.1 1.5 ± 0.1 
IER  1.4 ± 0.1 1.2 ± 0.1 
MED   1.6 ± 0.1 1.5 ± 0.1 
DASH   1.7 ± 0.2 1.5 ± 0.2 1.6 ± 0.1 
Folate (µg)    
IER+MED 393 ± 27 306 ± 27 287 ± 26 
IER  273 ± 22 225 ± 14 
MED   310 ± 30 309 ± 27 
DASH   355 ± 25 350 ± 39 428 ± 40 
Vitamin B12 (µg)    
IER+MED 7.0 ± 1.2 5.7 ± 1.4 6.8 ± 2.5 
IER  5.6 ± 1.5 5.4 ± 1.4 







DASH   5.6 ± 0.6 4.1 ± 0.5 4.9 ± 0.7 
Calcium (mg)    
IER+MED 550 ± 36 550 ± 43 517 ± 41 
IER  535 ± 41 481 ± 34 
MED   536 ± 39 527 ± 40 
DASH   586 ± 41 610 ± 67 661 ± 53 
Iron (mg)    
IER+MED 12.9 ± 0.9 10.4 ± 0.7 9.7 ± 1.1 
IER  9.2 ± 0.7 7.6 ± 0.6 
MED   10.5 ± 0.8 10.6 ± 1.0 
DASH   12.5 ± 0.9 10.8 ± 1.1 12.2 ± 1.0 
Magnesium (mg)    
IER+MED 240 ± 16 233 ± 20 197 ± 15 
IER  210 ± 17 165 ± 10 
MED   236 ± 17 215 ± 14 
DASH   254 ± 18 233 ± 20 259 ± 18 
Phosphorus (mg)    
IER+MED 995 ± 46 1002 ± 72 943 ± 61 
IER  912 ± 59 860 ± 49 
MED   1006 ± 67 974 ± 58 
DASH   1095 ± 69 994 ± 84 1099 ± 71 
Selenium (µg)    
IER+MED 107 ± 6 97 ± 9 90 ± 7 
IER  83 ± 7 87 ± 7 
MED   99 ± 9 91 ± 7 
DASH   111 ± 7 94 ± 7 102 ± 5 
Zinc (mg)    
IER+MED 9.8 ± 0.6 8.5 ± 0.6 8.3 ± 0.5 
IER  7.1 ± 0.5 6.9 ± 0.4 
MED   8.8 ± 0.6 8.9 ± 0.6 
DASH   10.3 ± 0.8 8.8 ± 0.8 9.9 ± 0.8 
Data are presented as mean/day ± standard error of the mean (SEM). IER+MED: Intermittent energy restriction combined with a 
Mediterranean diet. DASH: Dietary Approaches to Stop Hypertension diet. 1Analyzed using data from participants at baseline 
(IER+MED, n=30; DASH, n=30), and participants remaining in the study at Weeks 5-6 (IER+MED, n=26;  DASH, n=30), and Week 11 
(IER+MED, n=26;  DASH, n=28). 2 Weighted for five Mediterranean diet (MED) days and two intermittent energy restriction (IER) days. 









APPENDIX J. Proportion of participants meeting US EAR for vitamin and mineral intake, assessed using 4-day mobile food records 
(mFR™) captured by participants in the IER+MED group and DASH group over three time points 1. 
 Baseline Weeks 5-6 Week 11 
Calcium (mg)    
IER+MED 2 5 (16.7) 2 (8.0) 2 (8.0) 
DASH 8 (26.7) 10 (33.3) 10 (35.7) 
Vitamin C (mg)    
IER+MED  9 (30.0) 13 (52.0) 13 (52.0) 
DASH 8 (26.7) 13 (43.3) 12 (42.9) 
Alpha-tocopherol (mg)    
IER+MED 2 (6.7) 0 (0.0) 1 (4.0) 
DASH 3 (10.0) 1 (3.3) 2 (7.1) 
Thiamin (mg)    
IER+MED 25 (83.3) 15 (60.0) 10 (40.0) 
DASH 24 (80.0) 16 (53.3) 26 (92.9) 
Riboflavin (mg)    
IER+MED 27 (90.0) 22 (91.7) 21 (84.0) 
DASH 29 (96.7) 21 (72.4) 27 (96.4) 
Niacin (mg)    
IER+MED 26 (86.7) 22 (88.0) 22 (88.0) 
DASH 28 (93.3) 25 (83.3) 26 (92.9) 
Vitamin B6 (mg)    
IER+MED 20 (66.7) 17 (68.0) 16 (64.0) 
DASH 25 (83.3) 19 (63.3) 23 (82.1) 
Folate (µg)    
IER+MED 21 (70.0) 11 (44.0) 9 (36.0) 
DASH 16 (53.3) 12 (40.0) 19 (67.9) 
Vitamin B12 (µg)    
IER+MED 29 (96.7) 22 (88.0) 23 (92.0) 
DASH 29 (96.7) 24 (80.0) 24 (85.7) 
Iron (mg)    
IER+MED 27 (90.0) 22 (88.0) 20 (80.0) 
DASH 27 (90.0) 21 (70.0) 25 (89.3) 
Magnesium (mg)    
IER+MED 9 (30.0) 5 (20.0) 5 (20.0) 
DASH 5 (16.7) 10 (33.3) 11 (39.3) 
Phosphorus (mg)    
IER+MED 29 (96.7) 23 (92.0) 21 (84.0) 
DASH 30 (100.0) 24 (80.0) 26 (92.9) 
Selenium (µg)    
IER+MED 29 (96.7) 23 (92.0) 22 (88.0) 
DASH 30 (100.0) 27 (90.0) 28 (100.0) 
Zinc (mg)    
IER+MED 21 (70.0) 16 (64.0) 14 (56.0) 
DASH 23 (76.7) 17 (56.7) 22 (78.6) 
Data are presented as number (%). IER+MED: Intermittent energy restriction combined with a Mediterranean diet. DASH: Dietary 
Approaches to Stop Hypertension diet.1 Analyzed using data from participants in the study at baseline (IER+MED, n=30; DASH, 
n=30), and participants remaining in the study at Weeks 5-6 (IER+MED, n=26; DASH, n=30), and Week 11 (IER+MED, n=26; DASH, 








APPENDIX K. Baseline, Week 12, and change in body measures within and between trial groups, among participants 
completing the IER+MED (n = 26) or DASH diet (n = 28) 1. 
 Baseline Week 12 p 2 Change p 3 
Weight (kg)      
IER+MED  81.0 ± 2.4 75.1 ± 2.4 <0.001 -5.9 ± 0.7 0.005 
DASH   80.4 ± 2.3 77.2 ± 2.3 <0.001 -3.2 ± 0.6  
Body mass index (kg/m2)      
IER+MED 30.8 ± 0.6 28.6 ± 0.6 <0.001 -2.2 ± 0.2 0.001 
DASH 30.6 ± 0.6 29.4 ± 0.6 <0.001 -1.2 ± 0.2  
Waist circumference (cm)      
IER+MED 101.0 ± 1.7 94.0 ± 1.7 <0.001 -7.0 ± 0.8 0.020 
DASH   100.2 ± 1.6 95.7 ± 1.6 <0.001 - 4.5 ± 0.7  
Hip circumference (cm)      
IER+MED 107.9 ± 1.4 102.7 ± 1.4 <0.001 -5.3 ± 0.5 0.019 
DASH   107.0 ± 1.4 103.6 ± 1.4 <0.001 -3.4 ± 0.5  
Body fat (%)       
IER+MED 32.9 ± 1.3 30.9 ± 1.3 <0.001 -2.0 ± 0.4 0.023 
DASH   32.9 ± 1.2 32.1 ± 1.2 0.024 -0.8 ± 0.4  
Fat mass (kg)      
IER+MED 26.6 ± 1.2 23.3 ± 1.2 <0.001 -3.3 ± 0.4 0.004 
DASH   26.2 ± 1.2 24.6 ± 1.2 <0.001 -1.6 ± 0.4  
Muscle mass (kg)       
IER+MED 22.4 ± 1.0 21.3 ± 1.0 <0.001 -1.1 ± 0.2 0.012 
DASH   22.2 ± 1.0 21.7 ± 1.0 0.005 -0.5 ± 0.2  
Total lean body mass (kg)       
IER+MED 54.1 ± 2.0 51.8 ± 2.0 <0.001 -2.3 ± 0.4 0.041 
DASH   53.9 ± 1.8 52.7 ± 1.9 0.002 -1.2 ± 0.4  
Visceral adipose tissue area (cm2)       
IER+MED 136.0 ± 6.2 113.2 ± 6.2 <0.001 -22.8 ± 3.6 0.014 
DASH   130.1 ± 6.0 120.0 ± 6.0 0.006 -10.0 ± 3.5  
Subcutaneous adipose tissue area 
(cm2)  
     
IER+MED 375.5 ± 17.8 327.1 ± 17.8 <0.001 -48.4 ± 6.4 <0.001 
DASH   355.2 ± 17.1 340.4 ± 17.1 0.020 -15.0 ± 6.1  
VAT/SAT ratio 6      
IER+MED 0.38 ± 0.02 0.37 ± 0.02 0.146 -0.01 ± 0.01 0.892 
DASH   0.38 ± 0.02 0.37 ± 0.02 0.090 -0.01 ± 0.01  
Data are presented as mean ± standard error of the mean (SEM).  IER+MED: Intermittent energy 
restriction combined with a Mediterranean diet. DASH: Dietary Approaches to Stop Hypertension 
diet.1All data analyzed using a repeated measures mixed model for only the 54 participants who 
completed the study. 2 Within group difference from baseline to Week 12. 3 Between group difference 
(IER+MED vs. DASH) from baseline to Week 12. 6 Ratio of visceral adipose tissue area to subcutaneous 
adipose tissue area.  
 
 
